proposal_master_skey,director_master_skey,final_key,job_number,issuer_name,service,cusip6,mt_date,ml_date,record_date,mgmt_rec,proposal
2243324,-1,"2025-03-11||28252B||To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve any of the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve the adjournment of the Special Meeting to a later date if necessary to solicit additional proxies if there are not sufficient votes to approve any of the foregoing proposals at the time of the Special Meeting, or any adjournment or postponement thereof."
2243329,-1,"2025-03-11||28252B||The proposal updates the terms of October Series A & Series B warrants issued on October 30, 2024. For the Series A Warrants, both the exercise price and Floor Price are adjusted to $0.81, with an increase in the number of underlying common shares to maintain the overall exercise value. This adjustment is subject to modifications due to events like stock splits, combinations, & recapitalizations. Similarly, for Series B Warrants, exercise price & Floor Price are set at $0.54, with corresponding increases in common shares to preserve aggregate exercise value.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"The proposal updates the terms of October Series A & Series B warrants issued on October 30, 2024. For the Series A Warrants, both the exercise price and Floor Price are adjusted to $0.81, with an increase in the number of underlying common shares to maintain the overall exercise value. This adjustment is subject to modifications due to events like stock splits, combinations, & recapitalizations. Similarly, for Series B Warrants, exercise price & Floor Price are set at $0.54, with corresponding increases in common shares to preserve aggregate exercise value."
2243423,-1,"2025-03-11||28252B||To approve Amendment No. 3 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve to 5,000,000 common shares.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve Amendment No. 3 to the 1847 Holdings LLC 2023 Equity Incentive Plan to increase the share reserve to 5,000,000 common shares."
2243339,-1,"2025-03-11||28252B||Approval has been granted to issue all common shares related to the exercise of Pre-funded warrants, December Series A warrants, and December Series B warrants, all of which were issued on December 16, 2024. This approval encompasses shares issued due to adjustments in warrant terms, including voluntary price adjustments, modifications after a Share Combination Event, changes following the Reset Date, issuance adjustments after a Dilutive Issuance, and alternative cashless exercise provisions.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"Approval has been granted to issue all common shares related to the exercise of Pre-funded warrants, December Series A warrants, and December Series B warrants, all of which were issued on December 16, 2024. This approval encompasses shares issued due to adjustments in warrant terms, including voluntary price adjustments, modifications after a Share Combination Event, changes following the Reset Date, issuance adjustments after a Dilutive Issuance, and alternative cashless exercise provisions."
2243311,-1,"2025-03-11||28252B||To approve Amendment No. 4 to the Second Amended and Restated Operating Agreement of the Company to increase the number of authorized common shares to 2,000,000,000 shares.||-1||-1",S06269,1847 HOLDINGS LLC,BD,28252B,3/11/2025,2/4/2025,1/22/2025,F,"To approve Amendment No. 4 to the Second Amended and Restated Operating Agreement of the Company to increase the number of authorized common shares to 2,000,000,000 shares."
-1,1298195,2025-04-08||831865||03||Lois M. Martin,P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,,
2246653,-1,"2025-04-08||831865||Stockholder proposal requesting a Board report on our hiring practices with respect to formerly incarcerated people, if properly presented at the Annual Meeting.||-1||-1",P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,N,"Stockholder proposal requesting a Board report on our hiring practices with respect to formerly incarcerated people, if properly presented at the Annual Meeting."
2246719,-1,2025-04-08||831865||Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation.||-1||-1,P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,F,Proposal to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of the corporation.
-1,1298131,2025-04-08||831865||04||Adrian I. Peace,P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,,
2246616,-1,"2025-04-08||831865||Proposal to approve, by nonbinding advisory vote, the compensation of our named executive officers.||-1||-1",P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,F,"Proposal to approve, by nonbinding advisory vote, the compensation of our named executive officers."
-1,1298067,2025-04-08||831865||02||Michael M. Larsen,P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,,
-1,1298196,2025-04-08||831865||01||Todd W. Fister,P25806,A.O. SMITH CORPORATION,BN,831865,4/8/2025,2/28/2025,2/18/2025,,
2248540,-1,2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. Chung||-1||-1,P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Peter Y. Chung
2248860,-1,2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad Trivedi||-1||-1,P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Dhrupad Trivedi
2248735,-1,"2025-04-17||002121||To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2025.||-1||-1",P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,"To ratify the appointment of Grant Thornton LLP as our independent public accounting firm for our fiscal year ending December 31, 2025."
2248472,-1,2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Dana Wolf||-1||-1,P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Dana Wolf
2248569,-1,"2025-04-17||002121||To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares available for issuance by 2,500,000 shares.||-1||-1",P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,"To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares available for issuance by 2,500,000 shares."
2249043,-1,"2025-04-17||002121||To approve, on an advisory and non-binding basis, the compensation of our named executive officers.||-1||-1",P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,"To approve, on an advisory and non-binding basis, the compensation of our named executive officers."
2248675,-1,2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham||-1||-1,P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Tor R. Braham
2249054,-1,2025-04-17||002121||Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer||-1||-1,P24770,"A10 NETWORKS, INC.",BN,002121,4/17/2025,3/12/2025,2/21/2025,F,Election of Director to serve until the 2026 annual meeting of stockholders and until their successors are duly elected and qualified: Eric Singer
2232717,-1,2024-12-31||655187||Proposal to amend our certificate of incorporation to effect a reverse stock split.||-1||-1,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,Proposal to amend our certificate of incorporation to effect a reverse stock split.
-1,1292219,2024-12-31||655187||01||Jeffrey Thramann,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
2232821,-1,"2024-12-31||655187||The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024.||-1||-1",P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,"The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024."
2232701,-1,"2024-12-31||655187||Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Amended Equity line of Credit.||-1||-1",P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,"Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Amended Equity line of Credit."
2232755,-1,2024-12-31||655187||To approve an amendment to the Company's 2022 Equity Incentive Plan.||-1||-1,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,To approve an amendment to the Company's 2022 Equity Incentive Plan.
2243646,-1,"2025-03-05||655187||Proposal to grant discretionary authority to our board of directors to (i) amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 200,000,000 shares to 300,000,000 shares and (ii) effect such amendment, if at all, within one year of the date the proposal is approved by stockholders.||-1||-1",Z89237,"ACLARION, INC.",BN,655187,3/5/2025,2/5/2025,1/7/2025,F,"Proposal to grant discretionary authority to our board of directors to (i) amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 200,000,000 shares to 300,000,000 shares and (ii) effect such amendment, if at all, within one year of the date the proposal is approved by stockholders."
-1,1292217,2024-12-31||655187||05||David Neal,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
2243618,-1,"2025-03-05||655187||Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, issuable by the Company upon exercise of the Series A Common Warrants and the Series B Common Warrants.||-1||-1",Z89237,"ACLARION, INC.",BN,655187,3/5/2025,2/5/2025,1/7/2025,F,"Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, issuable by the Company upon exercise of the Series A Common Warrants and the Series B Common Warrants."
-1,1292243,2024-12-31||655187||02||Brent Ness,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
-1,1292232,2024-12-31||655187||07||Amanda Williams,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
-1,1292257,2024-12-31||655187||04||Stephen Deitsch,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
2232838,-1,"2024-12-31||655187||To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal.||-1||-1",P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,"To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal."
2243710,-1,"2025-03-05||655187||Proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies.||-1||-1",Z89237,"ACLARION, INC.",BN,655187,3/5/2025,2/5/2025,1/7/2025,F,"Proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies."
2232839,-1,"2024-12-31||655187||To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, pursuant to our Series C Preferred Issuance Proposal.||-1||-1",P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,F,"To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, pursuant to our Series C Preferred Issuance Proposal."
-1,1292267,2024-12-31||655187||03||Scott Breidbart,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
-1,1292262,2024-12-31||655187||06||William Wesmann,P21745,"ACLARION, INC.",BN,655187,12/31/2024,12/5/2024,11/15/2024,,
-1,1303985,2025-04-21||004816||07||Paul J. Conway,P26738,ACME UNITED CORPORATION,SH,004816,4/21/2025,3/25/2025,3/5/2025,,
-1,1303617,2025-04-21||004816||03||Brian S. Olschan,P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
2270340,-1,"2025-04-21||004816||Ratification of the appointment of CBIZ CPAs, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,F,"Ratification of the appointment of CBIZ CPAs, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2025."
-1,1303530,2025-04-21||004816||05||Rex L. Davidson,P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
-1,1303471,2025-04-21||004816||04||Susan H. Murphy,P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
-1,1303718,2025-04-21||004816||01||Walter C. Johnsen,P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
-1,1303720,2025-04-21||004816||06||Brian K. Barker,P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
-1,1303496,"2025-04-21||004816||02||Richmond Y. Holden, Jr.",P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,,
2270683,-1,"2025-04-21||004816||Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement.||-1||-1",P26614,ACME UNITED CORPORATION,BN,004816,4/21/2025,3/25/2025,3/5/2025,F,"Approval, by non-binding advisory vote, of the compensation of the named executive officers of the Company as described in the Proxy Statement."
2242682,-1,"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the ""July Warrant Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,007025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying common stock purchase warrants originally issued by the Company in July 2024 (the ""July Warrant Proposal"")."
2242713,-1,"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the ""Series A-1 Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,007025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series A-1 Convertible Preferred Stock originally issued by the Company in December 2023 (the ""Series A-1 Proposal"")."
2242806,-1,"2025-04-17||007025||To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the ""Series C-1 Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,007025,4/17/2025,1/31/2025,1/23/2025,F,"To approve, for the purpose of Nasdaq Marketplace Rule 5635(d), the issuance of shares of common stock underlying shares of Series C-1 Convertible Preferred Stock and common stock purchase warrants originally issued by the Company in May 2024 and August 2024 (the ""Series C-1 Proposal"")."
2242731,-1,"2025-04-17||007025||To grant discretionary authority to our BOD to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our BOD in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").||-1||-1",Z89366,"ADITXT, INC.",BN,007025,4/17/2025,1/31/2025,1/23/2025,F,"To grant discretionary authority to our BOD to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1:5) to a maximum of a one-for-two hundred fifty (1:250) split, with the exact ratio to be determined by our BOD in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"")."
2242798,-1,"2025-04-17||007025||To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals.||-1||-1",Z89366,"ADITXT, INC.",BN,007025,4/17/2025,1/31/2025,1/23/2025,F,"To authorize the adjournment of the Special Meeting if necessary or appropriate, including to solicit additional proxies in the event that there are not sufficient votes at the time of the Special Meeting or adjournment or postponement thereof to approve any of the foregoing proposals."
2249948,-1,"2025-04-22||00724F||Approve, on an advisory basis, the compensation of our named executive officers.||-1||-1",P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,"Approve, on an advisory basis, the compensation of our named executive officers."
2250283,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Amy Banse||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Amy Banse
2250367,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Daniel Rosensweig||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Daniel Rosensweig
2250252,-1,"2025-04-22||00724F||Approve the 2019 Equity Incentive Plan, as amended, to increase the available share reserve by 7 million shares.||-1||-1",P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,"Approve the 2019 Equity Incentive Plan, as amended, to increase the available share reserve by 7 million shares."
2250363,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Spencer Neumann||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Spencer Neumann
2250401,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Melanie Boulden||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Melanie Boulden
2250126,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: David Ricks||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: David Ricks
2250616,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Kathleen Oberg||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Kathleen Oberg
2250289,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Dheeraj Pandey||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Dheeraj Pandey
2250251,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Shantanu Narayen||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Shantanu Narayen
2250573,-1,"2025-04-22||00724F||Ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending on November 28, 2025.||-1||-1",P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,"Ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending on November 28, 2025."
2250472,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Laura Desmond||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Laura Desmond
2249971,-1,2025-04-22||00724F||Stockholder Proposal Regarding Vote on Golden Parachutes.||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,N,Stockholder Proposal Regarding Vote on Golden Parachutes.
2250200,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Frank Calderoni||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Frank Calderoni
2250325,-1,2025-04-22||00724F||Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Cristiano Amon||-1||-1,P23154,ADOBE INC.,BN,00724F,4/22/2025,3/11/2025,2/21/2025,F,Election of Director proposed in the accompanying Proxy Statement to serve for a one-year term: Cristiano Amon
2242207,-1,"2025-02-24||00791X||To approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock, par value $0.0001 (the ""Common Stock"") from 500,000,000 to 1,040,000,000 (the ""Authorized Share Increase Proposal"").||-1||-1",P24523,"AEON BIOPHARMA, INC.",BN,00791X,2/24/2025,1/29/2025,1/7/2025,F,"To approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock, par value $0.0001 (the ""Common Stock"") from 500,000,000 to 1,040,000,000 (the ""Authorized Share Increase Proposal"")."
2242726,-1,"2025-02-24||00791X||To authorize, for purposes of complying with NYSE American listing rule 711.05, the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on January 7, 2025 (the ""Issuance Proposal"").||-1||-1",Z89286,"AEON BIOPHARMA, INC.",SH,00791X,2/24/2025,2/3/2025,1/13/2025,F,"To authorize, for purposes of complying with NYSE American listing rule 711.05, the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on January 7, 2025 (the ""Issuance Proposal"")."
2242162,-1,"2025-02-24||00791X||To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Authorized Share Increase Proposal, Reverse Stock Split Proposal, or the Issuance Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, the Authorized Share Increase Proposal or the Issuance Proposal (the ""Adjournment Proposal"").||-1||-1",P24523,"AEON BIOPHARMA, INC.",BN,00791X,2/24/2025,1/29/2025,1/7/2025,F,"To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Authorized Share Increase Proposal, Reverse Stock Split Proposal, or the Issuance Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, the Authorized Share Increase Proposal or the Issuance Proposal (the ""Adjournment Proposal"")."
2242259,-1,"2025-02-24||00791X||To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five to a maximum of a one-for- one hundred fifty, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders.||-1||-1",P24523,"AEON BIOPHARMA, INC.",BN,00791X,2/24/2025,1/29/2025,1/7/2025,F,"To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five to a maximum of a one-for- one hundred fifty, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders."
2242102,-1,2025-03-13||00846U||To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.||-1||-1,P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,F,To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.
2242124,-1,2025-03-13||00846U||To elect each director annually.||-1||-1,P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,/,To elect each director annually.
2242277,-1,"2025-03-13||00846U||Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D.||-1||-1",P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,F,"Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D."
2242151,-1,"2025-03-13||00846U||To approve, on a non-binding advisory basis, the compensation of our named executive officers.||-1||-1",P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,F,"To approve, on a non-binding advisory basis, the compensation of our named executive officers."
2242166,-1,"2025-03-13||00846U||Election of Director for a three-year term: Otis W. Brawley, M.D.||-1||-1",P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,F,"Election of Director for a three-year term: Otis W. Brawley, M.D."
2242171,-1,2025-03-13||00846U||To approve the amendments to Agilent's Second Amended and Restated Certificate of Incorporation to remove supermajority voting requirements.||-1||-1,P23205,"AGILENT TECHNOLOGIES, INC.",BN,00846U,3/13/2025,1/31/2025,1/23/2025,F,To approve the amendments to Agilent's Second Amended and Restated Certificate of Incorporation to remove supermajority voting requirements.
2308137,-1,"2025-04-30||00901B||To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio of up to 1-for-100, such ratio to be determined by our Board of Directors in its sole discretion. We refer to this proposal as the ""Reverse Stock Split Proposal"" or ""Proposal 1.""||-1||-1",S12000,AIM IMMUNOTECH INC.,BN,00901B,4/30/2025,4/10/2025,3/25/2025,F,"To approve a series of alternate amendments to our Certificate of Incorporation to effect, at the option of our Board of Directors, a reverse stock split of our outstanding common stock at a ratio of up to 1-for-100, such ratio to be determined by our Board of Directors in its sole discretion. We refer to this proposal as the ""Reverse Stock Split Proposal"" or ""Proposal 1."""
2262880,-1,2025-05-02||00912X||Election of Director: Cheryl Gordon Krongard||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Cheryl Gordon Krongard
2262108,-1,2025-05-02||00912X||Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2025.||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Ratify the appointment of KPMG LLP as our independent registered public accounting firm for 2025.
2263246,-1,2025-05-02||00912X||Election of Director: Steven F. Udvar-Házy||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Steven F. Udvar-Házy
2263112,-1,2025-05-02||00912X||Election of Director: Marshall O. Larsen||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Marshall O. Larsen
2262489,-1,2025-05-02||00912X||Advisory vote to approve named executive officer compensation||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Advisory vote to approve named executive officer compensation
2262299,-1,2025-05-02||00912X||Election of Director: Robert A. Milton||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Robert A. Milton
2263007,-1,2025-05-02||00912X||Election of Director: Matthew J. Hart||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Matthew J. Hart
2262476,-1,2025-05-02||00912X||Election of Director: Yvette H. Clark||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Yvette H. Clark
2262499,-1,2025-05-02||00912X||Election of Director: Susan McCaw||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Susan McCaw
2262485,-1,2025-05-02||00912X||Election of Director: Ian M. Saines||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: Ian M. Saines
2262152,-1,2025-05-02||00912X||Election of Director: John L. Plueger||-1||-1,P27232,AIR LEASE CORPORATION,BN,00912X,5/2/2025,3/26/2025,3/7/2025,F,Election of Director: John L. Plueger
2238576,-1,"2025-02-28||016230||Approval of the amendment and restatement of the Alico, Inc. Stock Incentive Plan of 2015.||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Approval of the amendment and restatement of the Alico, Inc. Stock Incentive Plan of 2015."
2238606,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Benjamin D. Fishman||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Benjamin D. Fishman"
2238015,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: W. Andrew Krusen, Jr.||-1||-1",P22290,"ALICO, INC.",SH,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: W. Andrew Krusen, Jr."
2238700,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: George R. Brokaw||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: George R. Brokaw"
2238646,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: John E. Kiernan||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: John E. Kiernan"
2238578,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Henry R. Slack||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Henry R. Slack"
2238625,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Adam H. Putnam||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Adam H. Putnam"
2238659,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Katherine R. English||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Katherine R. English"
2238613,-1,"2025-02-28||016230||Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Toby K. Purse||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Election of Director to serve until the 2026 Annual Meeting of Shareholders, and until their respective successors have been duly elected and qualified: Toby K. Purse"
2238570,-1,"2025-02-28||016230||Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P22270,"ALICO, INC.",BN,016230,2/28/2025,1/21/2025,1/3/2025,F,"Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025."
2243614,-1,2025-03-05||032332||Election of Director: Robert C. Daigle||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,Election of Director: Robert C. Daigle
2243668,-1,"2025-03-05||032332||To approve the amendment of the Amtech Systems, Inc. 2022 Equity Incentive Plan.||-1||-1",P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,"To approve the amendment of the Amtech Systems, Inc. 2022 Equity Incentive Plan."
2243718,-1,"2025-03-05||032332||To ratify the appointment of KPMG LLP as our independent registered public accountants for the fiscal year ending September 30, 2025.||-1||-1",P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,"To ratify the appointment of KPMG LLP as our independent registered public accountants for the fiscal year ending September 30, 2025."
2243521,-1,2025-03-05||032332||Election of Director: Asif Jakwani||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,Election of Director: Asif Jakwani
2243355,-1,2025-03-05||032332||To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement.||-1||-1,P21223,"AMTECH SYSTEMS, INC.",SH,032332,3/5/2025,2/5/2025,1/13/2025,F,To approve the advisory (non-binding) resolution relating to the named executive officer compensation as disclosed in the accompanying proxy statement.
2243600,-1,2025-03-05||032332||Election of Director: Robert M. Averick||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,Election of Director: Robert M. Averick
2243689,-1,2025-03-05||032332||Election of Director: Michael Garnreiter||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,Election of Director: Michael Garnreiter
2243658,-1,2025-03-05||032332||Election of Director: Michael M. Ludwig||-1||-1,P20476,"AMTECH SYSTEMS, INC.",BN,032332,3/5/2025,2/6/2025,1/13/2025,F,Election of Director: Michael M. Ludwig
-1,1296695,2025-03-20||03528H||01||Dr. Amit Kumar,P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,,
-1,1296680,2025-03-20||03528H||03||Emily Gottschalk,P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,,
-1,1296649,"2025-03-20||03528H||04||Lewis H. Titterton, Jr.",P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,,
2242905,-1,"2025-03-20||03528H||To approve on a non-binding, advisory basis the compensation of our named executive officers.||-1||-1",P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,F,"To approve on a non-binding, advisory basis the compensation of our named executive officers."
2242978,-1,"2025-03-20||03528H||To ratify the appointment by the Board of Haskell & White LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2025.||-1||-1",P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,F,"To ratify the appointment by the Board of Haskell & White LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2025."
-1,1296717,2025-03-20||03528H||02||Dr. Arnold Baskies,P22298,"ANIXA BIOSCIENCES, INC.",BN,03528H,3/20/2025,2/11/2025,1/23/2025,,
2232829,-1,"2025-02-28||03815U||Approval, in accordance with Nasdaq Listing Rule 5635(d), of the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024.||-1||-1",S01991,"APPLIED DNA SCIENCES, INC.",BN,03815U,2/28/2025,12/13/2024,11/25/2024,F,"Approval, in accordance with Nasdaq Listing Rule 5635(d), of the exercisability of certain common stock purchase warrants, and the issuance of the common stock underlying such warrants, which warrants were issued in connection with an offering of securities of the Company that occurred on October 30, 2024."
2231974,-1,"2024-12-30||05072K||To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Series B Preferred Issuance Proposal."
-1,1292033,2024-12-30||05072K||04||Timothy Hanlon,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,,
-1,1292021,2024-12-30||05072K||02||Michael Lawless,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,,
-1,1292050,2024-12-30||05072K||01||Jeffrey Thramann,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,,
2232010,-1,2024-12-30||05072K||Proposal to amend the Company's certificate of incorporation to effect the reverse stock split.||-1||-1,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,Proposal to amend the Company's certificate of incorporation to effect the reverse stock split.
-1,1292053,2024-12-30||05072K||03||Stephen Deitsch,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,,
-1,1292020,2024-12-30||05072K||05||Thomas Birch,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,,
2232134,-1,"2024-12-30||05072K||To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock in connection with the Bridge Note Conversion Issuance Proposal.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"To authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock in connection with the Bridge Note Conversion Issuance Proposal."
2320819,-1,2025-05-02||05072K||Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to effect the reverse stock split.||-1||-1,S12670,AUDDIA INC,BN,05072K,5/2/2025,4/18/2025,4/4/2025,F,Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to effect the reverse stock split.
2321090,-1,"2025-05-02||05072K||Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 100,000,000 shares to 250,000,000 shares.||-1||-1",S12670,AUDDIA INC,BN,05072K,5/2/2025,4/18/2025,4/4/2025,F,"Proposal to grant discretionary authority to our board of directors to amend our Certificate of Incorporation to increase the number of our authorized shares of common stock from 100,000,000 shares to 250,000,000 shares."
2321281,-1,"2025-05-02||05072K||Proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies.||-1||-1",S12670,AUDDIA INC,BN,05072K,5/2/2025,4/18/2025,4/4/2025,F,"Proposal to adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies."
2232077,-1,2024-12-30||05072K||To approve an amendment to the Company's 2020 Equity Incentive Plan.||-1||-1,P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,To approve an amendment to the Company's 2020 Equity Incentive Plan.
2232054,-1,"2024-12-30||05072K||The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"The ratification of the appointment of Haynie & Company as the Company's independent registered public accounting firm for the year ending December 31, 2024."
2231997,-1,"2024-12-30||05072K||Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Equity Line of Credit.||-1||-1",P20766,AUDDIA INC,BN,05072K,12/30/2024,12/2/2024,11/14/2024,F,"Proposal to authorize, in accordance with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to the Company's Equity Line of Credit."
2253131,-1,2025-04-23||05329W||Election of Director: Claire Bennett||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Claire Bennett
2253086,-1,2025-04-23||05329W||Election of Director: G. Mike Mikan||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: G. Mike Mikan
2252759,-1,2025-04-23||05329W||Election of Director: David B. Edelson||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: David B. Edelson
2253506,-1,2025-04-23||05329W||Election of Director: Robert R. Grusky||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Robert R. Grusky
2253432,-1,2025-04-23||05329W||Election of Director: Michael Manley||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Michael Manley
2253178,-1,2025-04-23||05329W||Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for 2025.||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for 2025.
2252621,-1,"2025-04-23||05329W||Adoption of stockholder proposal regarding diversity, equity, and inclusion efforts.||-1||-1",P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,N,"Adoption of stockholder proposal regarding diversity, equity, and inclusion efforts."
2253241,-1,2025-04-23||05329W||Advisory vote to approve named executive officer compensation.||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Advisory vote to approve named executive officer compensation.
2253370,-1,2025-04-23||05329W||Election of Director: Lisa Lutoff-Perlo||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Lisa Lutoff-Perlo
2252572,-1,2025-04-23||05329W||Adoption of stockholder proposal regarding political contributions.||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,N,Adoption of stockholder proposal regarding political contributions.
2253188,-1,2025-04-23||05329W||Election of Director: Norman K. Jenkins||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Norman K. Jenkins
2252741,-1,2025-04-23||05329W||Election of Director: Jacqueline A. Travisano||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Jacqueline A. Travisano
2252715,-1,2025-04-23||05329W||Election of Director: Rick L. Burdick||-1||-1,P27482,"AUTONATION, INC.",BN,05329W,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Rick L. Burdick
2253424,-1,2025-04-24||05350V||Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2025.
2253283,-1,2025-04-24||05350V||Election of Director to serve until the 2026 Annual Meeting: Indrani L. Franchini||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Election of Director to serve until the 2026 Annual Meeting: Indrani L. Franchini
2253521,-1,"2025-04-24||05350V||Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares.||-1||-1",P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,"Approval of an amendment to the Company's 2021 Long Term Incentive Plan to increase the number of shares reserved for issuance thereunder by 2,250,000 shares."
2253352,-1,2025-04-24||05350V||Election of Director to serve until the 2026 Annual Meeting: Patrick J. O'Leary||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Election of Director to serve until the 2026 Annual Meeting: Patrick J. O'Leary
2253905,-1,2025-04-24||05350V||Election of Director to serve until the 2026 Annual Meeting: Gary D. Blackford||-1||-1,P25347,"AVANOS MEDICAL,INC.",SH,05350V,4/24/2025,3/14/2025,2/28/2025,F,Election of Director to serve until the 2026 Annual Meeting: Gary D. Blackford
2253038,-1,2025-04-24||05350V||Election of Director to serve until the 2026 Annual Meeting: Dr. Lisa Egbuonu-Davis||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Election of Director to serve until the 2026 Annual Meeting: Dr. Lisa Egbuonu-Davis
2253110,-1,2025-04-24||05350V||Election of Director to serve until the 2026 Annual Meeting: Dr. Julie Shimer||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Election of Director to serve until the 2026 Annual Meeting: Dr. Julie Shimer
2253356,-1,2025-04-24||05350V||Advisory vote to approve named executive officer compensation.||-1||-1,P25357,"AVANOS MEDICAL,INC.",BN,05350V,4/24/2025,3/21/2025,2/28/2025,F,Advisory vote to approve named executive officer compensation.
2240238,-1,"2025-02-20||05479L||To adjourn the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposal.||-1||-1",S07052,"AZITRA, INC.",BN,05479L,2/20/2025,1/21/2025,1/10/2025,F,"To adjourn the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposal."
2240138,-1,"2025-02-20||05479L||To approve an amendment (as set forth on Exhibit A to the Company's Proxy Statement, the ""Reverse Split Amendment"") to our Amended and Restated Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-seven (1:7), with the exact ratio within such range to be determined by the Board of Directors (the ""Reverse Split"").||-1||-1",S07052,"AZITRA, INC.",BN,05479L,2/20/2025,1/21/2025,1/10/2025,F,"To approve an amendment (as set forth on Exhibit A to the Company's Proxy Statement, the ""Reverse Split Amendment"") to our Amended and Restated Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse split of our issued and outstanding shares of common stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-seven (1:7), with the exact ratio within such range to be determined by the Board of Directors (the ""Reverse Split"")."
2239252,-1,2025-02-05||08579W||Election of Director: Stephen E. Sterrett||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Stephen E. Sterrett
2239121,-1,"2025-02-05||08579W||Election of Director: James T. Glerum, Jr.||-1||-1",P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,"Election of Director: James T. Glerum, Jr."
2239215,-1,2025-02-05||08579W||Election of Director: Jill A. Rahman||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Jill A. Rahman
2239117,-1,2025-02-05||08579W||Election of Director: Kevin J. Kwilinski||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Kevin J. Kwilinski
2239224,-1,"2025-02-05||08579W||To approve, on an advisory, non-binding basis, our executive compensation.||-1||-1",P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,"To approve, on an advisory, non-binding basis, our executive compensation."
2239080,-1,2025-02-05||08579W||Election of Director: Chaney M. Sheffield||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Chaney M. Sheffield
2241897,-1,"2025-02-25||08579W||Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the ""Berry Advisory Compensation Proposal.""||-1||-1",S05558,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/25/2025,1/29/2025,1/17/2025,F,"Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the ""Berry Advisory Compensation Proposal."""
2241922,-1,"2025-02-25||08579W||Proposal to adopt the Agreement and Plan of Merger, dated November 19, 2024, as it may be amended from time to time, which is referred to as the ""Merger Agreement,"" by and among Amcor plc, which is referred to as ""Amcor,"" Aurora Spirit, Inc., a wholly-owned subsidiary of Amcor, which is referred to as ""Merger Sub,"" and Berry, which proposal is referred to as the ""Berry Merger Proposal.""||-1||-1",S05558,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/25/2025,1/29/2025,1/17/2025,F,"Proposal to adopt the Agreement and Plan of Merger, dated November 19, 2024, as it may be amended from time to time, which is referred to as the ""Merger Agreement,"" by and among Amcor plc, which is referred to as ""Amcor,"" Aurora Spirit, Inc., a wholly-owned subsidiary of Amcor, which is referred to as ""Merger Sub,"" and Berry, which proposal is referred to as the ""Berry Merger Proposal."""
2239248,-1,"2025-02-05||08579W||To ratify the selection of Ernst & Young LLP as Berry's independent registered public accountants for the fiscal year ending September 27, 2025.||-1||-1",P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,"To ratify the selection of Ernst & Young LLP as Berry's independent registered public accountants for the fiscal year ending September 27, 2025."
2239139,-1,2025-02-05||08579W||Election of Director: Robert A. Steele||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Robert A. Steele
2239231,-1,2025-02-05||08579W||Election of Director: B. Evan Bayh||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: B. Evan Bayh
2239094,-1,2025-02-05||08579W||Election of Director: Jonathan F. Foster||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Jonathan F. Foster
2239074,-1,2025-02-05||08579W||Election of Director: Peter T. Thomas||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Peter T. Thomas
2239068,-1,2025-02-05||08579W||Election of Director: Meredith R. Harper||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Meredith R. Harper
2241932,-1,"2025-02-25||08579W||Proposal to approve the adjournment of the Berry Special Meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Berry Special Meeting to approve the Berry Merger Proposal, which proposal is referred to as the ""Berry Adjournment Proposal.""||-1||-1",S05558,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/25/2025,1/29/2025,1/17/2025,F,"Proposal to approve the adjournment of the Berry Special Meeting, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes at the time of the Berry Special Meeting to approve the Berry Merger Proposal, which proposal is referred to as the ""Berry Adjournment Proposal."""
2239098,-1,2025-02-05||08579W||Election of Director: Idalene F. Kesner||-1||-1,P22484,"BERRY GLOBAL GROUP, INC.",BN,08579W,2/5/2025,1/13/2025,1/6/2025,F,Election of Director: Idalene F. Kesner
2232006,-1,"2025-01-15||09075F||To approve a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the option of our Board of Directors, a reverse split of our common stock at a ratio between 1-for-25 and 1-for-75, inclusive, as determined by our Board of Directors in its sole discretion and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion.||-1||-1",S02517,"BIONANO GENOMICS, INC.",BN,09075F,1/15/2025,12/12/2024,11/21/2024,F,"To approve a series of alternate amendments to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the option of our Board of Directors, a reverse split of our common stock at a ratio between 1-for-25 and 1-for-75, inclusive, as determined by our Board of Directors in its sole discretion and with such reverse stock split to be effected at such time and date, if at all, as determined by our board of directors in its sole discretion."
2232083,-1,"2025-01-15||09075F||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C warrants and Series D warrants.||-1||-1",S02517,"BIONANO GENOMICS, INC.",BN,09075F,1/15/2025,12/12/2024,11/21/2024,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of up to an aggregate of 19,762,226 shares of common stock upon the exercise of certain Series C warrants and Series D warrants."
2253914,-1,"2025-04-23||094235||To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered certified public accounting firm for the fiscal year ending December 28, 2025||-1||-1",P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,"To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered certified public accounting firm for the fiscal year ending December 28, 2025"
2254159,-1,"2025-04-23||094235||To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers||-1||-1",P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,"To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers"
2253941,-1,2025-04-23||094235||Election of Director: R. Michael Mohan||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: R. Michael Mohan
2254349,-1,2025-04-23||094235||Election of Director: Rohit Lal||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Rohit Lal
2253851,-1,2025-04-23||094235||Election of Director: Tara Walpert Levy||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Tara Walpert Levy
2254151,-1,2025-04-23||094235||Election of Director: David George||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: David George
2254356,-1,2025-04-23||094235||To vote on a stockholder proposal regarding virtual stockholder meetings||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,N,To vote on a stockholder proposal regarding virtual stockholder meetings
2253646,-1,2025-04-23||094235||Election of Director: James L. Dinkins||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: James L. Dinkins
2253681,-1,"2025-04-23||094235||To approve the Bloomin' Brands, Inc. 2025 Omnibus Incentive Compensation Plan||-1||-1",P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,"To approve the Bloomin' Brands, Inc. 2025 Omnibus Incentive Compensation Plan"
2254088,-1,2025-04-23||094235||Election of Director: John J. Mahoney||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: John J. Mahoney
2253671,-1,2025-04-23||094235||Election of Director: Melanie Marein-Efron||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Melanie Marein-Efron
2254094,-1,2025-04-23||094235||Election of Director: Julie Kunkel||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Julie Kunkel
2253781,-1,2025-04-23||094235||Election of Director: Michael Spanos||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Michael Spanos
2253819,-1,2025-04-23||094235||Election of Director: Jonathan Sagal||-1||-1,P25294,"BLOOMIN' BRANDS, INC.",BN,094235,4/23/2025,3/17/2025,2/28/2025,F,Election of Director: Jonathan Sagal
2262760,-1,2025-05-01||101137||Election of Director: Michael F. Mahoney||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Michael F. Mahoney
2262887,-1,2025-05-01||101137||Election of Director: Yoshiaki Fujimori||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Yoshiaki Fujimori
2262893,-1,2025-05-01||101137||Election of Director: David S. Wichmann||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: David S. Wichmann
2262559,-1,2025-05-01||101137||Election of Director: Edward J. Ludwig||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Edward J. Ludwig
2262817,-1,2025-05-01||101137||Election of Director: Ellen M. Zane||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Ellen M. Zane
2262385,-1,2025-05-01||101137||Election of Director: Cheryl Pegus||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Cheryl Pegus
2262325,-1,2025-05-01||101137||Election of Director: Susan E. Morano||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Susan E. Morano
2262701,-1,2025-05-01||101137||Election of Director: John E. Sununu||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: John E. Sununu
2262143,-1,2025-05-01||101137||Election of Director: Jessica L. Mega||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: Jessica L. Mega
2263083,-1,"2025-05-01||101137||Stockholder proposal titled ""Support Simple Majority Vote.""||-1||-1",P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,/,"Stockholder proposal titled ""Support Simple Majority Vote."""
2262813,-1,2025-05-01||101137||To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year.||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2025 fiscal year.
2262664,-1,"2025-05-01||101137||To approve, on a non-binding, advisory basis, the compensation of our named executive officers.||-1||-1",P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,"To approve, on a non-binding, advisory basis, the compensation of our named executive officers."
2263215,-1,2025-05-01||101137||Election of Director: David C. Habiger||-1||-1,P22941,BOSTON SCIENTIFIC CORPORATION,BN,101137,5/1/2025,3/28/2025,3/7/2025,F,Election of Director: David C. Habiger
2238993,-1,"2025-02-18||14040H||A proposal to approve the issuance of Capital One Financial Corporation (""Capital One"") common stock in connection with the merger of Vega Merger Sub, Inc., a wholly owned subsidiary of Capital One (""Merger Sub""), with and into Discover Financial Services (""Discover"") as merger consideration to holders of Discover common stock pursuant to the Agreement and Plan of Merger, dated February 19, 2024, by and among Capital One, Discover, and Merger Sub (the ""Capital One share issuance proposal"").||-1||-1",S01544,CAPITAL ONE FINANCIAL CORPORATION,BN,14040H,2/18/2025,1/13/2025,12/27/2024,F,"A proposal to approve the issuance of Capital One Financial Corporation (""Capital One"") common stock in connection with the merger of Vega Merger Sub, Inc., a wholly owned subsidiary of Capital One (""Merger Sub""), with and into Discover Financial Services (""Discover"") as merger consideration to holders of Discover common stock pursuant to the Agreement and Plan of Merger, dated February 19, 2024, by and among Capital One, Discover, and Merger Sub (the ""Capital One share issuance proposal"")."
2238850,-1,"2025-02-18||14040H||A proposal to adjourn the special meeting of holders of Capital One common stock, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes to approve the Capital One share issuance proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to holders of Capital One common stock (the ""Capital One adjournment proposal"").||-1||-1",S01544,CAPITAL ONE FINANCIAL CORPORATION,BN,14040H,2/18/2025,1/13/2025,12/27/2024,F,"A proposal to adjourn the special meeting of holders of Capital One common stock, if necessary or appropriate, to solicit additional proxies if, immediately prior to such adjournment, there are not sufficient votes to approve the Capital One share issuance proposal or to ensure that any supplement or amendment to the accompanying joint proxy statement/prospectus is timely provided to holders of Capital One common stock (the ""Capital One adjournment proposal"")."
2239341,-1,"2025-03-26||872280||Merger Stock Issuance Proposal - To approve the issuance of shares of common stock, par value $0.01 per share, of Carlyle Secured Lending, Inc. (""CGBD"") to be issued pursuant to the Agreement and Plan of Merger, dated as of August 2, 2024, among Carlyle Secured Lending III, CGBD, Blue Fox Merger Sub, Inc., and, for the limited purposes set forth therein, CSL III Advisor, LLC and Carlyle Global Credit Investment Management L.L.C.||-1||-1",S05944,"CARLYLE SECURED LENDING, INC.",BN,872280,3/26/2025,1/15/2025,12/30/2024,F,"Merger Stock Issuance Proposal - To approve the issuance of shares of common stock, par value $0.01 per share, of Carlyle Secured Lending, Inc. (""CGBD"") to be issued pursuant to the Agreement and Plan of Merger, dated as of August 2, 2024, among Carlyle Secured Lending III, CGBD, Blue Fox Merger Sub, Inc., and, for the limited purposes set forth therein, CSL III Advisor, LLC and Carlyle Global Credit Investment Management L.L.C."
2231808,-1,"2025-01-13||74933X||To approve, in accordance with NYSE American Company Guide Section 713(a), the issuance of up to 10,695,962 shares of our outstanding common stock, par value $0.0001 per share (""Common Stock""), upon the exercise of our Series K Common Stock Purchase Warrants, with the right for such potential exercise to occur immediately following the date upon which our stockholders approve this proposal (the ""Warrant Exercise Proposal"" or ""Proposal No. 1"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve, in accordance with NYSE American Company Guide Section 713(a), the issuance of up to 10,695,962 shares of our outstanding common stock, par value $0.0001 per share (""Common Stock""), upon the exercise of our Series K Common Stock Purchase Warrants, with the right for such potential exercise to occur immediately following the date upon which our stockholders approve this proposal (the ""Warrant Exercise Proposal"" or ""Proposal No. 1"")."
2231652,-1,"2025-01-13||74933X||To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our Common Stock from thirty (30) million shares to sixty (60) million shares (the ""Certificate Amendment Proposal"" or ""Proposal No. 2"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our Common Stock from thirty (30) million shares to sixty (60) million shares (the ""Certificate Amendment Proposal"" or ""Proposal No. 2"")."
2231914,-1,"2025-01-13||74933X||To ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2025 (the ""Auditor Ratification Proposal"" or ""Proposal No. 4"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To ratify the appointment of WithumSmith+Brown, PC as the Company's independent registered public accounting firm for the fiscal year ended December 31, 2025 (the ""Auditor Ratification Proposal"" or ""Proposal No. 4"")."
2231791,-1,"2025-01-13||74933X||To approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposals No. 1, 2, 3, and/or 4 (the ""Adjournment Proposal"" or ""Proposal No. 5"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve the adjournment or postponement of the Special Meeting, if necessary, to continue to solicit votes for Proposals No. 1, 2, 3, and/or 4 (the ""Adjournment Proposal"" or ""Proposal No. 5"")."
2231855,-1,"2025-01-13||74933X||To approve an additional 1.5 million shares of Common Stock for issuance pursuant to our 2023 Equity Incentive Plan (the ""Equity Plan Amendment Proposal"" or ""Proposal No. 3"").||-1||-1",S02375,"CATHETER PRECISION, INC.",BN,74933X,1/13/2025,12/3/2024,11/18/2024,F,"To approve an additional 1.5 million shares of Common Stock for issuance pursuant to our 2023 Equity Incentive Plan (the ""Equity Plan Amendment Proposal"" or ""Proposal No. 3"")."
2262838,-1,2025-04-29||172967||Election of Director: Ellen M. Costello||-1||-1,P25216,CITIGROUP INC.,SH,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Ellen M. Costello
2263973,-1,2025-04-29||172967||Election of Director: Casper W. von Koskull||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Casper W. von Koskull
2263799,-1,2025-04-29||172967||Election of Director: Grace E. Dailey||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Grace E. Dailey
2262647,-1,2025-04-29||172967||Election of Director: Peter B. Henry||-1||-1,Z89420,CITIGROUP INC.,SH,172967,4/29/2025,3/25/2025,3/5/2025,F,Election of Director: Peter B. Henry
2264021,-1,2025-04-29||172967||Election of Director: Renée J. James||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Renée J. James
2263146,-1,2025-04-29||172967||Election of Director: Jane N. Fraser||-1||-1,P25216,CITIGROUP INC.,SH,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Jane N. Fraser
2264779,-1,2025-04-29||172967||Stockholder proposal requesting a shareholder vote regarding excessive golden parachutes.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,N,Stockholder proposal requesting a shareholder vote regarding excessive golden parachutes.
2264186,-1,2025-04-29||172967||Stockholder proposal requesting a report on the effectiveness of Citi's policies and practices in respecting Indigenous Peoples' rights in Citi's existing and proposed financing.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,N,Stockholder proposal requesting a report on the effectiveness of Citi's policies and practices in respecting Indigenous Peoples' rights in Citi's existing and proposed financing.
2263763,-1,2025-04-29||172967||Election of Director: Diana L. Taylor||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Diana L. Taylor
2262056,-1,2025-04-29||172967||Election of Director: James S. Turley||-1||-1,P25216,CITIGROUP INC.,SH,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: James S. Turley
2263974,-1,2025-04-29||172967||Stockholder proposal requesting a report disclosing the Board's oversight regarding material risks associated with animal welfare.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,N,Stockholder proposal requesting a report disclosing the Board's oversight regarding material risks associated with animal welfare.
2264503,-1,2025-04-29||172967||Election of Director: John C. Dugan||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: John C. Dugan
2264429,-1,2025-04-29||172967||Proposal to ratify the selection of KPMG LLP as Citi's independent registered public accounting firm for 2025.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Proposal to ratify the selection of KPMG LLP as Citi's independent registered public accounting firm for 2025.
2264898,-1,2025-04-29||172967||Stockholder proposal requesting a report on financial statement assumptions and climate change.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,N,Stockholder proposal requesting a report on financial statement assumptions and climate change.
2264556,-1,2025-04-29||172967||Approval of additional shares for the Citigroup 2019 Stock Incentive Plan.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Approval of additional shares for the Citigroup 2019 Stock Incentive Plan.
2264709,-1,2025-04-29||172967||Election of Director: Duncan P. Hennes||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Duncan P. Hennes
2264611,-1,2025-04-29||172967||Advisory vote to approve our 2024 Executive Compensation.||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Advisory vote to approve our 2024 Executive Compensation.
2262322,-1,2025-04-29||172967||Election of Director: Titi Cole||-1||-1,P25216,CITIGROUP INC.,SH,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Titi Cole
2264379,-1,2025-04-29||172967||Election of Director: Gary M. Reiner||-1||-1,P19825,CITIGROUP INC.,BN,172967,4/29/2025,3/27/2025,3/3/2025,F,Election of Director: Gary M. Reiner
2240640,-1,"2025-03-10||17322U||To approve the adjournment of the Annual Meeting, if necessary, to permit further solicitation and vote of proxies, if there are not sufficient votes at the time of the Annual Meeting or any adjournment or postponement thereof to approve one or more of the proposals presented at the Annual Meeting.||-1||-1",P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,"To approve the adjournment of the Annual Meeting, if necessary, to permit further solicitation and vote of proxies, if there are not sufficient votes at the time of the Annual Meeting or any adjournment or postponement thereof to approve one or more of the proposals presented at the Annual Meeting."
2240577,-1,"2025-03-10||17322U||To ratify the selection of Wolf & Company, P.C., an independent registered public accounting firm, as the auditor of the Company for the fiscal year ending September 30, 2025.||-1||-1",P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,"To ratify the selection of Wolf & Company, P.C., an independent registered public accounting firm, as the auditor of the Company for the fiscal year ending September 30, 2025."
-1,1295690,2025-03-10||17322U||04||Carol Webb,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
-1,1295708,2025-03-10||17322U||02||Leonard Mazur,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
2240621,-1,"2025-03-10||17322U||To approve an amendment to our Articles of Incorporation to increase the authorized number of shares from 26,000,000 to 260,000,000 and the authorized number of common shares from 16,000,000 to 250,000,000.||-1||-1",P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,"To approve an amendment to our Articles of Incorporation to increase the authorized number of shares from 26,000,000 to 260,000,000 and the authorized number of common shares from 16,000,000 to 250,000,000."
-1,1295667,2025-03-10||17322U||03||Suren Dutia,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
-1,1295723,2025-03-10||17322U||01||Myron Holubiak,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
-1,1295692,2025-03-10||17322U||06||Dennis M. McGrath,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
2240502,-1,2025-03-10||17322U||To approve on a non-binding advisory basis our executive compensation.||-1||-1,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,F,To approve on a non-binding advisory basis our executive compensation.
-1,1295675,2025-03-10||17322U||07||Robert Smith,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
-1,1295676,2025-03-10||17322U||05||Dr. Eugene Holuka,P22655,"CITIUS PHARMACEUTICALS, INC.",BN,17322U,3/10/2025,1/29/2025,1/14/2025,,
2253073,-1,2025-04-24||174610||Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2025 fiscal year.||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the 2025 fiscal year.
2252582,-1,2025-04-24||174610||Election of Director: Christopher J. Swift||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Christopher J. Swift
2253053,-1,2025-04-24||174610||Election of Director: Terrance J. Lillis||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Terrance J. Lillis
2253326,-1,2025-04-24||174610||Election of Director: Robert G. Leary||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Robert G. Leary
2252683,-1,2025-04-24||174610||Election of Director: Lee Alexander||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Lee Alexander
2252815,-1,2025-04-24||174610||Election of Director: Bruce Van Saun||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Bruce Van Saun
2252484,-1,2025-04-24||174610||Election of Director: Marita Zuraitis||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Marita Zuraitis
2252822,-1,2025-04-24||174610||Election of Director: William P. Hankowsky||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: William P. Hankowsky
2252498,-1,2025-04-24||174610||Election of Director: Michele N. Siekerka||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Michele N. Siekerka
2252491,-1,2025-04-24||174610||Election of Director: Tracy A. Atkinson||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Tracy A. Atkinson
2252644,-1,2025-04-24||174610||Election of Director: Claude E. Wade||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Claude E. Wade
2252636,-1,2025-04-24||174610||Election of Director: Christine M. Cumming||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Christine M. Cumming
2252884,-1,2025-04-24||174610||Advisory Vote on Executive Compensation.||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Advisory Vote on Executive Compensation.
2252748,-1,2025-04-24||174610||Election of Director: Kevin Cummings||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Kevin Cummings
2252949,-1,2025-04-24||174610||Election of Director: Edward J. Kelly III||-1||-1,P26766,"CITIZENS FINANCIAL GROUP, INC.",BN,174610,4/24/2025,3/17/2025,2/28/2025,F,Election of Director: Edward J. Kelly III
2259870,-1,2025-05-02||125896||Election of Director: Myrna M. Soto||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Myrna M. Soto
2259600,-1,2025-05-02||125896||Vote on a Shareholder Proposal: Support Shareholder Ability to Call for a Special Shareholder Meeting.||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,N,Vote on a Shareholder Proposal: Support Shareholder Ability to Call for a Special Shareholder Meeting.
2259654,-1,"2025-05-02||125896||Approve, on an advisory basis, the Company's executive compensation.||-1||-1",P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,"Approve, on an advisory basis, the Company's executive compensation."
2259100,-1,2025-05-02||125896||Ratify the appointment of independent registered public accounting firm (PricewaterhouseCoopers LLP).||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Ratify the appointment of independent registered public accounting firm (PricewaterhouseCoopers LLP).
2259593,-1,2025-05-02||125896||Election of Director: John G. Russell||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: John G. Russell
2259734,-1,2025-05-02||125896||Election of Director: Ralph Izzo||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Ralph Izzo
2257367,-1,2025-05-02||125896||Election of Director: Deborah H. Butler||-1||-1,P18945,CMS ENERGY CORPORATION,SH,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Deborah H. Butler
2259215,-1,2025-05-02||125896||Election of Director: Kurt L. Darrow||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Kurt L. Darrow
2259453,-1,2025-05-02||125896||Election of Director: Laura H. Wright||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Laura H. Wright
2258755,-1,2025-05-02||125896||Election of Director: Suzanne F. Shank||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Suzanne F. Shank
2257600,-1,2025-05-02||125896||Election of Director: Garrick J. Rochow||-1||-1,P18945,CMS ENERGY CORPORATION,SH,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Garrick J. Rochow
2259103,-1,2025-05-02||125896||Election of Director: John G. Sznewajs||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: John G. Sznewajs
2259531,-1,2025-05-02||125896||Election of Director: Ronald J. Tanski||-1||-1,P18870,CMS ENERGY CORPORATION,BN,125896,5/2/2025,3/26/2025,3/4/2025,F,Election of Director: Ronald J. Tanski
2242975,-1,"2025-03-11||19249H||To approve the Transaction, the Asset Purchase Agreement and the other transactions and ancillary documents contemplated by the Asset Purchase Agreement.||-1||-1",S05560,"COHERUS BIOSCIENCES, INC.",BN,19249H,3/11/2025,1/31/2025,1/27/2025,F,"To approve the Transaction, the Asset Purchase Agreement and the other transactions and ancillary documents contemplated by the Asset Purchase Agreement."
2242960,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: LaVerne H. Council||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: LaVerne H. Council
2242939,-1,2025-03-25||20602D||Ratification of the appointment of Ernst & Young LLP as the Company's independent public registered accounting firm for fiscal year 2025.||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Ratification of the appointment of Ernst & Young LLP as the Company's independent public registered accounting firm for fiscal year 2025.
2242961,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Kathryn Marinello||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Kathryn Marinello
2242925,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Ann Vezina||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Ann Vezina
2242843,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Nicolas Gheysens||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Nicolas Gheysens
2242938,-1,"2025-03-25||20602D||Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to permit stockholders owning at least 25% of our common stock to call a special meeting of stockholders.||-1||-1",P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,"Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to permit stockholders owning at least 25% of our common stock to call a special meeting of stockholders."
2242885,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Teh-Chien Chou||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Teh-Chien Chou
2242840,-1,"2025-03-25||20602D||Approval, on an advisory basis, of the compensation of the Company's named executive officers.||-1||-1",P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,"Approval, on an advisory basis, of the compensation of the Company's named executive officers."
2242977,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Jennifer Deason||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Jennifer Deason
2242924,-1,2025-03-25||20602D||Stockholder proposal - Give Stockholders the Ability to Call for a Special Stockholder Meeting.||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,N,Stockholder proposal - Give Stockholders the Ability to Call for a Special Stockholder Meeting.
2242878,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Chris Caldwell||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Chris Caldwell
2242842,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Kathryn Hayley||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Kathryn Hayley
2242937,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Olivier Duha||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Olivier Duha
2242863,-1,2025-03-25||20602D||Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Dennis Polk||-1||-1,P21144,CONCENTRIX CORPORATION,BN,20602D,3/25/2025,2/20/2025,1/28/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting or until their respective successors are duly elected and qualified: Dennis Polk
2237213,-1,"2025-01-14||228339||To ratify the appointment of BPM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.||-1||-1",S04340,CROWN ELECTROKINETICS CORP.,BN,228339,1/14/2025,12/27/2024,12/16/2024,F,"To ratify the appointment of BPM LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024."
2237189,-1,"2025-01-14||228339||To approve a reverse stock split of our common stock at a ratio of not more than 1-for-200, such ratio to be determined by the Board of Directors on or prior to December 31, 2025, in its sole discretion.||-1||-1",S04340,CROWN ELECTROKINETICS CORP.,BN,228339,1/14/2025,12/27/2024,12/16/2024,F,"To approve a reverse stock split of our common stock at a ratio of not more than 1-for-200, such ratio to be determined by the Board of Directors on or prior to December 31, 2025, in its sole discretion."
2276406,-1,"2025-05-01||228368||Ratification of the appointment of independent auditors for the fiscal year ending December 31, 2025.||-1||-1",P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,F,"Ratification of the appointment of independent auditors for the fiscal year ending December 31, 2025."
2275424,-1,2025-05-01||228368||Approval by advisory vote of the resolution on executive compensation as described in the Proxy Statement.||-1||-1,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,F,Approval by advisory vote of the resolution on executive compensation as described in the Proxy Statement.
-1,1304953,2025-05-01||228368||02||Richard H. Fearon,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1305033,2025-05-01||228368||05||B. Craig Owens,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1304785,2025-05-01||228368||06||Angela M. Snyder,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1304641,2025-05-01||228368||09||Dwayne A. Wilson,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1305011,2025-05-01||228368||04||Stephen J. Hagge,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
2275072,-1,2025-05-01||228368||Consideration of a Shareholder proposal regarding transparency in political spending.||-1||-1,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,N,Consideration of a Shareholder proposal regarding transparency in political spending.
-1,1304904,2025-05-01||228368||01||Timothy J. Donahue,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1304963,2025-05-01||228368||03||Andrea J. Funk,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1304940,2025-05-01||228368||07||Caesar F. Sweitzer,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1304769,2025-05-01||228368||08||Marsha C. Williams,P27552,"CROWN HOLDINGS, INC.",BN,228368,5/1/2025,3/26/2025,3/11/2025,,
-1,1294807,2025-02-04||126389||05||Stephen Webber,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,,
2238880,-1,"2025-02-04||126389||The ratification of the appointment of RSM US, LLP as the Company's independent auditors for fiscal 2025.||-1||-1",P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,F,"The ratification of the appointment of RSM US, LLP as the Company's independent auditors for fiscal 2025."
-1,1294805,2025-02-04||126389||03||Anthony Folger,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,,
-1,1294873,"2025-02-04||126389||02||Ismail ""Izzy"" Azeri",P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,,
-1,1294795,2025-02-04||126389||04||Marilyn T. Smith,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,,
2238985,-1,2025-02-04||126389||Advisory resolution to approve the compensation paid to the Company's named executive officers.||-1||-1,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,F,Advisory resolution to approve the compensation paid to the Company's named executive officers.
-1,1294862,2025-02-04||126389||01||Victor Dellovo,P22419,CSP INC.,BN,126389,2/4/2025,1/10/2025,12/20/2024,,
2238468,-1,2025-02-04||126389||Approve and adopt the CSP INC. 2025 Stock Incentive Plan.||-1||-1,P22534,CSP INC.,SH,126389,2/4/2025,1/8/2025,12/20/2024,F,Approve and adopt the CSP INC. 2025 Stock Incentive Plan.
2264533,-1,"2025-04-09||232109||VOTE ON THE PLAN (FOR = ACCEPT, AGAINST = REJECT) (ABSTAIN VOTES DO NOT COUNT)||-1||-1",Z89753,"CUTERA, INC.",BN,232109,4/9/2025,3/19/2025,3/6/2025,/,"VOTE ON THE PLAN (FOR = ACCEPT, AGAINST = REJECT) (ABSTAIN VOTES DO NOT COUNT)"
2264045,-1,"2025-04-09||232109||OPT-OUT OF THE RELEASE BY HOLDERS OF CLAIMS AND INTERESTS (FOR=OPT OUT, AGAINST OR ABSTAIN = DO NOT OPT OUT)||-1||-1",Z89753,"CUTERA, INC.",BN,232109,4/9/2025,3/19/2025,3/6/2025,/,"OPT-OUT OF THE RELEASE BY HOLDERS OF CLAIMS AND INTERESTS (FOR=OPT OUT, AGAINST OR ABSTAIN = DO NOT OPT OUT)"
2240508,-1,"2025-02-06||23254L||The approval of (i) the issuance to Mr. Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii) an amendment of the Series C Preferred Stock Certificate of Designations removing the Series C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c) and (d).||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of (i) the issuance to Mr. Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii) an amendment of the Series C Preferred Stock Certificate of Designations removing the Series C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c) and (d)."
2240614,-1,"2025-02-06||23254L||The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals."
2240639,-1,"2025-02-06||23254L||The ratification of the appointment of Bush & Associates CPA LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The ratification of the appointment of Bush & Associates CPA LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024."
2240771,-1,"2025-02-06||23254L||The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved."
2240586,-1,"2025-02-06||23254L||The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule 5635(d).||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule 5635(d)."
2240583,-1,"2025-02-06||23254L||The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the ""Reverse Stock Split,"" such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board of Directors.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the ""Reverse Stock Split,"" such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board of Directors."
2240625,-1,"2025-02-06||23254L||The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved.||-1||-1",Z89260,"CYCLACEL PHARMACEUTICALS, INC.",BN,23254L,2/6/2025,1/22/2025,1/9/2025,F,"The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved."
2238680,-1,"2025-01-30||23257B||Approval of, if necessary, the adjournment or postponement of the Special Meeting, to continue to solicit votes for Proposals 1, 2 and 3.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Approval of, if necessary, the adjournment or postponement of the Special Meeting, to continue to solicit votes for Proposals 1, 2 and 3."
2238693,-1,"2025-01-30||23257B||Grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-one hundred fifty (1-for-150) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our common stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-one hundred fifty (1-for-150) split, with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders."
2238699,-1,"2025-01-30||23257B||To authorize, for purposes of complying with NASDAQ Listing Rule 5635(D), the issuance of the Warrants, shares of our common stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on December 23, 2024.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"To authorize, for purposes of complying with NASDAQ Listing Rule 5635(D), the issuance of the Warrants, shares of our common stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on December 23, 2024."
2238681,-1,"2025-01-30||23257B||Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized common stock from 200,000,000 to 400,000,000 shares.||-1||-1",S02870,CYNGN INC.,BN,23257B,1/30/2025,1/9/2025,12/2/2024,F,"Approval of an amendment to the Company's Certificate of Incorporation to increase the number of authorized common stock from 200,000,000 to 400,000,000 shares."
2237794,-1,"2025-02-19||233912||Ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for fiscal 2025.||-1||-1",P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,"Ratification of the appointment of Baker Tilly US, LLP as the Company's independent registered public accounting firm for fiscal 2025."
2237773,-1,2025-02-19||233912||Election of Director: Mary Conlin||-1||-1,P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,Election of Director: Mary Conlin
2237879,-1,"2025-02-19||233912||Approval of stock settlement of up to 2,000 Director Restricted stock units.||-1||-1",P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,"Approval of stock settlement of up to 2,000 Director Restricted stock units."
2237832,-1,2025-02-19||233912||Election of Director: Rasool Rayani||-1||-1,P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,Election of Director: Rasool Rayani
2237812,-1,2025-02-19||233912||Election of Director: Steven Myhill-Jones||-1||-1,P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,Election of Director: Steven Myhill-Jones
2237837,-1,2025-02-19||233912||Election of Director: John B. Frank||-1||-1,P22766,DAILY JOURNAL CORPORATION,BN,233912,2/19/2025,1/14/2025,12/16/2024,F,Election of Director: John B. Frank
2234816,-1,2025-02-03||253798||Election of Director: Valerie Heusinkveld||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Election of Director: Valerie Heusinkveld
2234849,-1,"2025-02-03||253798||Company proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm of the company for the fiscal year ending September 30, 2025.||-1||-1",P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,"Company proposal to ratify the appointment of Deloitte & Touche LLP as independent registered public accounting firm of the company for the fiscal year ending September 30, 2025."
2234863,-1,2025-02-03||253798||Election of Director: Hatem H. Naguib||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Election of Director: Hatem H. Naguib
2234859,-1,2025-02-03||253798||Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan.||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Company proposal to approve the amendment and restatement of the Digi International Inc. 2021 Omnibus Incentive Plan.
2234911,-1,"2025-02-03||253798||Company proposal to approve, on a non-binding advisory basis, the compensation paid to named executive officers.||-1||-1",P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,"Company proposal to approve, on a non-binding advisory basis, the compensation paid to named executive officers."
2234910,-1,2025-02-03||253798||Election of Director: Spiro C. Lazarakis||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Election of Director: Spiro C. Lazarakis
2234805,-1,2025-02-03||253798||Election of Director: Allison West Hughes||-1||-1,P21220,DIGI INTERNATIONAL INC.,BN,253798,2/3/2025,12/20/2024,12/9/2024,F,Election of Director: Allison West Hughes
-1,1291713,2024-12-17||25382T||01||Stanton E. Ross,P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,,
2231416,-1,2024-12-17||25382T||Ratification of the appointment of RBSM LLP as our independent registered public accounting firm.||-1||-1,P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,F,Ratification of the appointment of RBSM LLP as our independent registered public accounting firm.
2231368,-1,"2024-12-17||25382T||Authorization of the Board, in its sole and absolute discretion, and without further action of stockholders, to file an amendment to our articles of inc, to effect a reverse stock split of our issued & outstanding Common Stock at a ratio to be determined by Board, ranging from one-for-five to one-for twenty, with such reverse stock split to be effected at such time & date, if at all, as determined by the Board in its sole discretion, but no later than 12/16/2025, when authority granted in this proposal to implement reverse stock split would terminate.||-1||-1",P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,F,"Authorization of the Board, in its sole and absolute discretion, and without further action of stockholders, to file an amendment to our articles of inc, to effect a reverse stock split of our issued & outstanding Common Stock at a ratio to be determined by Board, ranging from one-for-five to one-for twenty, with such reverse stock split to be effected at such time & date, if at all, as determined by the Board in its sole discretion, but no later than 12/16/2025, when authority granted in this proposal to implement reverse stock split would terminate."
-1,1291699,2024-12-17||25382T||03||D. Duke Daughtery,P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,,
2231584,-1,"2024-12-17||25382T||Approval of the transactions contemplated by the securities purchase agreement, entered into as of June 24, 2024, by and between the Company and investors, including the issuance of 20% or more of our outstanding shares of Common Stock upon (i) exercise of Series A Common Stock Purchase Warrant; and (ii) exercise of Series B Common Stock Purchase Warrant, each dated June 25, 2024.||-1||-1",P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,F,"Approval of the transactions contemplated by the securities purchase agreement, entered into as of June 24, 2024, by and between the Company and investors, including the issuance of 20% or more of our outstanding shares of Common Stock upon (i) exercise of Series A Common Stock Purchase Warrant; and (ii) exercise of Series B Common Stock Purchase Warrant, each dated June 25, 2024."
-1,1291638,2024-12-17||25382T||04||Charles M. Anderson,P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,,
-1,1291667,2024-12-17||25382T||02||Leroy C. Richie,P20881,"DIGITAL ALLY, INC.",BN,25382T,12/17/2024,11/27/2024,11/14/2024,,
-1,1300803,2025-04-23||25754A||07||James A. Goldman,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
-1,1300738,2025-04-23||25754A||02||C. Andrew Ballard,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
-1,1300773,2025-04-23||25754A||04||Corie S. Barry,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
-1,1300876,2025-04-23||25754A||05||Diane L. Cafritz,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
2257202,-1,2025-04-23||25754A||Approval of the adoption of the Company's Amended and Restated Certificate of Incorporation to eliminate the supermajority voting requirement.||-1||-1,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,F,Approval of the adoption of the Company's Amended and Restated Certificate of Incorporation to eliminate the supermajority voting requirement.
2258092,-1,2025-04-23||25754A||Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the 2025 fiscal year.||-1||-1,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,F,Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the 2025 fiscal year.
2257431,-1,2025-04-23||25754A||Approval of the adoption of the Company's Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting at a 25% threshold.||-1||-1,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,F,Approval of the adoption of the Company's Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting at a 25% threshold.
-1,1300812,2025-04-23||25754A||08||Patricia E. Lopez,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
2257921,-1,2025-04-23||25754A||Shareholder proposal regarding shareholder right to call a special meeting at a 15% threshold.||-1||-1,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,N,Shareholder proposal regarding shareholder right to call a special meeting at a 15% threshold.
-1,1300863,2025-04-23||25754A||06||Richard L. Federico,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
-1,1300793,2025-04-23||25754A||01||David A. Brandon,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
2257540,-1,2025-04-23||25754A||Advisory vote to approve the compensation of the named executive officers of the Company.||-1||-1,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,F,Advisory vote to approve the compensation of the named executive officers of the Company.
-1,1300804,2025-04-23||25754A||03||Andrew B. Balson,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
-1,1300861,2025-04-23||25754A||09||Russell J. Weiner,P21684,"DOMINO'S PIZZA, INC.",BN,25754A,4/23/2025,3/18/2025,2/28/2025,,
2259523,-1,2025-05-02||260003||To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2025.
2259669,-1,2025-05-02||260003||Election of Director: K. E. Wandell||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: K. E. Wandell
2259371,-1,2025-05-02||260003||To consider a shareholder proposal requesting an independent board chair.||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,N,To consider a shareholder proposal requesting an independent board chair.
2259119,-1,2025-05-02||260003||Election of Director: D. K. Ostling||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: D. K. Ostling
2260031,-1,2025-05-02||260003||Election of Director: R. J. Tobin||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: R. J. Tobin
2259586,-1,"2025-05-02||260003||Election of Director: H. J. Gilbertson, Jr.||-1||-1",P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,"Election of Director: H. J. Gilbertson, Jr."
2259609,-1,"2025-05-02||260003||To approve, on an advisory basis, named executive officer compensation.||-1||-1",P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,"To approve, on an advisory basis, named executive officer compensation."
2259245,-1,2025-05-02||260003||Election of Director: M. Manley||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: M. Manley
2259235,-1,2025-05-02||260003||Election of Director: M. A. Howze||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: M. A. Howze
2259616,-1,2025-05-02||260003||Election of Director: K. C. Graham||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: K. C. Graham
2260073,-1,2025-05-02||260003||Election of Director: E. A. Spiegel||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: E. A. Spiegel
2259721,-1,2025-05-02||260003||Election of Director: D. L. DeHaas||-1||-1,P22602,DOVER CORPORATION,BN,260003,5/2/2025,3/25/2025,3/10/2025,F,Election of Director: D. L. DeHaas
2252450,-1,2025-05-01||26441C||Election of Director: Nicholas C. Fanandakis||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Nicholas C. Fanandakis
2252803,-1,2025-05-01||26441C||Election of Director: Robert M. Davis||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Robert M. Davis
2252928,-1,2025-05-01||26441C||Election of Director: Michael J. Pacilio||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Michael J. Pacilio
2253214,-1,2025-05-01||26441C||Election of Director: John T. Herron||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: John T. Herron
2252795,-1,2025-05-01||26441C||Election of Director: Idalene F. Kesner||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Idalene F. Kesner
2247961,-1,2025-05-01||26441C||Election of Director: Caroline Dorsa||-1||-1,P24550,DUKE ENERGY CORPORATION,SH,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Caroline Dorsa
2253484,-1,"2025-05-01||26441C||Election of Director: Theodore F. Craver, Jr.||-1||-1",P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,"Election of Director: Theodore F. Craver, Jr."
2252699,-1,2025-05-01||26441C||Election of Director: Derrick Burks||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Derrick Burks
2252723,-1,2025-05-01||26441C||Election of Director: E. Marie McKee||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: E. Marie McKee
2252664,-1,2025-05-01||26441C||Election of Director: W. Roy Dunbar||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: W. Roy Dunbar
2252603,-1,2025-05-01||26441C||Election of Director: Harry K. Sideris||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Harry K. Sideris
2253158,-1,2025-05-01||26441C||Shareholder proposal regarding support simple majority vote||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Shareholder proposal regarding support simple majority vote
2252982,-1,2025-05-01||26441C||Ratification of Deloitte & Touche LLP as Duke Energy's independent registered public accounting firm for 2025||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Ratification of Deloitte & Touche LLP as Duke Energy's independent registered public accounting firm for 2025
2252696,-1,2025-05-01||26441C||Shareholder proposal regarding a net-zero audit||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,N,Shareholder proposal regarding a net-zero audit
2252387,-1,2025-05-01||26441C||Election of Director: Annette K. Clayton||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Annette K. Clayton
2253152,-1,"2025-05-01||26441C||Election of Director: William E. Webster, Jr.||-1||-1",P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,"Election of Director: William E. Webster, Jr."
2253344,-1,2025-05-01||26441C||Election of Director: Thomas E. Skains||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Election of Director: Thomas E. Skains
2253171,-1,2025-05-01||26441C||Advisory vote to approve Duke Energy's named executive officer compensation||-1||-1,P24563,DUKE ENERGY CORPORATION,BN,26441C,5/1/2025,3/17/2025,3/3/2025,F,Advisory vote to approve Duke Energy's named executive officer compensation
2237516,-1,"2025-01-27||28059P||To approve any adjournment of the Special Meeting from time to time, if necessary or appropriate, including to solicit additional votes in favor of Proposal One if there are not sufficient votes at the time of the Special Meeting to adopt Proposal One or to establish a quorum.||-1||-1",S04516,EDIBLE GARDEN AG INCORPORATED,BN,28059P,1/27/2025,12/31/2024,12/19/2024,F,"To approve any adjournment of the Special Meeting from time to time, if necessary or appropriate, including to solicit additional votes in favor of Proposal One if there are not sufficient votes at the time of the Special Meeting to adopt Proposal One or to establish a quorum."
2237534,-1,"2025-01-27||28059P||To approve an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company's common stock in a range of 1-for-5 to 1-for-25, at the discretion of the board of directors.||-1||-1",S04516,EDIBLE GARDEN AG INCORPORATED,BN,28059P,1/27/2025,12/31/2024,12/19/2024,F,"To approve an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the outstanding shares of the Company's common stock in a range of 1-for-5 to 1-for-25, at the discretion of the board of directors."
-1,1295285,2025-02-19||29271Q||05||Joseph L. Williams,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295321,2025-02-19||29271Q||08||Frank S. Lucente,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295253,2025-02-19||29271Q||02||Jack M. Reynolds,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295325,2025-02-19||29271Q||07||Patrick J. Farrell,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295244,2025-02-19||29271Q||04||Mark S. Prince,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
2239841,-1,"2025-02-19||29271Q||The ratification of the appointment of Urish Popeck & Co., LLC as our independent registered public accounting firm for the year ended September 30, 2025.||-1||-1",P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,F,"The ratification of the appointment of Urish Popeck & Co., LLC as our independent registered public accounting firm for the year ended September 30, 2025."
2239827,-1,"2025-02-19||29271Q||An Advisory, non-binding resolution with respect to our executive compensation.||-1||-1",P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,F,"An Advisory, non-binding resolution with respect to our executive compensation."
-1,1295257,2025-02-19||29271Q||03||Douglas V. Reynolds,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295326,2025-02-19||29271Q||06||Amy E. Abraham,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
-1,1295236,2025-02-19||29271Q||01||Marshall T. Reynolds,P22489,ENERGY SERVICES OF AMERICA CORP.,BN,29271Q,2/19/2025,1/16/2025,1/6/2025,,
2272665,-1,2025-04-23||29362U||Election of Director: James F. Gentilcore||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: James F. Gentilcore
2272579,-1,2025-04-23||29362U||Election of Director: David Reeder||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: David Reeder
2272932,-1,"2025-04-23||29362U||Ratify the appointment of KPMG LLP as Entegris, Inc.'s Independent Registered Public Accounting Firm for 2025.||-1||-1",P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,"Ratify the appointment of KPMG LLP as Entegris, Inc.'s Independent Registered Public Accounting Firm for 2025."
2272847,-1,2025-04-23||29362U||Election of Director: Yvette Kanouff||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: Yvette Kanouff
2273277,-1,"2025-04-23||29362U||Approval, by non-binding vote, of the compensation paid to Entegris, Inc.'s named executive officers (advisory vote).||-1||-1",P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,"Approval, by non-binding vote, of the compensation paid to Entegris, Inc.'s named executive officers (advisory vote)."
2273668,-1,2025-04-23||29362U||Stockholder Proposal Regarding Simple Majority Voting.||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,/,Stockholder Proposal Regarding Simple Majority Voting.
2273921,-1,2025-04-23||29362U||Election of Director: Mary Puma||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: Mary Puma
2273294,-1,2025-04-23||29362U||Election of Director: Azita Saleki-Gerhardt||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: Azita Saleki-Gerhardt
2273559,-1,2025-04-23||29362U||Election of Director: Bertrand Loy||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: Bertrand Loy
2272680,-1,2025-04-23||29362U||Election of Director: James P. Lederer||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: James P. Lederer
2273209,-1,2025-04-23||29362U||Election of Director: Rodney Clark||-1||-1,P26695,"ENTEGRIS, INC.",BN,29362U,4/23/2025,3/25/2025,3/7/2025,F,Election of Director: Rodney Clark
2236473,-1,"2025-01-17||29405E||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended (the ""Charter""), to, at the discretion of the Board of Directors of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.01 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-10 to 1-for-100 (""Range""), with the ratio within such Range to be determined at the discretion of the Board (the ""Reverse Stock Split Proposal"").||-1||-1",S03115,"ENVERIC BIOSCIENCES, INC.",BN,29405E,1/17/2025,12/20/2024,12/11/2024,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended (the ""Charter""), to, at the discretion of the Board of Directors of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.01 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-10 to 1-for-100 (""Range""), with the ratio within such Range to be determined at the discretion of the Board (the ""Reverse Stock Split Proposal"")."
2236382,-1,"2025-01-17||29405E||To approve an adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal (the ""Adjournment Proposal"").||-1||-1",S03115,"ENVERIC BIOSCIENCES, INC.",BN,29405E,1/17/2025,12/20/2024,12/11/2024,F,"To approve an adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal (the ""Adjournment Proposal"")."
2252182,-1,"2025-04-22||29460X||Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): R. Renee Koger||-1||-1",P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,"Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): R. Renee Koger"
2251968,-1,2025-04-22||29460X||Advisory vote to approve the compensation paid to the named executive officers of the Company.||-1||-1,P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,Advisory vote to approve the compensation paid to the named executive officers of the Company.
2251829,-1,"2025-04-22||29460X||Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): James S. Loving||-1||-1",P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,"Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): James S. Loving"
2252216,-1,"2025-04-22||29460X||Ratification of Crowe LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.||-1||-1",P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,"Ratification of Crowe LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025."
2252184,-1,"2025-04-22||29460X||Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): Jerry P. Maland||-1||-1",P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,"Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): Jerry P. Maland"
2251797,-1,2025-04-22||29460X||Approval of an amendment to the Company's Second Amended and Restated Articles of Incorporation to phase out the classified structure of the Company's Board of Directors.||-1||-1,P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,Approval of an amendment to the Company's Second Amended and Restated Articles of Incorporation to phase out the classified structure of the Company's Board of Directors.
2252247,-1,"2025-04-22||29460X||Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): Shawn D. Penner||-1||-1",P27045,"EQUITY BANCSHARES, INC.",BN,29460X,4/22/2025,3/18/2025,2/28/2025,F,"Election of Class I Director to a one-year term ending at the Company's 2026 Annual Meeting of Stockholders (or if Item 1 is not approved, for a three-year term ending at the Company's 2028 Annual Meeting of Stockholders): Shawn D. Penner"
2257669,-1,"2025-04-15||29667D||Approval of the Agreement and Plan of Merger, by and among CNB Financial Corporation, a Pennsylvania corporation, CNB Bank, a Pennsylvania-chartered nonmember bank (""CNB Bank"") and wholly owned subsidiary of CNB, ESSA, and ESSA Bank & Trust, a Pennsylvania-chartered stock savings bank (""ESSA Bank"") and wholly-owned subsidiary of ESSA, dated as of 1/9/25, pursuant to which (i) ESSA will merge with & into CNB, with CNB as surviving entity, and (ii) ESSA Bank will merge with and into CNB Bank, with CNB Bank as the surviving entity (""ESSA merger proposal"").||-1||-1",S10131,"ESSA BANCORP, INC.",BN,29667D,4/15/2025,3/13/2025,2/18/2025,F,"Approval of the Agreement and Plan of Merger, by and among CNB Financial Corporation, a Pennsylvania corporation, CNB Bank, a Pennsylvania-chartered nonmember bank (""CNB Bank"") and wholly owned subsidiary of CNB, ESSA, and ESSA Bank & Trust, a Pennsylvania-chartered stock savings bank (""ESSA Bank"") and wholly-owned subsidiary of ESSA, dated as of 1/9/25, pursuant to which (i) ESSA will merge with & into CNB, with CNB as surviving entity, and (ii) ESSA Bank will merge with and into CNB Bank, with CNB Bank as the surviving entity (""ESSA merger proposal"")."
2257235,-1,"2025-04-15||29667D||Approval of one or more adjournments of the ESSA special meeting, if necessary, to permit further solicitation of proxies if there are insufficient votes at the time of the special meeting, or at an adjournment or postponement of that meeting, to approve the ESSA merger proposal.||-1||-1",S10131,"ESSA BANCORP, INC.",BN,29667D,4/15/2025,3/13/2025,2/18/2025,F,"Approval of one or more adjournments of the ESSA special meeting, if necessary, to permit further solicitation of proxies if there are insufficient votes at the time of the special meeting, or at an adjournment or postponement of that meeting, to approve the ESSA merger proposal."
2257834,-1,"2025-04-15||29667D||Approval of an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of ESSA in connection with the merger.||-1||-1",S10131,"ESSA BANCORP, INC.",BN,29667D,4/15/2025,3/13/2025,2/18/2025,F,"Approval of an advisory (non-binding) basis, specified compensation that may become payable to the named executive officers of ESSA in connection with the merger."
2257727,-1,2025-05-01||30040W||Election of Trustee: Frederica M. Williams||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Frederica M. Williams
2257334,-1,2025-05-01||30040W||Election of Trustee: Linda Dorcena Forry||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Linda Dorcena Forry
2257796,-1,2025-05-01||30040W||Election of Trustee: David H. Long||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: David H. Long
2258116,-1,2025-05-01||30040W||Election of Trustee: Cotton M. Cleveland||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Cotton M. Cleveland
2257770,-1,2025-05-01||30040W||Election of Trustee: Gregory M. Jones||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Gregory M. Jones
2257063,-1,2025-05-01||30040W||Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.
2257344,-1,2025-05-01||30040W||Approve proposed amendments to our Declaration of Trust to eliminate supermajority voting requirements and allow virtual annual meetings of shareholders.||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Approve proposed amendments to our Declaration of Trust to eliminate supermajority voting requirements and allow virtual annual meetings of shareholders.
2258121,-1,2025-05-01||30040W||Consider an advisory proposal approving the compensation of our Named Executive Officers.||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Consider an advisory proposal approving the compensation of our Named Executive Officers.
2257123,-1,"2025-05-01||30040W||Election of Trustee: Joseph R. Nolan, Jr.||-1||-1",P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,"Election of Trustee: Joseph R. Nolan, Jr."
2257072,-1,2025-05-01||30040W||Election of Trustee: Daniel J. Nova||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Daniel J. Nova
2257660,-1,2025-05-01||30040W||Election of Trustee: Loretta D. Keane||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: Loretta D. Keane
2257570,-1,"2025-05-01||30040W||Vote on a shareholder proposal titled ""Support an Independent Board Chairman,"" if properly brought before the meeting.||-1||-1",P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,N,"Vote on a shareholder proposal titled ""Support an Independent Board Chairman,"" if properly brought before the meeting."
2257443,-1,2025-05-01||30040W||Election of Trustee: John Y. Kim||-1||-1,P26823,EVERSOURCE ENERGY,BN,30040W,5/1/2025,3/21/2025,3/4/2025,F,Election of Trustee: John Y. Kim
2241575,-1,"2025-02-14||317970||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock pursuant to the Purchase Agreement, dated December 20, 2024, between the Company and Arena Business Solutions Global SPC II, Ltd.||-1||-1",Z89240,"FIREFLY NEUROSCIENCE, INC.",BN,317970,2/14/2025,1/27/2025,1/7/2025,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock pursuant to the Purchase Agreement, dated December 20, 2024, between the Company and Arena Business Solutions Global SPC II, Ltd."
2241626,-1,"2025-02-14||317970||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock, pursuant to the Securities Purchase Agreement, dated as of December 20, 2024, between the Company and Helena Special Opportunities LLC (""Helena""), including upon the conversion of a convertible note issued to Helena and upon the exercise of a warrant issued to Helena.||-1||-1",Z89240,"FIREFLY NEUROSCIENCE, INC.",BN,317970,2/14/2025,1/27/2025,1/7/2025,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding common stock, pursuant to the Securities Purchase Agreement, dated as of December 20, 2024, between the Company and Helena Special Opportunities LLC (""Helena""), including upon the conversion of a convertible note issued to Helena and upon the exercise of a warrant issued to Helena."
2234233,-1,"2024-12-27||317970||To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.||-1||-1",P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,F,"To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers."
-1,1292720,2024-12-27||317970||02||Jon Olsen,P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,,
-1,1292702,2024-12-27||317970||03||Greg Lipschitz,P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,,
-1,1292716,2024-12-27||317970||01||David DeCaprio,P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,,
2234239,-1,"2024-12-27||317970||To approve the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.||-1||-1",P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,F,"To approve the adjournment of the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals."
2234088,-1,"2024-12-27||317970||To ratify the appointment of Marcum Canada, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.||-1||-1",P20915,"FIREFLY NEUROSCIENCE, INC.",BN,317970,12/27/2024,12/12/2024,11/15/2024,F,"To ratify the appointment of Marcum Canada, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024."
2238575,-1,"2025-02-14||317970||To approve an adjournment of the Special Meeting from time to time, to a later date or dates, if necessary or appropriate, under certain circumstances, including for the purpose of soliciting additional proxies in favor of the foregoing proposal in the event the Company does not receive the requisite stockholder vote to approve such proposal or to establish a quorum.||-1||-1",S07091,"FIREFLY NEUROSCIENCE, INC.",SH,317970,2/14/2025,1/24/2025,1/6/2025,F,"To approve an adjournment of the Special Meeting from time to time, to a later date or dates, if necessary or appropriate, under certain circumstances, including for the purpose of soliciting additional proxies in favor of the foregoing proposal in the event the Company does not receive the requisite stockholder vote to approve such proposal or to establish a quorum."
2257715,-1,"2025-04-29||318910||To ratify the appointment of Crowe, LLP as the independent auditors of the Company for 2025.||-1||-1",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,F,"To ratify the appointment of Crowe, LLP as the independent auditors of the Company for 2025."
-1,1300897,"2025-04-29||318910||02||James C. Crawford, III",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300755,"2025-04-29||318910||07||Carlie C. McLamb, Jr.",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300828,"2025-04-29||318910||10||O. Temple Sloan, III",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300787,2025-04-29||318910||08||Richard H. Moore,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
2257065,-1,"2025-04-29||318910||To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the accompanying proxy statement (""Say on Pay"").||-1||-1",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,F,"To approve, on a non-binding advisory basis, the compensation paid to the Company's named executive officers, as disclosed in the accompanying proxy statement (""Say on Pay"")."
-1,1300917,2025-04-29||318910||09||Dexter V. Perry,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300853,2025-04-29||318910||03||Suzanne S. DeFerie,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300757,2025-04-29||318910||06||John W. McCauley,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300769,2025-04-29||318910||04||Abby J. Donnelly,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300842,"2025-04-29||318910||11||Frederick L. Taylor, II",P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300868,2025-04-29||318910||05||Michael G. Mayer,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
-1,1300889,2025-04-29||318910||01||Mary Clara Capel,P27178,FIRST BANCORP,BN,318910,4/29/2025,3/26/2025,3/7/2025,,
2239180,-1,"2025-02-11||33621E||The approval of the First Savings Financial Group, Inc. 2025 Equity lncentive Plan.||-1||-1",P20239,"FIRST SAVINGS FINANCIAL GROUP, INC.",SH,33621E,2/11/2025,1/13/2025,12/31/2024,F,"The approval of the First Savings Financial Group, Inc. 2025 Equity lncentive Plan."
-1,1294989,2025-02-11||33621E||03||Frank N. Czeschin,P19529,"FIRST SAVINGS FINANCIAL GROUP, INC.",BN,33621E,2/11/2025,1/13/2025,12/31/2024,,
2239072,-1,"2025-02-11||33621E||The approval of a non-binding proposal to ratify the appointment of Forvis Mazars, LLP as the independent registered public accounting firm of First Savings Financial Group, Inc. for the fiscal year ending September 30, 2025.||-1||-1",P19529,"FIRST SAVINGS FINANCIAL GROUP, INC.",BN,33621E,2/11/2025,1/13/2025,12/31/2024,F,"The approval of a non-binding proposal to ratify the appointment of Forvis Mazars, LLP as the independent registered public accounting firm of First Savings Financial Group, Inc. for the fiscal year ending September 30, 2025."
-1,1294959,"2025-02-11||33621E||02||John P. Lawson, Jr.",P19529,"FIRST SAVINGS FINANCIAL GROUP, INC.",BN,33621E,2/11/2025,1/13/2025,12/31/2024,,
2239145,-1,2025-02-11||33621E||The approval of a non-binding resolution to approve the compensation of the named executive officers as disclosed in the accompanying proxy statement.||-1||-1,P19529,"FIRST SAVINGS FINANCIAL GROUP, INC.",BN,33621E,2/11/2025,1/13/2025,12/31/2024,F,The approval of a non-binding resolution to approve the compensation of the named executive officers as disclosed in the accompanying proxy statement.
2239245,-1,"2025-02-11||33621E||The approval of a non-binding proposal to ratify the appointment of Forvis Mazars, LLP as the independent registered public accounting firm First Savings Financial Group, Inc. for the fiscal year ending September 30, 2025.||-1||-1",P20239,"FIRST SAVINGS FINANCIAL GROUP, INC.",SH,33621E,2/11/2025,1/13/2025,12/31/2024,F,"The approval of a non-binding proposal to ratify the appointment of Forvis Mazars, LLP as the independent registered public accounting firm First Savings Financial Group, Inc. for the fiscal year ending September 30, 2025."
-1,1294988,2025-02-11||33621E||01||Douglas A. York,P20239,"FIRST SAVINGS FINANCIAL GROUP, INC.",SH,33621E,2/11/2025,1/13/2025,12/31/2024,,
-1,1295029,2025-02-11||33621E||04||Steven R. Stemler,P19529,"FIRST SAVINGS FINANCIAL GROUP, INC.",BN,33621E,2/11/2025,1/13/2025,12/31/2024,,
2259968,-1,2025-04-29||302491||Election of Director to serve for a one-year term: C. Scott Greer||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: C. Scott Greer
2259243,-1,2025-04-29||302491||Vote on an advisory management proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold.||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Vote on an advisory management proposal to provide stockholders the right to call a special meeting of stockholders at a 25% ownership threshold.
2258832,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Carol Anthony (John) Davidson||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Carol Anthony (John) Davidson
2259050,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Robert C. Pallash||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Robert C. Pallash
2259534,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Pierre Brondeau||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Pierre Brondeau
2259110,-1,2025-04-29||302491||Vote on an advisory stockholder proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold.||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,N,Vote on an advisory stockholder proposal to provide stockholders the right to call a special meeting of stockholders at a 10% ownership threshold.
2258962,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Margareth Øvrum||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Margareth Øvrum
2260012,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Steven T. Merkt||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Steven T. Merkt
2260018,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Kathy L. Fortmann||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Kathy L. Fortmann
2259883,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Patricia Verduin||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Patricia Verduin
2258746,-1,"2025-04-29||302491||Approval, by non-binding vote, of executive compensation.||-1||-1",P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,"Approval, by non-binding vote, of executive compensation."
2259530,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Dirk A. Kempthorne||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Dirk A. Kempthorne
2259742,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Eduardo E. Cordeiro||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Eduardo E. Cordeiro
2259515,-1,2025-04-29||302491||Vote on a proposal to eliminate supermajority voting provisions in FMC's certificate of incorporation.||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Vote on a proposal to eliminate supermajority voting provisions in FMC's certificate of incorporation.
2258822,-1,2025-04-29||302491||Election of Director to serve for a one-year term: John M. Raines||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: John M. Raines
2259326,-1,2025-04-29||302491||Election of Director to serve for a one-year term: Anthony DiSilvestro||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: Anthony DiSilvestro
2258975,-1,2025-04-29||302491||Election of Director to serve for a one-year term: K'Lynne Johnson||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Election of Director to serve for a one-year term: K'Lynne Johnson
2258839,-1,2025-04-29||302491||Ratification of the appointment of independent registered public accounting firm.||-1||-1,P21001,FMC CORPORATION,BN,302491,4/29/2025,3/21/2025,2/28/2025,F,Ratification of the appointment of independent registered public accounting firm.
2252538,-1,2025-03-27||34629L||The amend the Company's Certificate of Incorporation to effect the Reverse Stock Split.||-1||-1,S08832,"FORGE GLOBAL HOLDINGS, INC.",BN,34629L,3/27/2025,3/7/2025,2/24/2025,F,The amend the Company's Certificate of Incorporation to effect the Reverse Stock Split.
2238383,-1,2025-01-24||34962G||The approval of an amended and restated 2021 Equity Incentive Plan.||-1||-1,S03007,"FORTE BIOSCIENCES, INC.",BN,34962G,1/24/2025,1/9/2025,12/30/2024,F,The approval of an amended and restated 2021 Equity Incentive Plan.
-1,1306939,2025-04-04||349853||01||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1307126,2025-04-04||349853||07||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1307237,2025-04-04||349853||10||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1306840,2025-04-04||349853||11||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1307103,2025-04-04||349853||08||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1306844,2025-04-04||349853||06||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
2283122,-1,2025-04-04||349853||To approve the Company's 2025 Non-Employee Director Stock Plan.||-1||-1,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,F,To approve the Company's 2025 Non-Employee Director Stock Plan.
-1,1306887,2025-04-04||349853||09||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1307101,2025-04-04||349853||05||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
-1,1306988,2025-04-04||349853||03||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
2287460,-1,"2025-04-04||349853||Disregard notice, new information and new control number coming soon||-1||-1",P27281,FORWARD AIR CORPORATION,SH,349853,4/4/2025,4/1/2025,3/18/2025,F,"Disregard notice, new information and new control number coming soon"
-1,1307232,2025-04-04||349853||02||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
2284009,-1,"2025-04-04||349853||To approve, on a non-binding, advisory basis, the compensation of the named executive officers (the ""say on pay vote"").||-1||-1",P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,F,"To approve, on a non-binding, advisory basis, the compensation of the named executive officers (the ""say on pay vote"")."
-1,1307105,2025-04-04||349853||04||No nominee,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,,
2283681,-1,2025-04-04||349853||To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the 2025 fiscal year.||-1||-1,P27181,FORWARD AIR CORPORATION,BN,349853,4/4/2025,4/1/2025,3/18/2025,F,To ratify the appointment of KPMG LLP as the independent registered public accounting firm of the Company for the 2025 fiscal year.
2239159,-1,"2025-01-17||351471||To approve the adjournment of the Special Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposal if there are not sufficient votes to approve the foregoing proposal.||-1||-1",S07051,FOXO TECHNOLOGIES INC.,BN,351471,1/17/2025,1/14/2025,1/3/2025,F,"To approve the adjournment of the Special Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposal if there are not sufficient votes to approve the foregoing proposal."
2239209,-1,2025-01-17||351471||Such other matters as may properly come before the Special Meeting or any lawful adjournment or postponement thereof.||-1||-1,S07051,FOXO TECHNOLOGIES INC.,BN,351471,1/17/2025,1/14/2025,1/3/2025,F,Such other matters as may properly come before the Special Meeting or any lawful adjournment or postponement thereof.
2231007,-1,"2024-11-29||351471||To approve the adjournment of the Special Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals.||-1||-1",S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,"To approve the adjournment of the Special Meeting, if necessary or advisable, to solicit additional proxies in favor of the foregoing proposals if there are not sufficient votes to approve the foregoing proposals."
2230933,-1,"2024-11-29||351471||To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with Strata Purchase Agreement dated 10/13/2023 with ClearThink Capital Partners, LLC, as supplemented by the Supplement to Strata Purchase Agreement, dated as of 10/13/2023, & as amended, with ClearThink Capital Partners, LLC whereby ClearThink agreed to purchase up to $5,000,000 of shares.||-1||-1",S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,"To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with Strata Purchase Agreement dated 10/13/2023 with ClearThink Capital Partners, LLC, as supplemented by the Supplement to Strata Purchase Agreement, dated as of 10/13/2023, & as amended, with ClearThink Capital Partners, LLC whereby ClearThink agreed to purchase up to $5,000,000 of shares."
2230992,-1,"2024-11-29||351471||To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with the Exchange Agreement (the ""Smithline Exchange Agreement"") with Smithline Family Trust II (""Smithline"").||-1||-1",S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,"To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with the Exchange Agreement (the ""Smithline Exchange Agreement"") with Smithline Family Trust II (""Smithline"")."
2230903,-1,2024-11-29||351471||Such other matters as may properly come before the Special Meeting or any lawful adjournment or postponement thereof.||-1||-1,S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,Such other matters as may properly come before the Special Meeting or any lawful adjournment or postponement thereof.
2231029,-1,"2024-11-29||351471||To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with the Securities Purchase Agreement with an institutional investor pursuant to which the Company agreed to issue to the Purchaser and subsequent purchasers who will also be parties to the SPA Senior Notes in the aggregate principal amount of up to $2,800,000 (each a ""Note"" or, together, the ""Notes"").||-1||-1",S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,"To approve, for purposes of complying with NYSE American Rule 713, the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding immediately prior to such issuance in connection with the Securities Purchase Agreement with an institutional investor pursuant to which the Company agreed to issue to the Purchaser and subsequent purchasers who will also be parties to the SPA Senior Notes in the aggregate principal amount of up to $2,800,000 (each a ""Note"" or, together, the ""Notes"")."
2231064,-1,"2024-11-29||351471||To approve and adopt a proposal to amend our Third Amended and Restated Certificate of Incorporation, to effect a reverse stock split of our issued and outstanding Class A common stock, par value $0.0001 per share before 09/30/2025, at a ratio ranging from one-for-five (1:5) to one-for-one hundred (1:100) (""Reverse Split"") with the exact ratio within such range to be determined at the sole discretion of Board of our stockholders before the filing of an amendment to the Certificate of Incorporation effecting proposed Reverse Split.||-1||-1",S01913,FOXO TECHNOLOGIES INC.,BN,351471,11/29/2024,11/25/2024,11/15/2024,F,"To approve and adopt a proposal to amend our Third Amended and Restated Certificate of Incorporation, to effect a reverse stock split of our issued and outstanding Class A common stock, par value $0.0001 per share before 09/30/2025, at a ratio ranging from one-for-five (1:5) to one-for-one hundred (1:100) (""Reverse Split"") with the exact ratio within such range to be determined at the sole discretion of Board of our stockholders before the filing of an amendment to the Certificate of Incorporation effecting proposed Reverse Split."
2239150,-1,"2025-01-17||351471||To approve, for purposes of complying with NYSE American Rule 713, pursuant to the terms of the Company's Series A Cumulative Convertible Redeemable Preferred Stock (the ""Series A Preferred Stock""): (i) the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding when the Series A Preferred Stock was authorized, upon conversion of the shares of Series A Preferred Stock; and (ii) the voting terms thereof, which may constitute a ""Change of Control"" as defined by the NYSE American Rules.||-1||-1",S07051,FOXO TECHNOLOGIES INC.,BN,351471,1/17/2025,1/14/2025,1/3/2025,F,"To approve, for purposes of complying with NYSE American Rule 713, pursuant to the terms of the Company's Series A Cumulative Convertible Redeemable Preferred Stock (the ""Series A Preferred Stock""): (i) the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding when the Series A Preferred Stock was authorized, upon conversion of the shares of Series A Preferred Stock; and (ii) the voting terms thereof, which may constitute a ""Change of Control"" as defined by the NYSE American Rules."
2245581,-1,"2025-04-17||35952H||To approve, on a non-binding advisory basis, the compensation of FuelCell Energy, Inc.'s named executive officers as set forth in the ""Executive Compensation"" section of the Proxy Statement.||-1||-1",P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,"To approve, on a non-binding advisory basis, the compensation of FuelCell Energy, Inc.'s named executive officers as set forth in the ""Executive Compensation"" section of the Proxy Statement."
2245476,-1,"2025-04-17||35952H||To ratify the selection of KPMG LLP as FuelCell Energy, Inc.'s independent registered public accounting firm for the fiscal year ending October 31, 2025.||-1||-1",P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,"To ratify the selection of KPMG LLP as FuelCell Energy, Inc.'s independent registered public accounting firm for the fiscal year ending October 31, 2025."
2245440,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Jason Few||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Jason Few
2245472,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: James H. England||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: James H. England
2245641,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Betsy Bingham||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Betsy Bingham
2245439,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Tyrone Michael Jordan||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Tyrone Michael Jordan
2245509,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Natica von Althann||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Natica von Althann
2245615,-1,"2025-04-17||35952H||To approve the amendment and restatement of the FuelCell Energy, Inc. Fourth Amended and Restated 2018 Omnibus Incentive Plan.||-1||-1",P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,"To approve the amendment and restatement of the FuelCell Energy, Inc. Fourth Amended and Restated 2018 Omnibus Incentive Plan."
2245637,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Cynthia Hansen||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Cynthia Hansen
2245571,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Donna Sims Wilson||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Donna Sims Wilson
2245498,-1,2025-04-17||35952H||Election of Director to serve until the 2026 Annual Meeting: Matthew F. Hilzinger||-1||-1,P24866,"FUELCELL ENERGY, INC.",BD,35952H,4/17/2025,3/3/2025,2/12/2025,F,Election of Director to serve until the 2026 Annual Meeting: Matthew F. Hilzinger
2242495,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: Richard H. Osgood III||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: Richard H. Osgood III
2242416,-1,"2025-03-17||36872P||To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,"To ratify the appointment of Baker Tilly US, LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2025."
2242339,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: Mark Culhane||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: Mark Culhane
2242448,-1,2025-03-17||36872P||To approve the Genasys Inc. 2025 Equity Incentive Plan.||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,To approve the Genasys Inc. 2025 Equity Incentive Plan.
2242327,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: W. Craig Fugate||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: W. Craig Fugate
2242386,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: William H. Dodd||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: William H. Dodd
2242472,-1,2025-03-17||36872P||To consider an advisory vote on the compensation of our named executive officers.||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,To consider an advisory vote on the compensation of our named executive officers.
2242311,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: R. Rimmy Malhotra||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: R. Rimmy Malhotra
2242494,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: Richard S. Danforth||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: Richard S. Danforth
2242440,-1,2025-03-17||36872P||Election of Director to serve for the ensuing year and until their successors are elected: Susan Lee Schmeiser||-1||-1,P22767,GENASYS INC.,BD,36872P,3/17/2025,2/5/2025,1/21/2025,F,Election of Director to serve for the ensuing year and until their successors are elected: Susan Lee Schmeiser
-1,1301223,2025-05-01||376536||01||David Gladstone,P24867,GLADSTONE COMMERCIAL CORPORATION,BN,376536,5/1/2025,3/17/2025,3/7/2025,,
-1,1301129,2025-05-01||376536||02||John H. Outland,P24867,GLADSTONE COMMERCIAL CORPORATION,BN,376536,5/1/2025,3/17/2025,3/7/2025,,
2259039,-1,"2025-05-01||376536||To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025.||-1||-1",P24867,GLADSTONE COMMERCIAL CORPORATION,BN,376536,5/1/2025,3/17/2025,3/7/2025,F,"To ratify our Audit Committee's selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025."
2238418,-1,"2025-02-10||38358M||The ratification of the appointment of The Bonadio Group, CPAs, as independent public accountants for the fiscal year ending September 30, 2025.||-1||-1",P20760,"GOUVERNEUR BANCORP, INC.",BN,38358M,2/10/2025,1/9/2025,12/13/2024,F,"The ratification of the appointment of The Bonadio Group, CPAs, as independent public accountants for the fiscal year ending September 30, 2025."
2238495,-1,2025-02-10||38358M||Election of Director for the term of three years: Robert W. Barlow||-1||-1,P20760,"GOUVERNEUR BANCORP, INC.",BN,38358M,2/10/2025,1/9/2025,12/13/2024,F,Election of Director for the term of three years: Robert W. Barlow
2238465,-1,2025-02-10||38358M||Election of Director for the term of three years: David C. McClure||-1||-1,P20812,"GOUVERNEUR BANCORP, INC.",SH,38358M,2/10/2025,1/8/2025,12/13/2024,F,Election of Director for the term of three years: David C. McClure
2238440,-1,"2025-02-10||38358M||The approval of the Gouverneur Bancorp, Inc. 2025 Equity Incentive Plan.||-1||-1",P20812,"GOUVERNEUR BANCORP, INC.",SH,38358M,2/10/2025,1/8/2025,12/13/2024,F,"The approval of the Gouverneur Bancorp, Inc. 2025 Equity Incentive Plan."
2238502,-1,2025-02-10||38358M||Election of Director for the term of three years: Amy M. Rapholz||-1||-1,P20812,"GOUVERNEUR BANCORP, INC.",SH,38358M,2/10/2025,1/8/2025,12/13/2024,F,Election of Director for the term of three years: Amy M. Rapholz
2233708,-1,"2024-12-31||395330||To increase the number of shares eligible for sale under the Company's 2019 Equity Incentive Plan (the ""2019 Equity Incentive Plan"") to 317,568 shares, with an automatic adjustment, so that the number of shares eligible will equal 15% of the total shares of the Company's outstanding common stock (the ""2019 Equity Incentive Plan Proposal"").||-1||-1",P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,"To increase the number of shares eligible for sale under the Company's 2019 Equity Incentive Plan (the ""2019 Equity Incentive Plan"") to 317,568 shares, with an automatic adjustment, so that the number of shares eligible will equal 15% of the total shares of the Company's outstanding common stock (the ""2019 Equity Incentive Plan Proposal"")."
2233460,-1,"2024-12-31||395330||To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the 2019 Equity Incentive Plan Proposal and/or the Reverse Split Floor Price Decrease Proposal (the ""Adjournment Proposal"").||-1||-1",P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,"To approve an adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the 2019 Equity Incentive Plan Proposal and/or the Reverse Split Floor Price Decrease Proposal (the ""Adjournment Proposal"")."
2259573,-1,"2025-04-17||395330||To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Issuance Proposal and the Authorized Common Stock Increase Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, Authorized Common Stock Increase Proposal or the Issuance Proposal (the ""Adjournment Proposal"").||-1||-1",S10154,"GREENLANE HOLDINGS, INC.",BN,395330,4/17/2025,3/14/2025,2/21/2025,F,"To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Reverse Stock Split Proposal, the Issuance Proposal and the Authorized Common Stock Increase Proposal if there are not sufficient votes at the Special Meeting to approve and adopt the Reverse Stock Split Proposal, Authorized Common Stock Increase Proposal or the Issuance Proposal (the ""Adjournment Proposal"")."
2233695,-1,2024-12-31||395330||Election of Director: Barbara Sher||-1||-1,P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,Election of Director: Barbara Sher
2233408,-1,2024-12-31||395330||Election of Director: Aaron LoCascio||-1||-1,P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,Election of Director: Aaron LoCascio
2254969,-1,"2025-04-17||395330||To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of (1-for-3)] to a maximum of a (1-for-22)], with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"").||-1||-1",Z89677,"GREENLANE HOLDINGS, INC.",SH,395330,4/17/2025,3/17/2025,2/27/2025,F,"To grant discretionary authority to our board of directors to (i) amend our articles of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of (1-for-3)] to a maximum of a (1-for-22)], with the exact ratio to be determined by our board of directors in its sole discretion; and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Split Proposal"")."
2233710,-1,2024-12-31||395330||Election of Director: Donald Hunter||-1||-1,P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,Election of Director: Donald Hunter
2259983,-1,"2025-04-17||395330||To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 19, 2025 (the ""Issuance Proposal"").||-1||-1",S10154,"GREENLANE HOLDINGS, INC.",BN,395330,4/17/2025,3/14/2025,2/21/2025,F,"To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 19, 2025 (the ""Issuance Proposal"")."
2233412,-1,2024-12-31||395330||Election of Director: Renah Persofsky||-1||-1,P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,Election of Director: Renah Persofsky
2259911,-1,"2025-04-17||395330||To amend the articles of incorporation to increase the authorized shares of Class A common stock from 600,000,000 shares to 1,800,000,000 shares (the ""Authorized Common Stock Increase Proposal"").||-1||-1",S10154,"GREENLANE HOLDINGS, INC.",BN,395330,4/17/2025,3/14/2025,2/21/2025,F,"To amend the articles of incorporation to increase the authorized shares of Class A common stock from 600,000,000 shares to 1,800,000,000 shares (the ""Authorized Common Stock Increase Proposal"")."
2233467,-1,"2024-12-31||395330||Ratification of PKF O'Connor Davies, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.||-1||-1",P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,"Ratification of PKF O'Connor Davies, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024."
2233640,-1,"2024-12-31||395330||To approve, in accordance with Nasdaq listing rule 5635(d), the amendment of the 2024 August Warrant to purchase common stock in connection with an offering, and sale of securities of the Company that was consummated on August 13, 2024, to decrease the floor price provision in the event that the Company effects a Reverse Stock Split of its common stock in the future (the ""Reverse Split Floor Price Decrease Proposal"").||-1||-1",P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,"To approve, in accordance with Nasdaq listing rule 5635(d), the amendment of the 2024 August Warrant to purchase common stock in connection with an offering, and sale of securities of the Company that was consummated on August 13, 2024, to decrease the floor price provision in the event that the Company effects a Reverse Stock Split of its common stock in the future (the ""Reverse Split Floor Price Decrease Proposal"")."
2233603,-1,2024-12-31||395330||Election of Director: Michael C. Howe||-1||-1,P21369,"GREENLANE HOLDINGS, INC.",BN,395330,12/31/2024,12/10/2024,11/25/2024,F,Election of Director: Michael C. Howe
2240927,-1,"2025-02-11||3622AW||To approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the amendment to the Company's Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split.||-1||-1",S05943,GRI BIO INC,BD,3622AW,2/11/2025,1/24/2025,1/6/2025,F,"To approve the adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the amendment to the Company's Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split."
2240993,-1,"2025-02-11||3622AW||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of Company common stock by a ratio of not less than one-for-two and not more than one-for-23 (the ""Reverse Stock Split""), with the exact ratio to be set within this range by our board of directors in its sole discretion (without reducing the authorized number of shares of Company common stock).||-1||-1",S05943,GRI BIO INC,BD,3622AW,2/11/2025,1/24/2025,1/6/2025,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of Company common stock by a ratio of not less than one-for-two and not more than one-for-23 (the ""Reverse Stock Split""), with the exact ratio to be set within this range by our board of directors in its sole discretion (without reducing the authorized number of shares of Company common stock)."
2248940,-1,"2025-03-31||40423R||To approve an amendment to the Company's Certificate of Incorporation on or before the one-year anniversary of the Special Meeting to implement reverse stock splits of the outstanding shares of our Common Stock in a range from one-for- twenty (1:20) up to one-for-fifty (1:50), all as determined in the sole discretion of the Company's Board of Directors.||-1||-1",S09026,HCW BIOLOGICS INC.,BN,40423R,3/31/2025,3/3/2025,2/18/2025,F,"To approve an amendment to the Company's Certificate of Incorporation on or before the one-year anniversary of the Special Meeting to implement reverse stock splits of the outstanding shares of our Common Stock in a range from one-for- twenty (1:20) up to one-for-fifty (1:50), all as determined in the sole discretion of the Company's Board of Directors."
2248801,-1,"2025-03-31||40423R||To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of shares of our Common Stock upon conversion of up to $6,905,000 of principal amount of Senior Secured Notes issued by the Company to certain investors therein, including certain officers, directors and stockholders of the Company, pursuant to the Principal Terms as defined in the Proxy Statement.||-1||-1",S09026,HCW BIOLOGICS INC.,BN,40423R,3/31/2025,3/3/2025,2/18/2025,/,"To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of shares of our Common Stock upon conversion of up to $6,905,000 of principal amount of Senior Secured Notes issued by the Company to certain investors therein, including certain officers, directors and stockholders of the Company, pursuant to the Principal Terms as defined in the Proxy Statement."
2249021,-1,"2025-03-31||40423R||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of our Common Stock, or such lesser number of shares as the Board of Directors determines, pursuant to the Company's Equity Line of Credit (as defined in the Proxy Statement (the ""ELOC Proposal"")).||-1||-1",S09026,HCW BIOLOGICS INC.,BN,40423R,3/31/2025,3/3/2025,2/18/2025,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of our Common Stock, or such lesser number of shares as the Board of Directors determines, pursuant to the Company's Equity Line of Credit (as defined in the Proxy Statement (the ""ELOC Proposal""))."
2241653,-1,2025-03-14||422806||Election of Director: Carol F. Fine||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Carol F. Fine
2241579,-1,2025-03-14||422806||Election of Director: Eric A. Mendelson||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Eric A. Mendelson
2241533,-1,2025-03-14||422806||Election of Director: Julie Neitzel||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Julie Neitzel
2241656,-1,2025-03-14||422806||Election of Director: Dr. Alan Schriesheim||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Dr. Alan Schriesheim
2241544,-1,2025-03-14||422806||ADVISORY APPROVAL OF THE COMPANY'S EXECUTIVE COMPENSATION.||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,ADVISORY APPROVAL OF THE COMPANY'S EXECUTIVE COMPENSATION.
2241630,-1,2025-03-14||422806||Election of Director: Mark H. Hildebrandt||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Mark H. Hildebrandt
2241602,-1,"2025-03-14||422806||RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING OCTOBER 31, 2025.||-1||-1",P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,"RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING OCTOBER 31, 2025."
2241609,-1,2025-03-14||422806||Election of Director: Victor H. Mendelson||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Victor H. Mendelson
2241570,-1,2025-03-14||422806||Election of Director: Thomas M. Culligan||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Thomas M. Culligan
2241581,-1,2025-03-14||422806||Election of Director: Laurans A. Mendelson||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Laurans A. Mendelson
2241565,-1,2025-03-14||422806||Election of Director: Frank J. Schwitter||-1||-1,P23202,HEICO CORPORATION,BN,422806,3/14/2025,2/6/2025,1/17/2025,F,Election of Director: Frank J. Schwitter
2243617,-1,2025-03-14||422806||Election of Director: Adolfo Henriques||-1||-1,Z89188,HEICO CORPORATION,SH,422806,3/14/2025,2/7/2025,1/21/2025,F,Election of Director: Adolfo Henriques
2245626,-1,"2025-03-10||426897||Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to approve, on an advisory basis, the compensation of the Company's named executive officers."
2245425,-1,"2025-03-10||426897||Proposal to approve an amendment to the Company's Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse stock split of the Company's common stock at a ratio of between 1-for-10 and 1-for-50, with such ratio to be determined at the sole discretion of the board of directors of the Company and with such Reverse Stock Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to approve an amendment to the Company's Certificate of Incorporation, as amended (the ""Certificate of Incorporation"") to effect a reverse stock split of the Company's common stock at a ratio of between 1-for-10 and 1-for-50, with such ratio to be determined at the sole discretion of the board of directors of the Company and with such Reverse Stock Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion."
2245510,-1,"2025-03-10||426897||Election of Director: Kaouthar Lbiati, M.D.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Election of Director: Kaouthar Lbiati, M.D."
2245429,-1,"2025-03-10||426897||Proposal to ratify the appointment of Grassi & Co., CPAs, P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2024.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to ratify the appointment of Grassi & Co., CPAs, P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2024."
2227480,-1,"2024-12-12||426897||Proposal to approve and adopt the Agreement and Plan of Merger (""Merger Agreement""), dated July 19, 2024, by and among Hepion, Pharma Two B Ltd., a company organized under the laws of the State of Israel (""Pharma Two B"") and Pearl Merger Sub Inc., a Delaware corporation and indirect wholly-owned subsidiary of Pharma Two B.||-1||-1",S01652,"HEPION PHARMACEUTICALS, INC.",BN,426897,12/12/2024,11/13/2024,11/6/2024,F,"Proposal to approve and adopt the Agreement and Plan of Merger (""Merger Agreement""), dated July 19, 2024, by and among Hepion, Pharma Two B Ltd., a company organized under the laws of the State of Israel (""Pharma Two B"") and Pearl Merger Sub Inc., a Delaware corporation and indirect wholly-owned subsidiary of Pharma Two B."
2245544,-1,"2025-03-10||426897||Election of Director: Timothy Block, Ph.D.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Election of Director: Timothy Block, Ph.D."
2245486,-1,2025-03-10||426897||Election of Director: John P. Brancaccio||-1||-1,P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,Election of Director: John P. Brancaccio
2245769,-1,2025-03-10||426897||Election of Director: Michael Purcell||-1||-1,P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,Election of Director: Michael Purcell
2227581,-1,"2024-12-12||426897||Proposal to postpone or adjourn the special meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting.||-1||-1",S01652,"HEPION PHARMACEUTICALS, INC.",BN,426897,12/12/2024,11/13/2024,11/6/2024,F,"Proposal to postpone or adjourn the special meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting."
2245499,-1,"2025-03-10||426897||Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share, issuable by the Company upon exercise of the Series A Warrants and the Series B Warrants.||-1||-1",P25298,"HEPION PHARMACEUTICALS, INC.",BN,426897,3/10/2025,2/19/2025,1/17/2025,F,"Proposal to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share, issuable by the Company upon exercise of the Series A Warrants and the Series B Warrants."
2255367,-1,2025-04-23||G4412G||Election of Director: Michael O. Johnson||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Michael O. Johnson
2255490,-1,"2025-04-23||G4412G||Ratify, on an advisory basis, the appointment of the Company's independent registered public accounting firm for fiscal year 2025.||-1||-1",P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,"Ratify, on an advisory basis, the appointment of the Company's independent registered public accounting firm for fiscal year 2025."
2254857,-1,2025-04-23||G4412G||Election of Director: Celine Del Genes||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Celine Del Genes
2254896,-1,2025-04-23||G4412G||Election of Director: Maria Otero||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Maria Otero
2255401,-1,2025-04-23||G4412G||Election of Director: Juan Miguel Mendoza||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Juan Miguel Mendoza
2255057,-1,2025-04-23||G4412G||Election of Director: Rodica Macadrai||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Rodica Macadrai
2254821,-1,2025-04-23||G4412G||Election of Director: Don Mulligan||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Don Mulligan
2255065,-1,2025-04-23||G4412G||Election of Director: Michael Levitt||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Michael Levitt
2255484,-1,2025-04-23||G4412G||Election of Director: Perkins Miller||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Perkins Miller
2255329,-1,"2025-04-23||G4412G||Approve, on an advisory basis, the compensation of the Company's named executive officers.||-1||-1",P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,"Approve, on an advisory basis, the compensation of the Company's named executive officers."
2254817,-1,2025-04-23||G4412G||Election of Director: Sophie L'Hélias||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Sophie L'Hélias
2254827,-1,2025-04-23||G4412G||Election of Director: Richard H. Carmona||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Richard H. Carmona
2254994,-1,2025-04-23||G4412G||Election of Director: Lynda Cloud||-1||-1,P26520,HERBALIFE LTD.,BN,G4412G,4/23/2025,3/18/2025,2/25/2025,F,Election of Director: Lynda Cloud
2238878,-1,2025-02-26||436440||Election of Director: Charles J. Dockendorff||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Charles J. Dockendorff
2238973,-1,2025-02-26||436440||Election of Director: Stacey D. Stewart||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Stacey D. Stewart
2238926,-1,2025-02-26||436440||Election of Director: Stephen P. MacMillan||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Stephen P. MacMillan
2238951,-1,2025-02-26||436440||Election of Director: Ludwig N. Hantson||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Ludwig N. Hantson
2238925,-1,2025-02-26||436440||Election of Director: Amy M. Wendell||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Amy M. Wendell
2238972,-1,2025-02-26||436440||Election of Director: Nanaz Mohtashami||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Nanaz Mohtashami
2238896,-1,2025-02-26||436440||Election of Director: Christiana Stamoulis||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Christiana Stamoulis
2238990,-1,2025-02-26||436440||A non-binding advisory vote to approve executive compensation.||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,A non-binding advisory vote to approve executive compensation.
2238923,-1,2025-02-26||436440||Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2025.||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2025.
2239023,-1,2025-02-26||436440||Election of Director: Martin Madaus||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,F,Election of Director: Martin Madaus
2239024,-1,2025-02-26||436440||Advisory approval of a stockholder proposal to replace the supermajority voting provisions in our charter and bylaws with a simple majority voting standard.||-1||-1,P21545,"HOLOGIC, INC.",BN,436440,2/26/2025,1/24/2025,1/6/2025,/,Advisory approval of a stockholder proposal to replace the supermajority voting provisions in our charter and bylaws with a simple majority voting standard.
2255083,-1,2025-05-02||452308||Election of Director: E. Scott Santi||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: E. Scott Santi
2255032,-1,2025-05-02||452308||Election of Director: Darrell L. Ford||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Darrell L. Ford
2254795,-1,2025-05-02||452308||Election of Director: Christopher A. O'Herlihy||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Christopher A. O'Herlihy
2255314,-1,2025-05-02||452308||Election of Director: Susan Crown||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Susan Crown
2255270,-1,2025-05-02||452308||Election of Director: Daniel J. Brutto||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Daniel J. Brutto
2254800,-1,"2025-05-02||452308||A non-binding stockholder proposal, if properly presented at the meeting, for stockholder ratification of termination pay.||-1||-1",P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,N,"A non-binding stockholder proposal, if properly presented at the meeting, for stockholder ratification of termination pay."
2255088,-1,"2025-05-02||452308||Election of Director: David B. Smith, Jr.||-1||-1",P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,"Election of Director: David B. Smith, Jr."
2255469,-1,2025-05-02||452308||Election of Director: Jay L. Henderson||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Jay L. Henderson
2255070,-1,2025-05-02||452308||Election of Director: Kelly J. Grier||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Kelly J. Grier
2255340,-1,2025-05-02||452308||Ratification of the appointment of Deloitte & Touche LLP as ITW's independent registered public accounting firm for 2025.||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Ratification of the appointment of Deloitte & Touche LLP as ITW's independent registered public accounting firm for 2025.
2255414,-1,2025-05-02||452308||Election of Director: Richard H. Lenny||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Richard H. Lenny
2254793,-1,2025-05-02||452308||Election of Director: Jaime Irick||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Jaime Irick
2254761,-1,2025-05-02||452308||Election of Director: James W. Griffith||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: James W. Griffith
2254989,-1,2025-05-02||452308||Advisory vote to approve compensation of ITW's named executive officers.||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Advisory vote to approve compensation of ITW's named executive officers.
2254751,-1,2025-05-02||452308||Election of Director: Pamela B. Strobel||-1||-1,P21882,ILLINOIS TOOL WORKS INC.,BN,452308,5/2/2025,3/24/2025,3/3/2025,F,Election of Director: Pamela B. Strobel
2244153,-1,"2025-03-26||44967K||An amendment to the Company's Certificate of Incorporation, as amended from time to time, to increase the total number of shares of common stock authorized for issuance.||-1||-1",S08691,IMAC HOLDINGS INC,BN,44967K,3/26/2025,2/14/2025,1/27/2025,F,"An amendment to the Company's Certificate of Incorporation, as amended from time to time, to increase the total number of shares of common stock authorized for issuance."
2244175,-1,2025-03-26||44967K||The potential issuance of an excess of 19.99% of the Company's outstanding common stock under the Company's outstanding Series G Preferred Stock and related warrants.||-1||-1,S08691,IMAC HOLDINGS INC,BN,44967K,3/26/2025,2/14/2025,1/27/2025,F,The potential issuance of an excess of 19.99% of the Company's outstanding common stock under the Company's outstanding Series G Preferred Stock and related warrants.
2244152,-1,2025-03-26||44967K||The potential issuance of an excess of 19.99% of the Company's outstanding common stock pursuant to the Committed Equity Financing (as defined in the Proxy Statement).||-1||-1,S08691,IMAC HOLDINGS INC,BN,44967K,3/26/2025,2/14/2025,1/27/2025,F,The potential issuance of an excess of 19.99% of the Company's outstanding common stock pursuant to the Committed Equity Financing (as defined in the Proxy Statement).
2244142,-1,"2025-03-26||44967K||An amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock, subject to the Board of Directors' discretion.||-1||-1",S08691,IMAC HOLDINGS INC,BN,44967K,3/26/2025,2/14/2025,1/27/2025,F,"An amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's common stock, subject to the Board of Directors' discretion."
2250597,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Roger A. Carolin||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Roger A. Carolin
2250099,-1,"2025-04-17||45769N||Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,"Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025."
2250386,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Shahram Askarpour||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Shahram Askarpour
2250419,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Denise L. Devine||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Denise L. Devine
2250381,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Garry Dean||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Garry Dean
2249958,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Glen R. Bressner||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Glen R. Bressner
2250041,-1,2025-04-17||45769N||Election of Director of the Company for a term of one year: Stephen L. Belland||-1||-1,P26121,"INNOVATIVE SOLUTIONS AND SUPPORT,INC.",BN,45769N,4/17/2025,3/14/2025,2/20/2025,F,Election of Director of the Company for a term of one year: Stephen L. Belland
2264614,-1,2025-05-01||46120E||Election of Director: Sreelakshmi Kolli||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: Sreelakshmi Kolli
2264943,-1,"2025-05-01||46120E||The stockholder proposal that is titled ""Shareholder approval requirement for excessive golden parachutes,"" if properly presented at the Annual Meeting.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,N,"The stockholder proposal that is titled ""Shareholder approval requirement for excessive golden parachutes,"" if properly presented at the Annual Meeting."
2264704,-1,2025-05-01||46120E||Election of Director: Joseph C. Beery||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: Joseph C. Beery
2264295,-1,"2025-05-01||46120E||Election of Director: Monica P. Reed, M.D.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"Election of Director: Monica P. Reed, M.D."
2264347,-1,"2025-05-01||46120E||The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
2264841,-1,"2025-05-01||46120E||Election of Director: Craig H. Barratt, Ph.D.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"Election of Director: Craig H. Barratt, Ph.D."
2264956,-1,2025-05-01||46120E||Election of Director: Amal M. Johnson||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: Amal M. Johnson
2264191,-1,"2025-05-01||46120E||Election of Director: Keith R. Leonard, Jr.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"Election of Director: Keith R. Leonard, Jr."
2264366,-1,2025-05-01||46120E||Election of Director: Lewis Chew||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: Lewis Chew
2264485,-1,"2025-05-01||46120E||Election of Director: Amy L. Ladd, M.D.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"Election of Director: Amy L. Ladd, M.D."
2264241,-1,2025-05-01||46120E||The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.
2264765,-1,"2025-05-01||46120E||The stockholder proposal purportedly ""to improve the executive compensation program,"" if properly presented at the Annual Meeting.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,N,"The stockholder proposal purportedly ""to improve the executive compensation program,"" if properly presented at the Annual Meeting."
2264185,-1,"2025-05-01||46120E||To approve, by advisory vote, the compensation of the Company's Named Executive Officers.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"To approve, by advisory vote, the compensation of the Company's Named Executive Officers."
2264234,-1,2025-05-01||46120E||Election of Director: David J. Rosa||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: David J. Rosa
2264881,-1,"2025-05-01||46120E||Election of Director: Gary S. Guthart, Ph.D.||-1||-1",P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,"Election of Director: Gary S. Guthart, Ph.D."
2263756,-1,2025-05-01||46120E||Election of Director: Jami Dover Nachtsheim||-1||-1,P22172,"INTUITIVE SURGICAL, INC.",BN,46120E,5/1/2025,3/26/2025,3/3/2025,F,Election of Director: Jami Dover Nachtsheim
2248701,-1,"2025-04-24||46266C||Election of Director: John M. Leonard, M.D.||-1||-1",P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,"Election of Director: John M. Leonard, M.D."
2248557,-1,2025-04-24||46266C||Election of Director: Leslie Wims Morris||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Leslie Wims Morris
2248597,-1,2025-04-24||46266C||Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2025.||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2025.
2248722,-1,2025-04-24||46266C||Election of Director: Carol J. Burt||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Carol J. Burt
2248906,-1,2025-04-24||46266C||Approve a Company proposal to amend IQVIA's Certificate of Incorporation regarding officer exculpation.||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Approve a Company proposal to amend IQVIA's Certificate of Incorporation regarding officer exculpation.
2248972,-1,"2025-04-24||46266C||If properly presented, a stockholder proposal concerning special stockholder meetings.||-1||-1",P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,N,"If properly presented, a stockholder proposal concerning special stockholder meetings."
2248650,-1,2025-04-24||46266C||Election of Director: James A. Fasano||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: James A. Fasano
2248841,-1,2025-04-24||46266C||Election of Director: Sheila A. Stamps||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Sheila A. Stamps
2248877,-1,2025-04-24||46266C||Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).
2248461,-1,2025-04-24||46266C||Election of Director: Colleen A. Goggins||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Colleen A. Goggins
2248513,-1,2025-04-24||46266C||Election of Director: Todd B. Sisitsky||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Todd B. Sisitsky
2248911,-1,2025-04-24||46266C||Election of Director: John G. Danhakl||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: John G. Danhakl
2248530,-1,2025-04-24||46266C||Election of Director: Ari Bousbib||-1||-1,P25681,IQVIA HOLDINGS INC.,BN,46266C,4/24/2025,3/12/2025,2/24/2025,F,Election of Director: Ari Bousbib
2233375,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Christopher S. Holland||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Christopher S. Holland
2233513,-1,"2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: N.V. ""Tiger"" Tyagarajan||-1||-1",P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,"Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: N.V. ""Tiger"" Tyagarajan"
2233377,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: John C. Plant||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: John C. Plant
2233604,-1,"2025-01-23||466313||Ratify the appointment of Ernst & Young LLP as Jabil's independent registered public accounting firm for the fiscal year ending August 31, 2025.||-1||-1",P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,"Ratify the appointment of Ernst & Young LLP as Jabil's independent registered public accounting firm for the fiscal year ending August 31, 2025."
2233641,-1,2025-01-23||466313||Vote on a stockholder proposal requesting director election resignation governance guidelines.||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,N,Vote on a stockholder proposal requesting director election resignation governance guidelines.
2233642,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Mark T. Mondello||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Mark T. Mondello
2233533,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Michael Dastoor||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Michael Dastoor
2233556,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven A. Raymund||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Steven A. Raymund
2233373,-1,2025-01-23||466313||Vote on a stockholder proposal requesting that the Board adopt a policy to seek stockholder approval of certain termination pay arrangements.||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,N,Vote on a stockholder proposal requesting that the Board adopt a policy to seek stockholder approval of certain termination pay arrangements.
2233462,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Anousheh Ansari||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Anousheh Ansari
2233441,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: James Siminoff||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: James Siminoff
2233478,-1,2025-01-23||466313||Approve (on an advisory basis) Jabil's executive compensation.||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Approve (on an advisory basis) Jabil's executive compensation.
2233589,-1,2025-01-23||466313||Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Kathleen A. Walters||-1||-1,P21252,JABIL INC.,BN,466313,1/23/2025,12/17/2024,11/29/2024,F,Election of Director to serve until the next annual meeting of stockholders or until their respective successors are duly elected and qualified: Kathleen A. Walters
2242391,-1,"2025-02-21||47733C||To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.||-1||-1",P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,"To approve, on an advisory basis, the compensation of the Company's Named Executive Officers."
-1,1296501,2025-02-21||47733C||02||Chris Karlin,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
-1,1296485,2025-02-21||47733C||07||Mike Henningsen,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
-1,1296498,2025-02-21||47733C||09||Ian Wendler,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
2242360,-1,"2025-02-21||47733C||To confirm, ratify and approve all actions of the Directors and Officers carried out on behalf of the Company during the preceding year.||-1||-1",P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,"To confirm, ratify and approve all actions of the Directors and Officers carried out on behalf of the Company during the preceding year."
-1,1296480,2025-02-21||47733C||08||Subriana Pierce,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
2242390,-1,2025-02-21||47733C||To set the number of Directors at nine (9).||-1||-1,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,To set the number of Directors at nine (9).
-1,1296491,2025-02-21||47733C||03||Sarah Johnson,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
2242491,-1,2025-02-21||47733C||To transact such further or other business as may properly come before the Meeting and any adjournment or postponement thereof.||-1||-1,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,To transact such further or other business as may properly come before the Meeting and any adjournment or postponement thereof.
-1,1296495,2025-02-21||47733C||01||Charles E. Hopewell,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
2242411,-1,"2025-02-21||47733C||Appointment of Davidson & Company LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.||-1||-1",P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,"Appointment of Davidson & Company LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration."
-1,1296483,2025-02-21||47733C||06||Chad Summers,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
2242489,-1,"2025-02-21||47733C||To approve and ratify the 2024 Restricted Share Plan adopted by the Directors on January 10, 2025, as defined and set out in the Information Circular prepared for the Annual General Meeting.||-1||-1",P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,F,"To approve and ratify the 2024 Restricted Share Plan adopted by the Directors on January 10, 2025, as defined and set out in the Information Circular prepared for the Annual General Meeting."
-1,1296489,2025-02-21||47733C||05||Michelle Walker,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
-1,1296490,2025-02-21||47733C||04||Geoffrey Guilfoy,P23138,JEWETT-CAMERON TRADING COMPANY LTD.,BN,47733C,2/21/2025,1/30/2025,1/17/2025,,
-1,1294624,"2025-02-27||479167||02||John M. Fahey, Jr.",P19275,JOHNSON OUTDOORS INC.,BN,479167,2/27/2025,1/14/2025,12/19/2024,,
-1,1294525,2025-02-27||479167||06||Edward Stevens,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
-1,1294495,2025-02-27||479167||02||Liliann Annie Zipfel,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
-1,1294479,2025-02-27||479167||03||Katherine Button Bell,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
2238483,-1,"2025-02-27||479167||To ratify the appointment of RSM US LLP, an independent registered public accounting firm, as auditors of the Company for its fiscal year ending October 3, 2025.||-1||-1",P19275,JOHNSON OUTDOORS INC.,BN,479167,2/27/2025,1/14/2025,12/19/2024,F,"To ratify the appointment of RSM US LLP, an independent registered public accounting firm, as auditors of the Company for its fiscal year ending October 3, 2025."
2238503,-1,2025-02-27||479167||To approve a non-binding advisory proposal on executive compensation.||-1||-1,P19275,JOHNSON OUTDOORS INC.,BN,479167,2/27/2025,1/14/2025,12/19/2024,F,To approve a non-binding advisory proposal on executive compensation.
-1,1294629,2025-02-27||479167||01||Paul G. Alexander,P19275,JOHNSON OUTDOORS INC.,BN,479167,2/27/2025,1/14/2025,12/19/2024,,
-1,1294544,2025-02-27||479167||05||Richard Sheahan,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
-1,1294508,2025-02-27||479167||04||Edward F. Lang,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
-1,1294613,2025-02-27||479167||03||Jeffrey M. Stutz,P19275,JOHNSON OUTDOORS INC.,BN,479167,2/27/2025,1/14/2025,12/19/2024,,
-1,1294470,2025-02-27||479167||01||Helen P Johnson-Leipold,P19358,JOHNSON OUTDOORS INC.,SH,479167,2/27/2025,1/10/2025,12/19/2024,,
2236122,-1,"2025-01-30||48576U||To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 405,000,000 to 805,000,000 and the number of authorized shares of our common stock from 400,000,000 to 800,000,000.||-1||-1",S00771,KARYOPHARM THERAPEUTICS INC.,BD,48576U,1/30/2025,12/19/2024,12/4/2024,F,"To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our capital stock from 405,000,000 to 805,000,000 and the number of authorized shares of our common stock from 400,000,000 to 800,000,000."
2235981,-1,"2025-01-30||48576U||To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Inc, as amended, to effect a reverse stock split of our issued shares of common stock at a ratio within the range of not less than 1-for-5 and not greater than 1-for-15, and a proportionate reduction in the number of authorized shares of common stock, with the exact ratio within such range and the implementation & timing of such reverse stock split to be determined at sole discretion of Board of Directors, without further approval or authorization of our stockholders.||-1||-1",S00771,KARYOPHARM THERAPEUTICS INC.,BD,48576U,1/30/2025,12/19/2024,12/4/2024,F,"To adopt and approve an amendment to the Karyopharm Therapeutics Inc. Restated Certificate of Inc, as amended, to effect a reverse stock split of our issued shares of common stock at a ratio within the range of not less than 1-for-5 and not greater than 1-for-15, and a proportionate reduction in the number of authorized shares of common stock, with the exact ratio within such range and the implementation & timing of such reverse stock split to be determined at sole discretion of Board of Directors, without further approval or authorization of our stockholders."
2236078,-1,"2025-01-30||48576U||To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary to permit further solicitation of proxies in the event that there are insufficient votes for the adoption and approval of Proposal 1 or Proposal 2.||-1||-1",S00771,KARYOPHARM THERAPEUTICS INC.,BD,48576U,1/30/2025,12/19/2024,12/4/2024,F,"To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary to permit further solicitation of proxies in the event that there are insufficient votes for the adoption and approval of Proposal 1 or Proposal 2."
2241827,-1,2025-03-20||49338L||Election of Director for a three-year term: Joanne B. Olsen||-1||-1,P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,Election of Director for a three-year term: Joanne B. Olsen
2241752,-1,"2025-03-20||49338L||Approve, on a non-binding advisory basis, the compensation of Keysight's Named Executive Officers.||-1||-1",P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,"Approve, on a non-binding advisory basis, the compensation of Keysight's Named Executive Officers."
2241915,-1,2025-03-20||49338L||Election of Director for a three-year term: Michelle J. Holthaus||-1||-1,P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,Election of Director for a three-year term: Michelle J. Holthaus
2241812,-1,2025-03-20||49338L||Election of Director for a three-year term: James G. Cullen||-1||-1,P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,Election of Director for a three-year term: James G. Cullen
2241967,-1,2025-03-20||49338L||Election of Director for a three-year term: Jean M. Nye||-1||-1,P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,Election of Director for a three-year term: Jean M. Nye
2241968,-1,2025-03-20||49338L||Ratify the Audit and Finance Committee's appointment of Pricewaterhouse Coopers as the Company's independent auditor.||-1||-1,P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,F,Ratify the Audit and Finance Committee's appointment of Pricewaterhouse Coopers as the Company's independent auditor.
2241760,-1,"2025-03-20||49338L||Consider, on a non-binding advisory basis, the Stockholder Proposal: Elect Each Director Annually.||-1||-1",P22591,"KEYSIGHT TECHNOLOGIES, INC.",BN,49338L,3/20/2025,1/30/2025,1/22/2025,/,"Consider, on a non-binding advisory basis, the Stockholder Proposal: Elect Each Director Annually."
2263303,-1,2025-05-01||516544||Election of Class I Director: Ms. Mary Anne Heino||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,Election of Class I Director: Ms. Mary Anne Heino
2262142,-1,2025-05-01||516544||Election of Class I Director: Ms. Julie Eastland||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,Election of Class I Director: Ms. Julie Eastland
2263299,-1,"2025-05-01||516544||The approval, on an advisory basis, of the compensation paid to our named executive officers.||-1||-1",P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,"The approval, on an advisory basis, of the compensation paid to our named executive officers."
2262827,-1,2025-05-01||516544||The shareholder proposal regarding the declassification of our Board of Directors.||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,/,The shareholder proposal regarding the declassification of our Board of Directors.
2262268,-1,2025-05-01||516544||Election of Class I Director: Dr. Gérard Ber||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,Election of Class I Director: Dr. Gérard Ber
2262307,-1,2025-05-01||516544||Election of Class I Director: Mr. Samuel Leno||-1||-1,P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,Election of Class I Director: Mr. Samuel Leno
2262570,-1,"2025-05-01||516544||The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P25626,"LANTHEUS HOLDINGS, INC.",BN,516544,5/1/2025,3/31/2025,3/3/2025,F,"The ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025."
2262711,-1,2025-05-02||518415||Election of Director: Elizabeth Schwarting||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Elizabeth Schwarting
2262173,-1,2025-05-02||518415||Election of Director: James Lederer||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: James Lederer
2262235,-1,2025-05-02||518415||Election of Director: D. Jeffrey Richardson||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: D. Jeffrey Richardson
2262233,-1,2025-05-02||518415||Election of Director: Que Thanh Dallara||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Que Thanh Dallara
2262045,-1,2025-05-02||518415||Election of Director: Robin Abrams||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Robin Abrams
2262616,-1,"2025-05-02||518415||To approve on a non-binding, advisory basis, our Named Executive Officers' compensation.||-1||-1",P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,"To approve on a non-binding, advisory basis, our Named Executive Officers' compensation."
2262878,-1,2025-05-02||518415||Election of Director: Mark Jensen||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Mark Jensen
2263122,-1,2025-05-02||518415||Election of Director: Douglas Bettinger||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Douglas Bettinger
2263113,-1,"2025-05-02||518415||To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2026.||-1||-1",P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,"To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 3, 2026."
2263115,-1,2025-05-02||518415||Election of Director: Ford Tamer||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: Ford Tamer
2263099,-1,2025-05-02||518415||Election of Director: John Forsyth||-1||-1,P26926,LATTICE SEMICONDUCTOR CORPORATION,BN,518415,5/2/2025,3/25/2025,3/3/2025,F,Election of Director: John Forsyth
2238473,-1,2025-02-27||523768||Election of Director: Mary E. Junck||-1||-1,P21557,"LEE ENTERPRISES, INCORPORATED",BN,523768,2/27/2025,1/28/2025,12/31/2024,F,Election of Director: Mary E. Junck
2238415,-1,"2025-02-27||523768||Approve, by non-binding vote, the Company's compensation of its Named Executive Officers (""Say-On-Pay"" vote).||-1||-1",P21557,"LEE ENTERPRISES, INCORPORATED",BN,523768,2/27/2025,1/28/2025,12/31/2024,F,"Approve, by non-binding vote, the Company's compensation of its Named Executive Officers (""Say-On-Pay"" vote)."
2239577,-1,2025-02-27||523768||Approve to amend the 2020 Long-Term Incentive Plan.||-1||-1,P21595,"LEE ENTERPRISES, INCORPORATED",SH,523768,2/27/2025,1/28/2025,12/31/2024,F,Approve to amend the 2020 Long-Term Incentive Plan.
2239508,-1,2025-02-27||523768||Election of Director: Kevin D. Mowbray||-1||-1,P21595,"LEE ENTERPRISES, INCORPORATED",SH,523768,2/27/2025,1/28/2025,12/31/2024,F,Election of Director: Kevin D. Mowbray
2239599,-1,"2025-02-27||523768||To ratify the selection of BDO USA, P.C. as the Company's Independent registered public accounting firm for fiscal year 2025.||-1||-1",P21595,"LEE ENTERPRISES, INCORPORATED",SH,523768,2/27/2025,1/28/2025,12/31/2024,F,"To ratify the selection of BDO USA, P.C. as the Company's Independent registered public accounting firm for fiscal year 2025."
2238361,-1,2025-02-27||523768||Election of Director: Herbert W. Moloney||-1||-1,P21557,"LEE ENTERPRISES, INCORPORATED",BN,523768,2/27/2025,1/28/2025,12/31/2024,F,Election of Director: Herbert W. Moloney
2241892,-1,"2025-03-12||527064||Adoption of the Exculpation Amendment, limiting the liability of certain Company officers.||-1||-1",P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,"Adoption of the Exculpation Amendment, limiting the liability of certain Company officers."
2241917,-1,2025-03-12||527064||Election of Class I Director: Maile Naylor||-1||-1,P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,Election of Class I Director: Maile Naylor
2241853,-1,"2025-03-12||527064||Adoption of the Removal Amendment, permitting the removal of directors with or without cause as of the 2027 Annual Meeting.||-1||-1",P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,"Adoption of the Removal Amendment, permitting the removal of directors with or without cause as of the 2027 Annual Meeting."
2241761,-1,"2025-03-12||527064||Non-binding, advisory vote to approve named executive officer compensation.||-1||-1",P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,"Non-binding, advisory vote to approve named executive officer compensation."
2241950,-1,2025-03-12||527064||Election of Class I Director: Yolanda Daniel||-1||-1,P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,Election of Class I Director: Yolanda Daniel
2241839,-1,2025-03-12||527064||Election of Class I Director: Jason McDonell||-1||-1,P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,Election of Class I Director: Jason McDonell
2241762,-1,"2025-03-12||527064||Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending October 4, 2025.||-1||-1",P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,"Ratification of the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending October 4, 2025."
2241789,-1,2025-03-12||527064||Election of Class II Director: Lorna Nagler||-1||-1,P22698,"LESLIE'S, INC.",BN,527064,3/12/2025,1/31/2025,1/15/2025,F,Election of Class II Director: Lorna Nagler
-1,1299007,2025-04-15||53115L||03||James R. McDonald,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,,
-1,1299120,2025-04-15||53115L||01||Peter A. Dea,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,,
2249632,-1,2025-04-15||53115L||Approve miscellaneous amendments to clarify and update the Company's certificate of incorporation.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Approve miscellaneous amendments to clarify and update the Company's certificate of incorporation.
2249607,-1,2025-04-15||53115L||Advisory vote to approve the compensation of the Company's named executive officers.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Advisory vote to approve the compensation of the Company's named executive officers.
2249457,-1,"2025-04-15||53115L||Approve an amendment to the Company's certificate of incorporation to remove the 66 2/3% supermajority vote requirements to amend, alter, or repeal the Company's certificate of incorporation and bylaws and to remove directors from office.||-1||-1",P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,"Approve an amendment to the Company's certificate of incorporation to remove the 66 2/3% supermajority vote requirements to amend, alter, or repeal the Company's certificate of incorporation and bylaws and to remove directors from office."
2249266,-1,2025-04-15||53115L||Approve an amendment to the Company's certificate of incorporation to delete the waiver of Section 203 of the Delaware General Corporation Law.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Approve an amendment to the Company's certificate of incorporation to delete the waiver of Section 203 of the Delaware General Corporation Law.
2249839,-1,2025-04-15||53115L||Ratification of appointment of the Company's independent registered public accounting firm.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Ratification of appointment of the Company's independent registered public accounting firm.
2249519,-1,2025-04-15||53115L||Approve an amendment to the Company's certificate of incorporation to limit the liability of certain officers.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Approve an amendment to the Company's certificate of incorporation to limit the liability of certain officers.
2249726,-1,2025-04-15||53115L||Approve an amendment to the Company's certificate of incorporation to declassify the board of directors.||-1||-1,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,F,Approve an amendment to the Company's certificate of incorporation to declassify the board of directors.
-1,1299100,2025-04-15||53115L||02||William F. Kimble,P25793,LIBERTY ENERGY INC.,BN,53115L,4/15/2025,3/13/2025,2/19/2025,,
2280579,-1,"2025-04-24||531465||A proposal to approve the adoption of an amendment to the Liberty TripAdvisor certificate of incorporation, which amends certain provisions of the certificate of designations to provide that, in connection with the merger, all shares of Liberty TripAdvisor preferred stock issued and outstanding immediately prior to the effective time of the merger (other than the excluded treasury shares) will be converted into the right to receive the preferred share merger consideration (the ""charter amendment proposal"").||-1||-1",S12443,"LIBERTY TRIPADVISOR HOLDINGS, INC.",BN,531465,4/24/2025,3/28/2025,3/21/2025,F,"A proposal to approve the adoption of an amendment to the Liberty TripAdvisor certificate of incorporation, which amends certain provisions of the certificate of designations to provide that, in connection with the merger, all shares of Liberty TripAdvisor preferred stock issued and outstanding immediately prior to the effective time of the merger (other than the excluded treasury shares) will be converted into the right to receive the preferred share merger consideration (the ""charter amendment proposal"")."
2280354,-1,"2025-04-24||531465||A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Liberty TripAdvisor's named executive officers that is based on or related to the merger agreement and the transactions contemplated thereby.||-1||-1",S12443,"LIBERTY TRIPADVISOR HOLDINGS, INC.",BN,531465,4/24/2025,3/28/2025,3/21/2025,F,"A proposal to approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Liberty TripAdvisor's named executive officers that is based on or related to the merger agreement and the transactions contemplated thereby."
2281283,-1,"2025-04-24||531465||A proposal to approve the adjournment of the special meeting from time to time to solicit additional proxies in favor of the merger proposal or the charter amendment proposal, as applicable, if there are insufficient votes at the time of such adjournment to approve the merger proposal or the charter amendment proposal, as applicable, or if otherwise determined by the chairperson of the meeting to be necessary or appropriate.||-1||-1",S12443,"LIBERTY TRIPADVISOR HOLDINGS, INC.",BN,531465,4/24/2025,3/28/2025,3/21/2025,F,"A proposal to approve the adjournment of the special meeting from time to time to solicit additional proxies in favor of the merger proposal or the charter amendment proposal, as applicable, if there are insufficient votes at the time of such adjournment to approve the merger proposal or the charter amendment proposal, as applicable, or if otherwise determined by the chairperson of the meeting to be necessary or appropriate."
2280753,-1,"2025-04-24||531465||A proposal to approve the adoption of the Agreement and Plan of Merger, dated December 18, 2024 (as may be amended from time to time, the ""merger agreement""), by and among Tripadvisor, Inc., a Delaware corporation (""Tripadvisor""), Liberty TripAdvisor Holdings, Inc., a Delaware corporation (""Liberty TripAdvisor""), and Telluride Merger Sub Corp., a Delaware corporation and an indirect wholly owned subsidiary of Tripadvisor (""Merger Sub""), pursuant to which Merger Sub will merge with and into Liberty ...(due to space limits, see proxy material for full proposal).||-1||-1",S12443,"LIBERTY TRIPADVISOR HOLDINGS, INC.",BN,531465,4/24/2025,3/28/2025,3/21/2025,F,"A proposal to approve the adoption of the Agreement and Plan of Merger, dated December 18, 2024 (as may be amended from time to time, the ""merger agreement""), by and among Tripadvisor, Inc., a Delaware corporation (""Tripadvisor""), Liberty TripAdvisor Holdings, Inc., a Delaware corporation (""Liberty TripAdvisor""), and Telluride Merger Sub Corp., a Delaware corporation and an indirect wholly owned subsidiary of Tripadvisor (""Merger Sub""), pursuant to which Merger Sub will merge with and into Liberty ...(due to space limits, see proxy material for full proposal)."
-1,1299367,2025-04-09||532746||01||Barbara Carbone,P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,,
-1,1299200,2025-04-09||532746||02||Gordon E. Kimball,P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,,
-1,1299341,2025-04-09||532746||03||Scott S. Slater,P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,,
2250603,-1,"2025-04-09||532746||To vote on an advisory resolution to approve the compensation of the Named Executive Officers as disclosed in this proxy statement (""Proposal 2"").||-1||-1",P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,F,"To vote on an advisory resolution to approve the compensation of the Named Executive Officers as disclosed in this proxy statement (""Proposal 2"")."
2249920,-1,"2025-04-09||532746||To ratify the appointment of Deloitte & Touche LLP to service as the independent registered public accounting firm for Limoneira Company for the fiscal year ending October 31, 2025 (""Proposal 3"").||-1||-1",P25367,LIMONEIRA COMPANY,BN,532746,4/9/2025,3/4/2025,2/12/2025,F,"To ratify the appointment of Deloitte & Touche LLP to service as the independent registered public accounting firm for Limoneira Company for the fiscal year ending October 31, 2025 (""Proposal 3"")."
2253959,-1,2025-04-24||536797||Election of Director: Sidney B. DeBoer||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Sidney B. DeBoer
2253990,-1,2025-04-24||536797||Election of Director: Cassandra M. McKinney||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Cassandra M. McKinney
2253797,-1,2025-04-24||536797||Election of Director: James E. Lentz||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: James E. Lentz
2253804,-1,"2025-04-24||536797||Vote on a shareholder proposal requesting shareholder approval of certain executive severance arrangements, if properly presented.||-1||-1",P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,N,"Vote on a shareholder proposal requesting shareholder approval of certain executive severance arrangements, if properly presented."
2254172,-1,2025-04-24||536797||Election of Director: Louis P. Miramontes||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Louis P. Miramontes
2253733,-1,2025-04-24||536797||Election of Director: Bryan B. DeBoer||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Bryan B. DeBoer
2253689,-1,"2025-04-24||536797||To approve the company's 2013 Stock Incentive Plan, as amended to increase the number of shares authorized for issuance by 1,160,000 shares.||-1||-1",P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,"To approve the company's 2013 Stock Incentive Plan, as amended to increase the number of shares authorized for issuance by 1,160,000 shares."
2254068,-1,2025-04-24||536797||Election of Director: Shauna F. McIntyre||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Shauna F. McIntyre
2253758,-1,"2025-04-24||536797||To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025.||-1||-1",P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,"To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year ending December 31, 2025."
2254115,-1,"2025-04-24||536797||To approve, by an advisory vote, named executive officer compensation.||-1||-1",P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,"To approve, by an advisory vote, named executive officer compensation."
2253920,-1,2025-04-24||536797||Election of Director: Stacy C. Loretz-Congdon||-1||-1,P25914,"LITHIA MOTORS, INC.",BN,536797,4/24/2025,3/24/2025,2/28/2025,F,Election of Director: Stacy C. Loretz-Congdon
2225964,-1,"2024-11-25||538146||Approval of an amendment and restatement of the 2019 Employee Stock Purchase Plan, including to increase the number of shares available for issuance and to make certain other changes.||-1||-1",Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,"Approval of an amendment and restatement of the 2019 Employee Stock Purchase Plan, including to increase the number of shares available for issuance and to make certain other changes."
2225882,-1,"2024-11-25||538146||Ratification of the appointment of BDO USA, P.C. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024.||-1||-1",Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,"Ratification of the appointment of BDO USA, P.C. as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024."
2225917,-1,2024-11-25||538146||Approval of an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.||-1||-1,Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,Approval of an amendment to the Company's Fourth Amended and Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.
2225842,-1,"2024-11-25||538146||LIVEPERSON, INC. NOMINEE: Karin-Joyce (K.J.) Tjon||-1||-1",Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,"LIVEPERSON, INC. NOMINEE: Karin-Joyce (K.J.) Tjon"
2225819,-1,"2024-11-25||538146||Approval of an amendment and restatement of the 2019 Stock Incentive Plan, including to increase the number of shares available for issuance and to make certain other changes.||-1||-1",Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,"Approval of an amendment and restatement of the 2019 Stock Incentive Plan, including to increase the number of shares available for issuance and to make certain other changes."
2225840,-1,2024-11-25||538146||IKON NOMINEE OPPOSED BY THE COMPANY: NOMINEE WITHDRAWN||-1||-1,Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,W,IKON NOMINEE OPPOSED BY THE COMPANY: NOMINEE WITHDRAWN
2225955,-1,"2024-11-25||538146||Approval of the Company's Tax Benefits Preservation Plan so that it may remain in effect through January 21, 2027 unless earlier terminated by the Company's Board of Directors.||-1||-1",Z88877,"LIVEPERSON, INC.",DR,538146,11/25/2024,11/7/2024,11/5/2024,F,"Approval of the Company's Tax Benefits Preservation Plan so that it may remain in effect through January 21, 2027 unless earlier terminated by the Company's Board of Directors."
2259692,-1,"2025-03-27||67091J||To approve, for purposes of Rule 5635(d) of The Nasdaq Stock Market LLC, the issuance of 20% or more of the Company's outstanding shares of common stock, par value $0.0001 per share (""Common Stock""), upon exercise of the Company's Series C common stock purchase warrants and the Company's Series D common stock purchase warrants, dated February 18, 2025.||-1||-1",S10023,"LOGICMARK, INC.",BN,67091J,3/27/2025,3/14/2025,2/18/2025,F,"To approve, for purposes of Rule 5635(d) of The Nasdaq Stock Market LLC, the issuance of 20% or more of the Company's outstanding shares of common stock, par value $0.0001 per share (""Common Stock""), upon exercise of the Company's Series C common stock purchase warrants and the Company's Series D common stock purchase warrants, dated February 18, 2025."
2258769,-1,"2025-03-27||67091J||To authorize the Company's board of directors (the ""Board"") to amend the Company's articles of incorporation, as amended, as then in effect (the ""Charter""), to effect a reverse stock split of all of the outstanding shares of Common Stock by a ratio in the range of one-for-ten to one-for-fifty, no later than December 31, 2025 (the ""Common Stock Reverse Stock Split Proposal"").||-1||-1",S10023,"LOGICMARK, INC.",BN,67091J,3/27/2025,3/14/2025,2/18/2025,F,"To authorize the Company's board of directors (the ""Board"") to amend the Company's articles of incorporation, as amended, as then in effect (the ""Charter""), to effect a reverse stock split of all of the outstanding shares of Common Stock by a ratio in the range of one-for-ten to one-for-fifty, no later than December 31, 2025 (the ""Common Stock Reverse Stock Split Proposal"")."
2260047,-1,"2025-03-27||67091J||To authorize the Board to amend the Charter by amending the Company's Certificate of Designations, Preferences and Rights of Series C Non-Convertible Voting Preferred Stock to (i) effect a reverse stock split of all outstanding shares of Series C Preferred Stock, by the same ratio that the Board selects for the Common Stock reverse stock split and simultaneously therewith and (ii) proportionally adjust the stated value of the Series C Preferred Stock to reflect such ratio.||-1||-1",S10023,"LOGICMARK, INC.",BN,67091J,3/27/2025,3/14/2025,2/18/2025,F,"To authorize the Board to amend the Charter by amending the Company's Certificate of Designations, Preferences and Rights of Series C Non-Convertible Voting Preferred Stock to (i) effect a reverse stock split of all outstanding shares of Series C Preferred Stock, by the same ratio that the Board selects for the Common Stock reverse stock split and simultaneously therewith and (ii) proportionally adjust the stated value of the Series C Preferred Stock to reflect such ratio."
2259791,-1,"2025-03-27||67091J||To authorize the Board to amend the Charter to increase the number of authorized shares of the Company's capital stock from 110,000,000 shares to up to 880,000,000 shares, provided that the ratio between the number of authorized shares of Common Stock and the number of authorized shares of the Company's ""blank check"" preferred stock, par value $0.0001 per share, remains at all times 10:1, no later than December 31, 2025.||-1||-1",S10023,"LOGICMARK, INC.",BN,67091J,3/27/2025,3/14/2025,2/18/2025,F,"To authorize the Board to amend the Charter to increase the number of authorized shares of the Company's capital stock from 110,000,000 shares to up to 880,000,000 shares, provided that the ratio between the number of authorized shares of Common Stock and the number of authorized shares of the Company's ""blank check"" preferred stock, par value $0.0001 per share, remains at all times 10:1, no later than December 31, 2025."
2243151,-1,"2025-02-19||565788||To approve an amendment to our Restated Articles of Incorporation to increase the number of shares of common stock authorized for issuance from 500,000,000 shares to 800,000,000 shares.||-1||-1",Z89369,"MARATHON DIGITAL HOLDINGS, INC.",BN,565788,2/19/2025,2/4/2025,1/23/2025,F,"To approve an amendment to our Restated Articles of Incorporation to increase the number of shares of common stock authorized for issuance from 500,000,000 shares to 800,000,000 shares."
2243107,-1,2025-02-19||565788||To approve one or more adjournments of the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if we conclude that there are insufficient votes to approve Proposal No. 1 at the time of the Special Meeting (or any adjournment thereof).||-1||-1,Z89369,"MARATHON DIGITAL HOLDINGS, INC.",BN,565788,2/19/2025,2/4/2025,1/23/2025,F,To approve one or more adjournments of the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if we conclude that there are insufficient votes to approve Proposal No. 1 at the time of the Special Meeting (or any adjournment thereof).
2254058,-1,2025-04-30||56585A||Ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent auditor for 2025.||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Ratification of the appointment of PricewaterhouseCoopers LLP as the company's independent auditor for 2025.
2254121,-1,2025-04-30||56585A||Election of Class II Director: Kim K.W. Rucker||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Election of Class II Director: Kim K.W. Rucker
2253745,-1,"2025-04-30||56585A||Approval, on an advisory basis, of the company's named executive officer compensation.||-1||-1",P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,"Approval, on an advisory basis, of the company's named executive officer compensation."
2253947,-1,2025-04-30||56585A||Approval of an amendment to the company's Restated Certificate of Incorporation to eliminate supermajority provisions.||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Approval of an amendment to the company's Restated Certificate of Incorporation to eliminate supermajority provisions.
2253918,-1,2025-04-30||56585A||Approval of an amendment to the company's Restated Certificate of Incorporation to declassify the Board of Directors.||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Approval of an amendment to the company's Restated Certificate of Incorporation to declassify the Board of Directors.
2253769,-1,2025-04-30||56585A||Election of Class II Director: Evan Bayh||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Election of Class II Director: Evan Bayh
2254091,-1,2025-04-30||56585A||Shareholder proposal to support a simple majority vote.||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,N,Shareholder proposal to support a simple majority vote.
2254164,-1,2025-04-30||56585A||Election of Class II Director: Kimberly N. Ellison-Taylor||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Election of Class II Director: Kimberly N. Ellison-Taylor
2253676,-1,2025-04-30||56585A||Election of Class II Director: Jeffrey C. Campbell||-1||-1,P22201,MARATHON PETROLEUM CORPORATION,BN,56585A,4/30/2025,3/26/2025,3/3/2025,F,Election of Class II Director: Jeffrey C. Campbell
2257895,-1,"2025-03-20||57064P||To adopt and approve an amendment to our Certificate of Incorporation (the ""Certificate of Amendment"") to effect a reverse stock split of our common stock at a ratio of 1-for-20, the implementation and timing of such reverse stock split to be determined by our Board of Directors (the ""Board"") in its sole discretion, subject to the Board's authority to abandon such reverse stock split (the ""Reverse Split Proposal"").||-1||-1",S10688,"MARKETWISE, INC.",BN,57064P,3/20/2025,3/13/2025,2/27/2025,F,"To adopt and approve an amendment to our Certificate of Incorporation (the ""Certificate of Amendment"") to effect a reverse stock split of our common stock at a ratio of 1-for-20, the implementation and timing of such reverse stock split to be determined by our Board of Directors (the ""Board"") in its sole discretion, subject to the Board's authority to abandon such reverse stock split (the ""Reverse Split Proposal"")."
2257789,-1,"2025-03-20||57064P||To transact such other business as may properly come before the Special Meeting or any continuation, postponement or adjournment of the Special Meeting (the ""Adjournment Proposal"").||-1||-1",S10688,"MARKETWISE, INC.",BN,57064P,3/20/2025,3/13/2025,2/27/2025,F,"To transact such other business as may properly come before the Special Meeting or any continuation, postponement or adjournment of the Special Meeting (the ""Adjournment Proposal"")."
2257726,-1,"2025-03-20||57064P||To adopt and approve a Certificate of Amendment to decrease the number of authorized shares of (a) all classes of stock from 1,350,000,000 to 162,500,000, (b) our Class A common stock from 950,000,000 to 47,500,000 and (c) our Class B common stock from 300,000,000 to 15,000,000 (the ""Authorized Shares Proposal"").||-1||-1",S10688,"MARKETWISE, INC.",BN,57064P,3/20/2025,3/13/2025,2/27/2025,F,"To adopt and approve a Certificate of Amendment to decrease the number of authorized shares of (a) all classes of stock from 1,350,000,000 to 162,500,000, (b) our Class A common stock from 950,000,000 to 47,500,000 and (c) our Class B common stock from 300,000,000 to 15,000,000 (the ""Authorized Shares Proposal"")."
2255308,-1,"2025-04-29||574795||To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2026.||-1||-1",P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,"To ratify the selection of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending January 3, 2026."
2254907,-1,2025-04-29||574795||Election of Director: Timothy Scannell||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: Timothy Scannell
2255264,-1,2025-04-29||574795||Election of Director: Wendy Lane||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: Wendy Lane
2255393,-1,2025-04-29||574795||Election of Director: Darlene Solomon||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: Darlene Solomon
2254913,-1,2025-04-29||574795||Election of Director: Catherine Szyman||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: Catherine Szyman
2254755,-1,2025-04-29||574795||Election of Director: William Jellison||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,Election of Director: William Jellison
2254870,-1,2025-04-29||574795||An advisory vote to approve the compensation of our named executive officers.||-1||-1,P24742,MASIMO CORPORATION,BN,574795,4/29/2025,4/4/2025,3/3/2025,F,An advisory vote to approve the compensation of our named executive officers.
-1,1301378,2025-04-22||578605||02||Jay O. Rothman,P21843,"MAYVILLE ENGINEERING COMPANY, INC.",BN,578605,4/22/2025,3/17/2025,2/21/2025,,
2261457,-1,2025-04-22||578605||Advisory vote to approve the compensation of our named executive officers.||-1||-1,P21843,"MAYVILLE ENGINEERING COMPANY, INC.",BN,578605,4/22/2025,3/17/2025,2/21/2025,F,Advisory vote to approve the compensation of our named executive officers.
-1,1297359,2025-04-22||578605||01||Jagadeesh A. Reddy,P22297,"MAYVILLE ENGINEERING COMPANY, INC.",SH,578605,4/22/2025,3/17/2025,2/21/2025,,
2261396,-1,2025-04-22||578605||Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.||-1||-1,P21843,"MAYVILLE ENGINEERING COMPANY, INC.",BN,578605,4/22/2025,3/17/2025,2/21/2025,F,Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2025.
2248096,-1,"2025-03-06||58450D||The issuance of (i) up to 28,206,152 shares of MediaCo Class A Common Stock, upon the exercise of a warrant issued in connection with MediaCo's acquisition of certain assets of Estrella Broadcasting, Inc. and its subsidiaries, and (ii) 7,051,538 shares of MediaCo Class A Common Stock, upon the exercise of the option right held by a subsidiary of MediaCo to purchase, or the put right held by Estrella Media, Inc. to sell equity interests of certain of its subsidiaries holding certain broadcast assets.||-1||-1",S09960,MEDIACO HOLDING INC.,BN,58450D,3/6/2025,2/28/2025,2/13/2025,F,"The issuance of (i) up to 28,206,152 shares of MediaCo Class A Common Stock, upon the exercise of a warrant issued in connection with MediaCo's acquisition of certain assets of Estrella Broadcasting, Inc. and its subsidiaries, and (ii) 7,051,538 shares of MediaCo Class A Common Stock, upon the exercise of the option right held by a subsidiary of MediaCo to purchase, or the put right held by Estrella Media, Inc. to sell equity interests of certain of its subsidiaries holding certain broadcast assets."
2236019,-1,"2025-01-30||55279B||To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement.||-1||-1",P22004,"MEI PHARMA, INC.",BN,55279B,1/30/2025,12/30/2024,12/9/2024,F,"To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement."
2235972,-1,"2025-01-30||55279B||To ratify the appointment of Deloitte & Touche LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending June 30, 2025.||-1||-1",P22004,"MEI PHARMA, INC.",BN,55279B,1/30/2025,12/30/2024,12/9/2024,F,"To ratify the appointment of Deloitte & Touche LLP, an independent registered public accounting firm, as our independent auditors for the fiscal year ending June 30, 2025."
2236159,-1,2025-01-30||55279B||Election of Director to serve until the term in fiscal year 2028 and until their successor is elected and qualified: Frederick W. Driscoll||-1||-1,P22004,"MEI PHARMA, INC.",BN,55279B,1/30/2025,12/30/2024,12/9/2024,F,Election of Director to serve until the term in fiscal year 2028 and until their successor is elected and qualified: Frederick W. Driscoll
2236144,-1,"2025-01-30||55279B||Election of Director to serve until the term in fiscal year 2028 and until their successor is elected and qualified: Nicholas R. Glover, Ph.D||-1||-1",P22004,"MEI PHARMA, INC.",BN,55279B,1/30/2025,12/30/2024,12/9/2024,F,"Election of Director to serve until the term in fiscal year 2028 and until their successor is elected and qualified: Nicholas R. Glover, Ph.D"
2248997,-1,"2025-04-11||59503A||To approve an amendment to the Company's Certificate of Incorporation, as amended and/or restated from time to time (the ""Certificate of Incorporation""), to increase the total number of shares of common stock authorized for issuance (the ""Increase Proposal"").||-1||-1",Z89510,MICROBOT MEDICAL INC.,BN,59503A,4/11/2025,3/7/2025,2/11/2025,F,"To approve an amendment to the Company's Certificate of Incorporation, as amended and/or restated from time to time (the ""Certificate of Incorporation""), to increase the total number of shares of common stock authorized for issuance (the ""Increase Proposal"")."
2248458,-1,"2025-04-11||59503A||To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Issuance Proposal and/or the Increase Proposal, if there are not sufficient votes at the Special Meeting to approve and adopt the Issuance Proposal or the Increase Proposal.||-1||-1",Z89510,MICROBOT MEDICAL INC.,BN,59503A,4/11/2025,3/7/2025,2/11/2025,F,"To approve one or more adjournments of the Special Meeting, if necessary or appropriate, to solicit additional proxies in favor of the Issuance Proposal and/or the Increase Proposal, if there are not sufficient votes at the Special Meeting to approve and adopt the Issuance Proposal or the Increase Proposal."
2248454,-1,"2025-04-11||59503A||To approve the issuance of Series I preferred investment options and placement agent options issued in connection therewith, and shares of common stock underlying such options, issued in connection with an offering and sale of securities of the Company that was consummated on February 11, 2025, for purposes of complying with Nasdaq listing rule 5635(d) and satisfying our contractual obligations to the holders of such options (the ""Issuance Proposal"").||-1||-1",Z89510,MICROBOT MEDICAL INC.,BN,59503A,4/11/2025,3/7/2025,2/11/2025,F,"To approve the issuance of Series I preferred investment options and placement agent options issued in connection therewith, and shares of common stock underlying such options, issued in connection with an offering and sale of securities of the Company that was consummated on February 11, 2025, for purposes of complying with Nasdaq listing rule 5635(d) and satisfying our contractual obligations to the holders of such options (the ""Issuance Proposal"")."
2242953,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Kimberly S. Stevenson||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Kimberly S. Stevenson
2242864,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Donna C. Wells||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Donna C. Wells
2242858,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Rahul Gupta||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Rahul Gupta
2242890,-1,"2025-03-04||606710||To ratify the appointment of BDO USA, P.C. as our independent public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,"To ratify the appointment of BDO USA, P.C. as our independent public accounting firm for the fiscal year ending September 30, 2025."
2242929,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: James D. Fay||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: James D. Fay
2242969,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Susan Repo||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Susan Repo
2242898,-1,"2025-03-04||606710||To approve, on an advisory (non-binding) basis, the compensaiton of our named executive officers as presented in the Proxy Statement accompanying this notice.||-1||-1",P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,"To approve, on an advisory (non-binding) basis, the compensaiton of our named executive officers as presented in the Proxy Statement accompanying this notice."
2242862,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Mark Rossi||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Mark Rossi
2242968,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Scott Carter||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Scott Carter
2242892,-1,2025-03-04||606710||Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Edward West||-1||-1,P22743,"MITEK SYSTEMS, INC.",BN,606710,3/4/2025,2/3/2025,1/17/2025,F,Election of Director to serve until our 2026 annual meeting of stockholders and until their respective successors have been elected and qualified: Edward West
2243418,-1,2025-03-13||60783X||Coliseum Transactions Proposal||-1||-1,S08231,MODIVCARE INC,BN,60783X,3/13/2025,2/4/2025,1/22/2025,F,Coliseum Transactions Proposal
2243348,-1,2025-03-13||60783X||Adjournment Proposal||-1||-1,S08231,MODIVCARE INC,BN,60783X,3/13/2025,2/4/2025,1/22/2025,F,Adjournment Proposal
2242980,-1,2025-02-28||60785L||Election of Director: Paul DiPerna||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Paul DiPerna
2242866,-1,2025-02-28||60785L||Election of Director: Carmen Volkart||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Carmen Volkart
2242854,-1,"2025-02-28||60785L||To ratify the appointment of Farber Hass Hurley LLP as independent registered public accounting firm for the fiscal year ending March 31, 2025.||-1||-1",P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,"To ratify the appointment of Farber Hass Hurley LLP as independent registered public accounting firm for the fiscal year ending March 31, 2025."
2242919,-1,2025-02-28||60785L||Election of Director: Philip Sheibley||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Philip Sheibley
2242909,-1,"2025-02-28||60785L||To approve an amendment to the Amended and Restated 2017 Equity Incentive Plan to increase by 3,000,000 the number of shares of common stock available for issuance.||-1||-1",P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,"To approve an amendment to the Amended and Restated 2017 Equity Incentive Plan to increase by 3,000,000 the number of shares of common stock available for issuance."
2242918,-1,2025-02-28||60785L||Election of Director: Ellen O'Connor Vos||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Ellen O'Connor Vos
2242941,-1,2025-02-28||60785L||Election of Director: Steven Felsher||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Steven Felsher
2242848,-1,2025-02-28||60785L||Election of Director: Morgan C. Frank||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Morgan C. Frank
2242886,-1,2025-02-28||60785L||Election of Director: Duane DeSisto||-1||-1,P23302,MODULAR MEDICAL INC,BN,60785L,2/28/2025,2/3/2025,1/17/2025,F,Election of Director: Duane DeSisto
2257922,-1,"2025-04-30||60855R||To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers.||-1||-1",P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,"To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers."
2257966,-1,"2025-04-30||60855R||Stockholder proposal regarding stockholders' ability to call a special stockholders meeting, if properly presented.||-1||-1",P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,N,"Stockholder proposal regarding stockholders' ability to call a special stockholders meeting, if properly presented."
2257038,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Richard C. Zoretic||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Richard C. Zoretic
2257080,-1,2025-04-30||60855R||To consider and approve the Company's 2025 Equity Incentive Plan.||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,To consider and approve the Company's 2025 Equity Incentive Plan.
2258050,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Joseph M. Zubretsky||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Joseph M. Zubretsky
2257968,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Steven J. Orlando||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Steven J. Orlando
2257469,-1,2025-04-30||60855R||To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025.||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025.
2257478,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Stephen H. Lockhart||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Stephen H. Lockhart
2257486,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Ronna E. Romney||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Ronna E. Romney
2258048,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Richard M. Schapiro||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Richard M. Schapiro
2257753,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Barbara L. Brasier||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Barbara L. Brasier
2257976,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Leo P. Grohowski||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Leo P. Grohowski
2257637,-1,2025-04-30||60855R||Election of Director to hold office until the 2026 Annual Meeting: Dale B. Wolf||-1||-1,P24787,"MOLINA HEALTHCARE, INC.",BD,60855R,4/30/2025,3/25/2025,3/7/2025,F,Election of Director to hold office until the 2026 Annual Meeting: Dale B. Wolf
2283312,-1,2025-04-25||62011B||Election of Class I Director: Navtej Singh Sunner||-1||-1,P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,Election of Class I Director: Navtej Singh Sunner
2284353,-1,"2025-04-25||62011B||Approval to adjourn the 2025 Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 4.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval to adjourn the 2025 Annual Meeting to a later date, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Proposal No. 4."
2284724,-1,2025-04-25||62011B||Election of Class I Director: Andrew P. Jacobson||-1||-1,P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,Election of Class I Director: Andrew P. Jacobson
2284481,-1,"2025-04-25||62011B||Approval of the exercise of warrants issued on July 29, 2024 to purchase up to an aggregate of 949,310 shares of Class A Common Stock under applicable rules and regulations of the Nasdaq Stock Market LLC.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval of the exercise of warrants issued on July 29, 2024 to purchase up to an aggregate of 949,310 shares of Class A Common Stock under applicable rules and regulations of the Nasdaq Stock Market LLC."
2282930,-1,"2025-04-25||62011B||Approval of an amendment to the Amended and Restated Motorsport Games Inc. 2021 Equity Incentive Plan to increase the number of shares of the Company's Class A common stock available for awards thereunder by 200,000 shares.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Approval of an amendment to the Amended and Restated Motorsport Games Inc. 2021 Equity Incentive Plan to increase the number of shares of the Company's Class A common stock available for awards thereunder by 200,000 shares."
2284228,-1,"2025-04-25||62011B||Ratification of the selection of Grassi & Co., CPAs, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025.||-1||-1",P28868,MOTORSPORT GAMES INC.,BN,62011B,4/25/2025,3/31/2025,3/11/2025,F,"Ratification of the selection of Grassi & Co., CPAs, P.C. as the Company's independent registered public accounting firm for the year ending December 31, 2025."
2254060,-1,2025-05-01||626755||Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: R. Andrew Clyde||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: R. Andrew Clyde
2254124,-1,2025-05-01||626755||Ratification of Appointment of Independent Registered Public Accounting Firm for Fiscal 2025.||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,Ratification of Appointment of Independent Registered Public Accounting Firm for Fiscal 2025.
2254006,-1,2025-05-01||626755||Stockholder Proposal-Elect Each Director Annually.||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,N,Stockholder Proposal-Elect Each Director Annually.
2253852,-1,2025-05-01||626755||Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: Rosemary L. Turner||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: Rosemary L. Turner
2253910,-1,2025-05-01||626755||Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: R. Madison Murphy||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: R. Madison Murphy
2253854,-1,2025-05-01||626755||Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: David B. Miller||-1||-1,P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,Election of Class III Director Whose Current Terms Expire on the Date of the Annual Meeting: David B. Miller
2254061,-1,"2025-05-01||626755||Approval of Executive Compensation on an Advisory, Non-Binding Basis.||-1||-1",P24914,MURPHY USA INC.,BN,626755,5/1/2025,3/27/2025,3/4/2025,F,"Approval of Executive Compensation on an Advisory, Non-Binding Basis."
2242249,-1,"2025-02-24||63008J||Approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.||-1||-1",S08140,"NANOVIBRONIX, INC.",BN,63008J,2/24/2025,1/29/2025,1/17/2025,F,"Approval of a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals."
2242223,-1,"2025-02-24||63008J||Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of shares of the Company's common stock underlying certain warrants issued by the Company pursuant that certain Securities Exchange Agreement, dated January 7, 2025, upon exercise of such warrants in an amount equal to or in excess of 20% of the Company's common stock outstanding immediately prior to the execution of the Securities Exchange Agreement.||-1||-1",S08140,"NANOVIBRONIX, INC.",BN,63008J,2/24/2025,1/29/2025,1/17/2025,F,"Approval, for purposes of complying with Nasdaq Listing Rule 5635(d), of the issuance of shares of the Company's common stock underlying certain warrants issued by the Company pursuant that certain Securities Exchange Agreement, dated January 7, 2025, upon exercise of such warrants in an amount equal to or in excess of 20% of the Company's common stock outstanding immediately prior to the execution of the Securities Exchange Agreement."
2242176,-1,"2025-02-24||63008J||Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company's Board of Directors but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of the Company's common stock, at a ratio in the range of 1-for- 2 to 1-for-11, with such ratio to be determined by the Board of Directors in its discretion & included in a public announcement.||-1||-1",S08140,"NANOVIBRONIX, INC.",BN,63008J,2/24/2025,1/29/2025,1/17/2025,F,"Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company's Board of Directors but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of the Company's common stock, at a ratio in the range of 1-for- 2 to 1-for-11, with such ratio to be determined by the Board of Directors in its discretion & included in a public announcement."
-1,1306247,2025-04-30||633707||07||Patrick Sobers,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306163,2025-04-30||633707||04||Alka Gupta,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306161,2025-04-30||633707||01||Ralph W. Clermont,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306270,2025-04-30||633707||08||Micho F. Spring,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306185,2025-04-30||633707||06||G. Timothy Laney,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306043,2025-04-30||633707||02||Robert E. Dean,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
2279605,-1,2025-04-30||633707||To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year 2025.||-1||-1,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,F,To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year 2025.
-1,1306183,2025-04-30||633707||09||Art Zeile,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
2280991,-1,"2025-04-30||633707||To adopt a resolution approving, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers, as disclosed, pursuant to Item 402 of Regulation S-K, in the Proxy Statement.||-1||-1",P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,F,"To adopt a resolution approving, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers, as disclosed, pursuant to Item 402 of Regulation S-K, in the Proxy Statement."
-1,1306319,2025-04-30||633707||05||Fred J. Joseph,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
-1,1306047,2025-04-30||633707||03||Robin A. Doyle,P24567,NATIONAL BANK HOLDINGS CORP,BN,633707,4/30/2025,3/28/2025,3/10/2025,,
2261230,-1,2025-05-01||635309||Election of Director: Juliana F. Hill||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: Juliana F. Hill
2260775,-1,"2025-05-01||635309||Election of Director: Nathan ""Tripp"" Lane||-1||-1",P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,"Election of Director: Nathan ""Tripp"" Lane"
2260770,-1,2025-05-01||635309||Election of Director: Nicholas Bell||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: Nicholas Bell
2260719,-1,2025-05-01||635309||Election of Director: Thomas F. Lesinski||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: Thomas F. Lesinski
2261141,-1,2025-05-01||635309||Election of Director: David E. Glazek||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: David E. Glazek
2260975,-1,"2025-05-01||635309||To approve, on an advisory basis, our executive compensation||-1||-1",P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,"To approve, on an advisory basis, our executive compensation"
2260748,-1,2025-05-01||635309||Election of Director: Kelly Campbell||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: Kelly Campbell
2260861,-1,2025-05-01||635309||Election of Director: Joseph Marchese||-1||-1,P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,Election of Director: Joseph Marchese
2261058,-1,"2025-05-01||635309||To ratify the appointment of Grant Thornton LLP as our independent auditors for the fiscal year ending January 1, 2026||-1||-1",P26928,"NATIONAL CINEMEDIA, INC.",BN,635309,5/1/2025,3/24/2025,3/10/2025,F,"To ratify the appointment of Grant Thornton LLP as our independent auditors for the fiscal year ending January 1, 2026"
2231787,-1,2025-01-15||63911H||To approve the issuance of shares of the Company's common stock pursuant to the November 2024 Debentures.||-1||-1,S99556,"NAUTICUS ROBOTICS, INC.",BN,63911H,1/15/2025,11/29/2024,11/4/2024,F,To approve the issuance of shares of the Company's common stock pursuant to the November 2024 Debentures.
2231819,-1,2025-01-15||63911H||To approve a proposal to adjourn the Special Meeting to a later date or dates.||-1||-1,S99556,"NAUTICUS ROBOTICS, INC.",BN,63911H,1/15/2025,11/29/2024,11/4/2024,F,To approve a proposal to adjourn the Special Meeting to a later date or dates.
2231617,-1,2025-01-15||63911H||To approve an amendment to our Second Amended and Restated Certificate of Incorporation.||-1||-1,S99556,"NAUTICUS ROBOTICS, INC.",BN,63911H,1/15/2025,11/29/2024,11/4/2024,F,To approve an amendment to our Second Amended and Restated Certificate of Incorporation.
2231820,-1,2025-01-15||63911H||To approve the issuance of shares of the Company's common stock pursuant to the Exchange Agreement and the corresponding Certificate of Designations.||-1||-1,S99556,"NAUTICUS ROBOTICS, INC.",BN,63911H,1/15/2025,11/29/2024,11/4/2024,F,To approve the issuance of shares of the Company's common stock pursuant to the Exchange Agreement and the corresponding Certificate of Designations.
-1,1300632,2025-05-02||65441V||01||Darryl K. Willis,P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,,
2256234,-1,"2025-05-02||65441V||Approval, on an advisory basis, of the compensation of our named executive officers||-1||-1",P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,F,"Approval, on an advisory basis, of the compensation of our named executive officers"
-1,1300608,2025-05-02||65441V||02||Julie A. Peffer,P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,,
2256176,-1,2025-05-02||65441V||Approval of the Third Amendment to the 2011 Stock incentive Plan||-1||-1,P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,F,Approval of the Third Amendment to the 2011 Stock incentive Plan
2256612,-1,"2025-05-02||65441V||Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025||-1||-1",P26667,"NINE ENERGY SERVICE, INC.",BN,65441V,5/2/2025,3/21/2025,3/3/2025,F,"Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2025"
2268402,-1,"2025-04-22||669549||To ratify the appointment of S.R. Snodgrass, P.C. as our independent auditors for the fiscal year ending December 31, 2025.||-1||-1",P27193,NORWOOD FINANCIAL CORP.,BN,669549,4/22/2025,3/21/2025,3/4/2025,F,"To ratify the appointment of S.R. Snodgrass, P.C. as our independent auditors for the fiscal year ending December 31, 2025."
2268671,-1,2025-04-22||669549||Election of Director: Dr. Andrew A. Forte||-1||-1,P27193,NORWOOD FINANCIAL CORP.,BN,669549,4/22/2025,3/21/2025,3/4/2025,F,Election of Director: Dr. Andrew A. Forte
2268595,-1,2025-04-22||669549||Election of Director: Ralph A. Matergia||-1||-1,P27193,NORWOOD FINANCIAL CORP.,BN,669549,4/22/2025,3/21/2025,3/4/2025,F,Election of Director: Ralph A. Matergia
2268519,-1,2025-04-22||669549||Election of Director: Alexandra K. Nolan||-1||-1,P27193,NORWOOD FINANCIAL CORP.,BN,669549,4/22/2025,3/21/2025,3/4/2025,F,Election of Director: Alexandra K. Nolan
2243577,-1,"2025-02-21||67079Y||To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of shares of our common stock pursuant to senior secured convertible notes and related warrants, and any future adjustments of the conversion price of the notes and exercise price of the warrants, purchased pursuant to the Securities Purchase Agreement, in excess of the 19.99% share cap contained therein, and the issuance of shares pursuant to such senior secured convertible notes and warrants issued to one of our executive officers.||-1||-1",Z89395,NUVVE HOLDING CORP.,BN,67079Y,2/21/2025,2/6/2025,1/27/2025,F,"To approve, for purposes of complying with Nasdaq Listing Rules 5635(c) and 5635(d), the issuance of shares of our common stock pursuant to senior secured convertible notes and related warrants, and any future adjustments of the conversion price of the notes and exercise price of the warrants, purchased pursuant to the Securities Purchase Agreement, in excess of the 19.99% share cap contained therein, and the issuance of shares pursuant to such senior secured convertible notes and warrants issued to one of our executive officers."
2236034,-1,"2025-01-13||67079Y||To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to senior secured convertible notes and related warrants, and any future adjustments of the conversion price of the notes and exercise price of the warrants, purchased pursuant to the Securities Purchase Agreement, in excess of the 19.99% share cap contained therein.||-1||-1",Z89085,NUVVE HOLDING CORP.,BN,67079Y,1/13/2025,12/20/2024,12/9/2024,F,"To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock pursuant to senior secured convertible notes and related warrants, and any future adjustments of the conversion price of the notes and exercise price of the warrants, purchased pursuant to the Securities Purchase Agreement, in excess of the 19.99% share cap contained therein."
2243714,-1,"2025-02-21||67079Y||To approve an amendment of the Company's Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock, from 100,000,000 shares to 200,000,000.||-1||-1",Z89395,NUVVE HOLDING CORP.,BN,67079Y,2/21/2025,2/6/2025,1/27/2025,F,"To approve an amendment of the Company's Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock, from 100,000,000 shares to 200,000,000."
2243525,-1,"2025-02-21||67079Y||To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies.||-1||-1",Z89395,NUVVE HOLDING CORP.,BN,67079Y,2/21/2025,2/6/2025,1/27/2025,F,"To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies."
2235978,-1,"2025-01-13||67079Y||To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies.||-1||-1",Z89085,NUVVE HOLDING CORP.,BN,67079Y,1/13/2025,12/20/2024,12/9/2024,F,"To approve an adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies."
2239491,-1,2025-03-04||67401P||Election of Director to serve until the Company's 2028 Annual Meeting of Stockholder: Phyllis R. Caldwell||-1||-1,P22299,OAKTREE SPECIALTY LENDING CORPORATION,BN,67401P,3/4/2025,1/23/2025,1/6/2025,F,Election of Director to serve until the Company's 2028 Annual Meeting of Stockholder: Phyllis R. Caldwell
2239561,-1,"2025-03-04||67401P||To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock.||-1||-1",S03087,OAKTREE SPECIALTY LENDING CORPORATION,BN,67401P,3/4/2025,1/16/2025,1/3/2025,F,"To authorize the Company, with the approval of the Board of Directors, to sell or otherwise issue shares of its common stock at a price below its then current net asset value per share, provided that the number of shares issued does not exceed 25% of its then outstanding common stock."
2239531,-1,"2025-03-04||67401P||To ratify the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for the Company for the fiscal year ending September 30, 2025.||-1||-1",P22299,OAKTREE SPECIALTY LENDING CORPORATION,BN,67401P,3/4/2025,1/23/2025,1/6/2025,F,"To ratify the appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for the Company for the fiscal year ending September 30, 2025."
-1,1290943,2025-01-16||674870||02||Philipp Stratmann,P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,,
-1,1290917,2025-01-16||674870||04||Diana G. Purcel,P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,,
-1,1291036,2025-01-16||674870||05||Peter E. Slaiby,P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,,
2229981,-1,"2025-01-16||674870||To approve the Amended and Restated 2015 Omnibus Incentive Plan (the ""2015 Plan"").||-1||-1",P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,F,"To approve the Amended and Restated 2015 Omnibus Incentive Plan (the ""2015 Plan"")."
2230076,-1,"2025-01-16||674870||To consider and take action on the ratification of the selection of Moss Adams LLP as our independent registered public accounting firm for fiscal year ending April 30, 2025.||-1||-1",P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,F,"To consider and take action on the ratification of the selection of Moss Adams LLP as our independent registered public accounting firm for fiscal year ending April 30, 2025."
2285968,-1,"2025-04-30||674870||To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock, par value $.001 per share (the ""Common Stock""), from 200,000,000 to 300,000,000.||-1||-1",S11640,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,4/30/2025,3/31/2025,3/17/2025,F,"To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of common stock, par value $.001 per share (the ""Common Stock""), from 200,000,000 to 300,000,000."
2229977,-1,"2025-01-16||674870||To approve, by a non-binding advisory vote, the compensation of OPT's named executive officers.||-1||-1",P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,F,"To approve, by a non-binding advisory vote, the compensation of OPT's named executive officers."
2286595,-1,"2025-04-30||674870||To approve an adjournment of the Special Meeting from time to time, if necessary or appropriate (as determined in good faith by the Board of Directors or a committee thereof), to solicit additional proxies if there are not sufficient votes in favor of the charter amendment proposal.||-1||-1",S11640,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,4/30/2025,3/31/2025,3/17/2025,F,"To approve an adjournment of the Special Meeting from time to time, if necessary or appropriate (as determined in good faith by the Board of Directors or a committee thereof), to solicit additional proxies if there are not sufficient votes in favor of the charter amendment proposal."
-1,1291064,2025-01-16||674870||01||Terence J. Cryan,P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,,
-1,1290963,2025-01-16||674870||03||Clyde W. Hewlett,P20836,"OCEAN POWER TECHNOLOGIES, INC.",BN,674870,1/16/2025,11/22/2024,11/18/2024,,
2305380,-1,"2025-05-02||684023||Approval of the adjournment of the Annual Meeting in the event that the number of shares of Common Stock and Series G Mirroring Preferred Stock present or represented by proxy at the Annual Meeting and voting ""FOR"" the adoption of Proposal 4 or Proposal 5 are insufficient.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Approval of the adjournment of the Annual Meeting in the event that the number of shares of Common Stock and Series G Mirroring Preferred Stock present or represented by proxy at the Annual Meeting and voting ""FOR"" the adoption of Proposal 4 or Proposal 5 are insufficient."
2304608,-1,2025-05-02||684023||Election of Director: Robert C. Koski||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Election of Director: Robert C. Koski
2305742,-1,"2025-05-02||684023||Ratification of the selection of Cherry Bekaert LLP as the Company's independent auditors for the year ending December 31, 2025.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Ratification of the selection of Cherry Bekaert LLP as the Company's independent auditors for the year ending December 31, 2025."
2305576,-1,"2025-05-02||684023||To approve an amendment to the Company's 2021 Equity Incentive Plan to increase the number of common shares available for issuance under the Plan to 3,166,667 shares of Common Stock.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"To approve an amendment to the Company's 2021 Equity Incentive Plan to increase the number of common shares available for issuance under the Plan to 3,166,667 shares of Common Stock."
2305256,-1,2025-05-02||684023||Election of Director: Charles L. Pope||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Election of Director: Charles L. Pope
2304602,-1,2025-05-02||684023||Advisory vote on executive compensation.||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Advisory vote on executive compensation.
2304923,-1,"2025-05-02||684023||Approval of an amendment to the Company's Articles of Incorporation, as amended, to increase the Company's authorized shares of common stock to 350,000,000 in the event a Reverse Stock Split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Approval of an amendment to the Company's Articles of Incorporation, as amended, to increase the Company's authorized shares of common stock to 350,000,000 in the event a Reverse Stock Split of our common stock is effectuated prior to approval of the Reverse Stock Split Proposal."
2305293,-1,"2025-05-02||684023||Approval of a proposal to authorize the Company's Board of Directors, in its discretion at any time within one year after shareholder approval is obtained, to effect a Reverse Stock Split of then-outstanding shares of the Company's Common Stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-fifty (1:50), with the exact ratio to be determined by the Company's Board.||-1||-1",P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,"Approval of a proposal to authorize the Company's Board of Directors, in its discretion at any time within one year after shareholder approval is obtained, to effect a Reverse Stock Split of then-outstanding shares of the Company's Common Stock, at a ratio of not less than one-for-five (1:5) and not greater than one-for-fifty (1:50), with the exact ratio to be determined by the Company's Board."
2304007,-1,2025-05-02||684023||Election of Director: John Gandolfo||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Election of Director: John Gandolfo
2304538,-1,2025-05-02||684023||Election of Director: Dr. Alan Dunton||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Election of Director: Dr. Alan Dunton
2304414,-1,2025-05-02||684023||Election of Director: Dr. Frederick W. Telling||-1||-1,P28298,"ORAGENICS, INC.",BN,684023,5/2/2025,4/7/2025,3/21/2025,F,Election of Director: Dr. Frederick W. Telling
2255234,-1,2025-04-29||693718||Election of Director to serve for one-year term: Mark A. Schulz||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Mark A. Schulz
2255145,-1,2025-04-29||693718||Election of Director to serve for one-year term: Barbara B. Hulit||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Barbara B. Hulit
2255520,-1,2025-04-29||693718||Stockholder proposal regarding a shareholder vote on excessive golden parachutes||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,N,Stockholder proposal regarding a shareholder vote on excessive golden parachutes
2254883,-1,2025-04-29||693718||Election of Director to serve for one-year term: Brice A. Hill||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Brice A. Hill
2255437,-1,2025-04-29||693718||Election of Director to serve for one-year term: Mark C. Pigott||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Mark C. Pigott
2255238,-1,2025-04-29||693718||Advisory vote on the ratification of independent auditors||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Advisory vote on the ratification of independent auditors
2255248,-1,2025-04-29||693718||Election of Director to serve for one-year term: Kirk S. Hachigian||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Kirk S. Hachigian
2255326,-1,2025-04-29||693718||Election of Director to serve for one-year term: Cynthia A. Niekamp||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Cynthia A. Niekamp
2255047,-1,2025-04-29||693718||Election of Director to serve for one-year term: Ganesh Ramaswamy||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Ganesh Ramaswamy
2255353,-1,2025-04-29||693718||Election of Director to serve for one-year term: Pierre R. Breber||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Pierre R. Breber
2255491,-1,2025-04-29||693718||Election of Director to serve for one-year term: Luiz A. S. Pretti||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Luiz A. S. Pretti
2254967,-1,2025-04-29||693718||Election of Director to serve for one-year term: Dame Alison J. Carnwath||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: Dame Alison J. Carnwath
2255042,-1,2025-04-29||693718||Election of Director to serve for one-year term: R. Preston Feight||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: R. Preston Feight
2255258,-1,2025-04-29||693718||Advisory resolution to approve executive compensation||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Advisory resolution to approve executive compensation
2255255,-1,2025-04-29||693718||Election of Director to serve for one-year term: John M. Pigott||-1||-1,P26810,PACCAR INC,BN,693718,4/29/2025,3/20/2025,3/4/2025,F,Election of Director to serve for one-year term: John M. Pigott
2236641,-1,"2024-12-30||G6891L||To approve the issuance of the Merger Shares in accordance with the shareholder approval requirements of Nasdaq Listing Rule 5635 (referred to as ""Proposal 1"").||-1||-1",S01603,PANGAEA LOGISTICS SOLUTIONS LTD.,BN,G6891L,12/30/2024,12/24/2024,11/4/2024,F,"To approve the issuance of the Merger Shares in accordance with the shareholder approval requirements of Nasdaq Listing Rule 5635 (referred to as ""Proposal 1"")."
2236664,-1,"2024-12-30||G6891L||To adjourn or postpone the Special Meeting if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to constitute a quorum or to approve Proposal 1 or Proposal 2, and to ensure that any supplement or amendment to the proxy statement is timely provided to the Company's shareholders (referred to as ""Proposal 2"").||-1||-1",S01603,PANGAEA LOGISTICS SOLUTIONS LTD.,BN,G6891L,12/30/2024,12/24/2024,11/4/2024,F,"To adjourn or postpone the Special Meeting if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to constitute a quorum or to approve Proposal 1 or Proposal 2, and to ensure that any supplement or amendment to the proxy statement is timely provided to the Company's shareholders (referred to as ""Proposal 2"")."
2287815,-1,2025-05-01||698813||Election of Director: Christopher L. Coleman||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Christopher L. Coleman
2287509,-1,2025-05-01||698813||Election of Director: Sonya E. Medina||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Sonya E. Medina
2288493,-1,2025-05-01||698813||Election of Director: John W. Garratt||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: John W. Garratt
2286537,-1,2025-05-01||698813||Ratification of the Selection of Independent Auditors: To ratify the selection of Ernst & Young LLP as the Company's independent auditors for the 2025 fiscal year.||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Ratification of the Selection of Independent Auditors: To ratify the selection of Ernst & Young LLP as the Company's independent auditors for the 2025 fiscal year.
2287698,-1,2025-05-01||698813||Election of Director: Jocelyn C. Mangan||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Jocelyn C. Mangan
2288379,-1,2025-05-01||698813||Advisory approval of the Company's executive compensation.||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Advisory approval of the Company's executive compensation.
2287934,-1,2025-05-01||698813||Election of Director: John C. Miller||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: John C. Miller
2287501,-1,2025-05-01||698813||Election of Director: Laurette T. Koellner||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Laurette T. Koellner
2287487,-1,"2025-05-01||698813||Stockholder proposal regarding simple majority vote, if properly presented at the meeting.||-1||-1",P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,/,"Stockholder proposal regarding simple majority vote, if properly presented at the meeting."
2288060,-1,"2025-05-01||698813||Approval of the First Amendment to the Papa John's International, Inc. 2018 Omnibus Incentive Plan to increase the amount of shares reserved for issuance by 4,900,000 shares.||-1||-1",P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,"Approval of the First Amendment to the Papa John's International, Inc. 2018 Omnibus Incentive Plan to increase the amount of shares reserved for issuance by 4,900,000 shares."
2286413,-1,2025-05-01||698813||Election of Director: Stephen L. Gibbs||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Stephen L. Gibbs
2288647,-1,2025-05-01||698813||Election of Director: Todd A. Penegor||-1||-1,P22033,"PAPA JOHN'S INTERNATIONAL, INC.",BN,698813,5/1/2025,4/1/2025,3/11/2025,F,Election of Director: Todd A. Penegor
2272717,-1,2025-04-22||700885||Election of Director of the Company to a term of three years: Jeffrey H. Kripitz||-1||-1,P27759,"PARKE BANCORP, INC.",BN,700885,4/22/2025,3/25/2025,3/12/2025,F,Election of Director of the Company to a term of three years: Jeffrey H. Kripitz
2273618,-1,2025-04-22||700885||Election of Director of the Company to a term of three years: Fred G. Choate||-1||-1,P27759,"PARKE BANCORP, INC.",BN,700885,4/22/2025,3/25/2025,3/12/2025,F,Election of Director of the Company to a term of three years: Fred G. Choate
2272511,-1,"2025-04-22||700885||Election of Director of the Company to a term of three years: Jack C. Sheppard, Jr.||-1||-1",P27759,"PARKE BANCORP, INC.",BN,700885,4/22/2025,3/25/2025,3/12/2025,F,"Election of Director of the Company to a term of three years: Jack C. Sheppard, Jr."
2273443,-1,"2025-04-22||700885||To ratify the appointment of S.R. Snodgrass as our independent auditor for the fiscal year ending December 31, 2025||-1||-1",P27759,"PARKE BANCORP, INC.",BN,700885,4/22/2025,3/25/2025,3/12/2025,F,"To ratify the appointment of S.R. Snodgrass as our independent auditor for the fiscal year ending December 31, 2025"
2233934,-1,2025-01-15||70387R||Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the special meeting to approve the foregoing proposals.||-1||-1,S02772,PAVMED INC.,BN,70387R,1/15/2025,12/11/2024,11/25/2024,F,Approval of the adjournment of the Special Meeting to the extent there are insufficient votes at the special meeting to approve the foregoing proposals.
2233773,-1,"2025-01-15||70387R||Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Exchange Agreement.||-1||-1",S02772,PAVMED INC.,BN,70387R,1/15/2025,12/11/2024,11/25/2024,F,"Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Exchange Agreement."
2233762,-1,"2025-01-15||70387R||Approval of an amendment to the Company's certificate of incorporation, as amended, to increase the total number of shares of common stock the Company is authorized to issue by 200,000,000 shares, from 50,000,000 shares to 250,000,000 shares.||-1||-1",S02772,PAVMED INC.,BN,70387R,1/15/2025,12/11/2024,11/25/2024,F,"Approval of an amendment to the Company's certificate of incorporation, as amended, to increase the total number of shares of common stock the Company is authorized to issue by 200,000,000 shares, from 50,000,000 shares to 250,000,000 shares."
2233981,-1,"2025-01-15||70387R||Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Securities Purchase Agreement.||-1||-1",S02772,PAVMED INC.,BN,70387R,1/15/2025,12/11/2024,11/25/2024,F,"Approval, for the purposes of Nasdaq Listing Rule 5635, of the issuance of shares of the Company's common stock upon conversion of the Series C Convertible Preferred Stock of the Company, which shares of Series C Preferred Stock are to be issued by the Company under the Securities Purchase Agreement."
2233940,-1,2025-02-04||70806A||Election of Director: Adam Bernstein||-1||-1,P21648,PENNANTPARK FLOATING RATE CAPITAL LTD.,BN,70806A,2/4/2025,12/19/2024,12/4/2024,F,Election of Director: Adam Bernstein
2233778,-1,"2025-02-04||70806A||To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P21648,PENNANTPARK FLOATING RATE CAPITAL LTD.,BN,70806A,2/4/2025,12/19/2024,12/4/2024,F,"To ratify the selection of RSM US LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025."
2233865,-1,2025-02-04||70806A||Election of Director: Jeffrey Flug||-1||-1,P21648,PENNANTPARK FLOATING RATE CAPITAL LTD.,BN,70806A,2/4/2025,12/19/2024,12/4/2024,F,Election of Director: Jeffrey Flug
2247749,-1,"2025-04-22||708430||A proposal to approve, on an advisory basis, specified compensation that may be payable to the named executive officers of Penns Woods in connection with the merger.||-1||-1",S09977,"PENNS WOODS BANCORP, INC.",BN,708430,4/22/2025,2/26/2025,2/19/2025,F,"A proposal to approve, on an advisory basis, specified compensation that may be payable to the named executive officers of Penns Woods in connection with the merger."
2247515,-1,"2025-04-22||708430||A proposal to approve the adjournment of the special meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Agreement and Plan of Merger.||-1||-1",S09977,"PENNS WOODS BANCORP, INC.",BN,708430,4/22/2025,2/26/2025,2/19/2025,F,"A proposal to approve the adjournment of the special meeting, if necessary, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to adopt and approve the Agreement and Plan of Merger."
2247709,-1,"2025-04-22||708430||A proposal to adopt and approve the Agreement and Plan of Merger, dated as of December 16, 2024, by and between Northwest Bancshares, Inc. and Penns Woods Bancorp, Inc., and the transactions contemplated thereby, including the merger of Penns Woods Bancorp, Inc. into Northwest Bancshares, Inc.||-1||-1",S09977,"PENNS WOODS BANCORP, INC.",BN,708430,4/22/2025,2/26/2025,2/19/2025,F,"A proposal to adopt and approve the Agreement and Plan of Merger, dated as of December 16, 2024, by and between Northwest Bancshares, Inc. and Penns Woods Bancorp, Inc., and the transactions contemplated thereby, including the merger of Penns Woods Bancorp, Inc. into Northwest Bancshares, Inc."
-1,1307480,2025-05-01||710577||02||James S. Abernethy,P26483,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",SH,710577,5/1/2025,4/2/2025,3/7/2025,,
2290586,-1,2025-05-01||710577||Approve the compensation of the Company's named executive officers (advisory vote).||-1||-1,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,F,Approve the compensation of the Company's named executive officers (advisory vote).
-1,1308733,2025-05-01||710577||07||Gary E. Matthews,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1308730,2025-05-01||710577||11||Benjamin I. Zachary,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1308704,2025-05-01||710577||01||Ashton V. Abernethy,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1308628,"2025-05-01||710577||03||Robert C. Abernethy, Sr",P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
2290312,-1,"2025-05-01||710577||To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,F,"To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
-1,1308850,"2025-05-01||710577||08||Billy L. Price, Jr., MD",P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1308999,2025-05-01||710577||05||Douglas S. Howard,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1307681,"2025-05-01||710577||04||Robert C. Abernethy, Jr",P26483,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",SH,710577,5/1/2025,4/2/2025,3/7/2025,,
-1,1308833,"2025-05-01||710577||10||Dan Ray Timmerman, Jr.",P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
-1,1307672,"2025-05-01||710577||06||John W. Lineberger, Jr.",P26483,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",SH,710577,5/1/2025,4/2/2025,3/7/2025,,
-1,1308831,2025-05-01||710577||09||William Gregory Terry,P26291,"PEOPLES BANCORP OF NORTH CAROLINA, INC.",BN,710577,5/1/2025,4/3/2025,3/7/2025,,
2274233,-1,"2025-04-10||71678J||To approve an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock, at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the Board in its discretion and included in a public announcement.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company's stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock, at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the Board in its discretion and included in a public announcement."
2273652,-1,"2025-04-10||71678J||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock."
2273965,-1,"2025-04-10||71678J||To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals."
2272829,-1,"2025-04-10||71678J||To approve the Third Amendment to the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company's Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve the Third Amendment to the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company's Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares."
2274161,-1,"2025-04-10||71678J||To approve pursuant to Nasdaq Listing Rule 5635(d), the issuance of common stock underlying Series A and Series B Warrants, including by operation of certain anti-dilution provisions, and including 81,911,262.80 shares underlying 40,000,000 Series A Warrants and 982,935,153.58 shares underlying 40,000,000 Series B Warrants (assuming full exercise of the Warrants at a Floor price of $0.0586 and all Series B Warrants are exercised on the ""zero exercise price"" basis) issued on 2/19/2024.||-1||-1",S10163,"PETROS PHARMACEUTICALS, INC.",BN,71678J,4/10/2025,3/25/2025,2/19/2025,F,"To approve pursuant to Nasdaq Listing Rule 5635(d), the issuance of common stock underlying Series A and Series B Warrants, including by operation of certain anti-dilution provisions, and including 81,911,262.80 shares underlying 40,000,000 Series A Warrants and 982,935,153.58 shares underlying 40,000,000 Series B Warrants (assuming full exercise of the Warrants at a Floor price of $0.0586 and all Series B Warrants are exercised on the ""zero exercise price"" basis) issued on 2/19/2024."
2253267,-1,2025-04-24||717081||Election of Director: Shantanu Narayen||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Shantanu Narayen
2252832,-1,2025-04-24||717081||2025 advisory approval of executive compensation||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,2025 advisory approval of executive compensation
2252577,-1,2025-04-24||717081||Election of Director: Cyrus Taraporevala||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Cyrus Taraporevala
2253195,-1,2025-04-24||717081||Shareholder Vote Regarding Golden Parachutes||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,N,Shareholder Vote Regarding Golden Parachutes
2252640,-1,2025-04-24||717081||Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,N,Issue a Report Evaluating the Risks Related to Religious Discrimination Against Employees
2253141,-1,2025-04-24||717081||Election of Director: Scott Gottlieb||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Scott Gottlieb
2253509,-1,2025-04-24||717081||Election of Director: Ronald E. Blaylock||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Ronald E. Blaylock
2253320,-1,2025-04-24||717081||Election of Director: Suzanne Nora Johnson||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Suzanne Nora Johnson
2252878,-1,2025-04-24||717081||Election of Director: Dan R. Littman||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Dan R. Littman
2253070,-1,2025-04-24||717081||Election of Director: Susan Hockfield||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Susan Hockfield
2253148,-1,2025-04-24||717081||Election of Director: Susan Desmond-Hellmann||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Susan Desmond-Hellmann
2253196,-1,2025-04-24||717081||Election of Director: Joseph J. Echevarria||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Joseph J. Echevarria
2252752,-1,2025-04-24||717081||Ratify the selection of KPMG LLP as independent registered public accounting firm for 2025||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Ratify the selection of KPMG LLP as independent registered public accounting firm for 2025
2252382,-1,2025-04-24||717081||Election of Director: Mortimer J. Buckley||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Mortimer J. Buckley
2252439,-1,2025-04-24||717081||Election of Director: Albert Bourla||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: Albert Bourla
2252590,-1,2025-04-24||717081||Election of Director: James C. Smith||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: James C. Smith
2252571,-1,2025-04-24||717081||Election of Director: James Quincey||-1||-1,P26510,PFIZER INC.,BN,717081,4/24/2025,3/17/2025,2/26/2025,F,Election of Director: James Quincey
-1,1299975,2025-04-24||71715X||02||Jonathan L. Schechter,P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,,
2253234,-1,"2025-04-24||71715X||To ratify the appointment of CBIZ CPAs P.C. as PharmaCyte Biotech, Inc.'s independent registered public accounting firm for the fiscal year ending April 30, 2025.||-1||-1",P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,F,"To ratify the appointment of CBIZ CPAs P.C. as PharmaCyte Biotech, Inc.'s independent registered public accounting firm for the fiscal year ending April 30, 2025."
2252739,-1,"2025-04-24||71715X||To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement.||-1||-1",P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,F,"To approve by an advisory vote the compensation of our named executive officers, as disclosed in this proxy statement."
-1,1300097,2025-04-24||71715X||03||Michael M. Abecassis,P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,,
-1,1299854,2025-04-24||71715X||04||Robert Weinstein,P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,,
-1,1300133,2025-04-24||71715X||05||Wayne R. Walker,P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,,
-1,1300003,2025-04-24||71715X||01||Joshua N. Silverman,P26626,"PHARMACYTE BIOTECH, INC.",BN,71715X,4/24/2025,3/14/2025,3/3/2025,,
2242769,-1,"2025-04-17||72814P||Approve the adjournment of the Special Meeting, if necessary, to continue to solicit votes in favor of Proposal 1 above.||-1||-1",S08507,"PLBY GROUP, INC.",BN,72814P,4/17/2025,2/6/2025,1/23/2025,F,"Approve the adjournment of the Special Meeting, if necessary, to continue to solicit votes in favor of Proposal 1 above."
2242799,-1,"2025-04-17||72814P||Approve, for purposes of Nasdaq Listing Rule 5635(b), the issuance by PLBY Group, Inc. of 16,956,842 shares of its common stock, par value $0.0001 per share, at a sale price of $1.50 per share to The Million S.a.r.l., pursuant to the terms of the Securities Purchase Agreement, dated December 14, 2024, by and between PLBY Group, Inc. and The Million S.a.r.l.||-1||-1",S08507,"PLBY GROUP, INC.",BN,72814P,4/17/2025,2/6/2025,1/23/2025,F,"Approve, for purposes of Nasdaq Listing Rule 5635(b), the issuance by PLBY Group, Inc. of 16,956,842 shares of its common stock, par value $0.0001 per share, at a sale price of $1.50 per share to The Million S.a.r.l., pursuant to the terms of the Securities Purchase Agreement, dated December 14, 2024, by and between PLBY Group, Inc. and The Million S.a.r.l."
2252855,-1,"2025-03-26||73017P||To approve the adjournment of the Special Shareholders Meeting, if necessary, to solicit additional votes if there are insufficient votes at the time of the Special Meeting to approve one or more of the proposals.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the adjournment of the Special Shareholders Meeting, if necessary, to solicit additional votes if there are insufficient votes at the time of the Special Meeting to approve one or more of the proposals."
2252966,-1,"2025-03-26||73017P||To approve the issuance of 3,036,437 shares of non-trading, non-convertible Series B Preferred Stock to GB Capital Ltd, a British Columbia, Canada corporation, wholly owned by our Chief Executive Officer, Chief Financial Officer, and Director, Graydon Bensler, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Employee Chief Executive Officer between the Company and GB Capital, as amended.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the issuance of 3,036,437 shares of non-trading, non-convertible Series B Preferred Stock to GB Capital Ltd, a British Columbia, Canada corporation, wholly owned by our Chief Executive Officer, Chief Financial Officer, and Director, Graydon Bensler, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Employee Chief Executive Officer between the Company and GB Capital, as amended."
2253235,-1,"2025-03-26||73017P||To approve the issuance of 138,484 shares of Common Stock, in the aggregate, upon the exercise of warrants issued to certain investors pursuant to that certain Warrant Inducement Agreement entered into between the Company and certain investors on January 27, 2025, and approval of the adjustment terms as set forth in the warrants.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the issuance of 138,484 shares of Common Stock, in the aggregate, upon the exercise of warrants issued to certain investors pursuant to that certain Warrant Inducement Agreement entered into between the Company and certain investors on January 27, 2025, and approval of the adjustment terms as set forth in the warrants."
2252567,-1,"2025-03-26||73017P||To approve an amendment to our Articles of Incorporation to increase the authorized shares of Common Stock from 285,714,286 million to 10 billion.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve an amendment to our Articles of Incorporation to increase the authorized shares of Common Stock from 285,714,286 million to 10 billion."
2253255,-1,"2025-03-26||73017P||To approve an amendment to our Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve an amendment to our Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms."
2252432,-1,"2025-03-26||73017P||To approve the issuance of 3,336,437 shares of non-trading, non-convertible Series B Preferred Stock to Northstrive Companies, a California corporation wholly owned by our Chairman, Braeden Lichti, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Executive Chairman between the Company and NorthStrive, as amended.||-1||-1",Z89434,PMGC HOLDINGS INC.,BN,73017P,3/26/2025,3/10/2025,2/5/2025,F,"To approve the issuance of 3,336,437 shares of non-trading, non-convertible Series B Preferred Stock to Northstrive Companies, a California corporation wholly owned by our Chairman, Braeden Lichti, as a signing bonus pursuant to that certain Second Amended and Restated Consulting Agreement for Non-Executive Chairman between the Company and NorthStrive, as amended."
2232065,-1,2025-01-30||737446||Advisory approval of the Company's executive compensation.||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Advisory approval of the Company's executive compensation.
2232100,-1,2025-01-30||737446||Election of Director: Gregory L. Curl||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: Gregory L. Curl
2232020,-1,2025-01-30||737446||Election of Director: Robert V. Vitale||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: Robert V. Vitale
2232064,-1,2025-01-30||737446||Management proposal to eliminate certain supermajority voting requirements.||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Management proposal to eliminate certain supermajority voting requirements.
2232035,-1,2025-01-30||737446||Election of Director: Dorothy M. Burwell||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: Dorothy M. Burwell
2232007,-1,"2025-01-30||737446||Approval of the Post Holdings, Inc. Amended and Restated 2021 Long-Term Incentive Plan.||-1||-1",P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,"Approval of the Post Holdings, Inc. Amended and Restated 2021 Long-Term Incentive Plan."
2231950,-1,2025-01-30||737446||Election of Director: Jennifer Kuperman||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: Jennifer Kuperman
2232171,-1,2025-01-30||737446||Shareholder proposal concerning adoption of a director election resignation guideline.||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,N,Shareholder proposal concerning adoption of a director election resignation guideline.
2232074,-1,2025-01-30||737446||Shareholder proposal to eliminate all supermajority voting requirements.||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,N,Shareholder proposal to eliminate all supermajority voting requirements.
2232036,-1,2025-01-30||737446||Election of Director: David P. Skarie||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: David P. Skarie
2232114,-1,"2025-01-30||737446||Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2025.||-1||-1",P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,"Ratification of PricewaterhouseCoopers LLP as the Company's Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2025."
2232024,-1,2025-01-30||737446||Election of Director: William P. Stiritz||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: William P. Stiritz
2232087,-1,2025-01-30||737446||Election of Director: Thomas C. Erb||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: Thomas C. Erb
2232079,-1,2025-01-30||737446||Election of Director: David W. Kemper||-1||-1,P21230,"POST HOLDINGS, INC.",BN,737446,1/30/2025,12/10/2024,11/25/2024,F,Election of Director: David W. Kemper
2231002,-1,"2024-12-30||74039M||Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.||-1||-1",P21327,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,11/26/2024,11/13/2024,F,"Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024."
2230923,-1,2024-12-30||74039M||Election of Class III Director: Raymond F. Vennare||-1||-1,P21327,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,11/26/2024,11/13/2024,F,Election of Class III Director: Raymond F. Vennare
2232572,-1,2024-12-30||74039M||Vote on a non-binding advisory resolution to approve compensation of the Company's executive officers.||-1||-1,P21329,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,12/5/2024,11/27/2024,F,Vote on a non-binding advisory resolution to approve compensation of the Company's executive officers.
2232470,-1,"2024-12-30||74039M||Election of Class III Director: Veena Rao, Ph.D.||-1||-1",P21329,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,12/5/2024,11/27/2024,F,"Election of Class III Director: Veena Rao, Ph.D."
2230950,-1,2024-12-30||74039M||Vote on a proposal to approve the 2024 Equity Incentive Plan.||-1||-1,P21327,PREDICTIVE ONCOLOGY INC.,BN,74039M,12/30/2024,11/26/2024,11/13/2024,F,Vote on a proposal to approve the 2024 Equity Incentive Plan.
2236486,-1,"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Brent Morrison||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Brent Morrison"
2236378,-1,"2025-01-14||75903M||To ratify the appointment of Cherry Bekaert, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 (""Proposal 2"").||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"To ratify the appointment of Cherry Bekaert, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024 (""Proposal 2"")."
2236493,-1,"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Steven L. Martin||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Steven L. Martin"
2236369,-1,"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: David A. Tenwick||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: David A. Tenwick"
2236274,-1,"2025-01-14||75903M||Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Kenneth W. Taylor||-1||-1",P22079,"REGIONAL HEALTH PROPERTIES, INC.",BN,75903M,1/14/2025,12/23/2024,12/2/2024,F,"Election of Director to serve until the Company's 2025 Annual Meeting of Shareholders and until their successors are elected and qualified, or until their earlier death, resignation or removal: Kenneth W. Taylor"
2248083,-1,2025-04-16||7591EP||Ratification of Appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for 2025.||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Ratification of Appointment of Ernst & Young LLP as the Independent Registered Public Accounting Firm for 2025.
2248014,-1,2025-04-16||7591EP||Election of Director: Joia M. Johnson||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Joia M. Johnson
2247377,-1,2025-04-16||7591EP||Election of Director: Alison S. Rand||-1||-1,P24485,REGIONS FINANCIAL CORPORATION,SH,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Alison S. Rand
2248103,-1,2025-04-16||7591EP||Election of Director: Ruth Ann Marshall||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Ruth Ann Marshall
2247725,-1,2025-04-16||7591EP||Election of Director: James T. Prokopanko||-1||-1,P24485,REGIONS FINANCIAL CORPORATION,SH,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: James T. Prokopanko
2248059,-1,2025-04-16||7591EP||Advisory Vote to Approve Regions' Executive Compensation.||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Advisory Vote to Approve Regions' Executive Compensation.
2248256,-1,"2025-04-16||7591EP||Election of Director: William C. Rhodes, III||-1||-1",P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,"Election of Director: William C. Rhodes, III"
2248104,-1,2025-04-16||7591EP||Shareholder Proposal Relating to Simple Majority Vote.||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,/,Shareholder Proposal Relating to Simple Majority Vote.
2248276,-1,"2025-04-16||7591EP||Election of Director: John M. Turner, Jr.||-1||-1",P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,"Election of Director: John M. Turner, Jr."
2248129,-1,2025-04-16||7591EP||Regions Financial Corporation 2025 Long Term Incentive Plan.||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Regions Financial Corporation 2025 Long Term Incentive Plan.
2248296,-1,2025-04-16||7591EP||Election of Director: Zhanna Golodryga||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Zhanna Golodryga
2248086,-1,2025-04-16||7591EP||Election of Director: Timothy Vines||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Timothy Vines
2248189,-1,2025-04-16||7591EP||Election of Director: José S. Suquet||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: José S. Suquet
2248327,-1,2025-04-16||7591EP||Election of Director: Noopur Davis||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Noopur Davis
2248212,-1,2025-04-16||7591EP||Election of Director: Lee J. Styslinger III||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Lee J. Styslinger III
2248260,-1,2025-04-16||7591EP||Election of Director: J. Thomas Hill||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: J. Thomas Hill
2247722,-1,2025-04-16||7591EP||Election of Director: Mark A. Crosswhite||-1||-1,P24485,REGIONS FINANCIAL CORPORATION,SH,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Mark A. Crosswhite
2248240,-1,2025-04-16||7591EP||Election of Director: Roger W. Jenkins||-1||-1,P22499,REGIONS FINANCIAL CORPORATION,BN,7591EP,4/16/2025,3/13/2025,2/18/2025,F,Election of Director: Roger W. Jenkins
2270069,-1,2025-04-01||76090R||Approve the share issuance proposal for the equity line of credit under the Nasdaq rules.||-1||-1,Z89694,"RESHAPE LIFESCIENCES, INC",BN,76090R,4/1/2025,3/21/2025,3/3/2025,F,Approve the share issuance proposal for the equity line of credit under the Nasdaq rules.
2270336,-1,2025-04-01||76090R||Approve the warrant exercise proposal under the Nasdaq rules.||-1||-1,Z89694,"RESHAPE LIFESCIENCES, INC",BN,76090R,4/1/2025,3/21/2025,3/3/2025,F,Approve the warrant exercise proposal under the Nasdaq rules.
2270067,-1,2025-04-01||76090R||Authorize the Board to effect a reverse stock split.||-1||-1,Z89694,"RESHAPE LIFESCIENCES, INC",BN,76090R,4/1/2025,3/21/2025,3/3/2025,F,Authorize the Board to effect a reverse stock split.
2238671,-1,2025-02-27||749527||Approval of an amendment to our Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Approval of an amendment to our Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions.
2238649,-1,2025-02-27||749527||Approval of an amendment to our Amended and Restated Certificate of Incorporation to eliminate inoperative provisions and implement certain other miscellaneous amendments.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Approval of an amendment to our Amended and Restated Certificate of Incorporation to eliminate inoperative provisions and implement certain other miscellaneous amendments.
2238616,-1,"2025-02-27||749527||Ratification of RSM US LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2025.||-1||-1",P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,"Ratification of RSM US LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2025."
2238631,-1,2025-02-27||749527||Advisory vote on the compensation of our named executive officers.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Advisory vote on the compensation of our named executive officers.
2238597,-1,2025-02-27||749527||Election of Class II Director: Maureen O'Connell||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Election of Class II Director: Maureen O'Connell
2238577,-1,2025-02-27||749527||Election of Class II Director: Mark Skonieczny||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Election of Class II Director: Mark Skonieczny
2238687,-1,2025-02-27||749527||Approval of an amendment to our Amended and Restated Certificate of Incorporation to limit liability of officers as permitted by Delaware law.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Approval of an amendment to our Amended and Restated Certificate of Incorporation to limit liability of officers as permitted by Delaware law.
2238694,-1,2025-02-27||749527||Approval of an amendment to our Amended and Restated Certificate of Incorporation to add a federal forum selection provision.||-1||-1,P22301,"REV GROUP, INC.",BN,749527,2/27/2025,1/22/2025,1/3/2025,F,Approval of an amendment to our Amended and Restated Certificate of Incorporation to add a federal forum selection provision.
2235606,-1,2025-01-17||76135L||Amend the Company's amended and restated certificate of incorporation to effect the reverse stock split.||-1||-1,S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,Amend the Company's amended and restated certificate of incorporation to effect the reverse stock split.
2235715,-1,"2025-01-17||76135L||Approve the reservation and issuance of shares of our common stock pursuant to Class F Common Stock Warrants and Class G Common Stock Warrants (the ""Warrants""), dated December 3, 2024, entered into between us and certain purchasers in connection with a warrant inducement letter dated the same date, to the extent that issuances under the Warrants may exceed 20% of the Company's total outstanding shares, which could trigger the share issuance cap under Rule 5635(d) of the Nasdaq Stock Market Rules (the ""Exchange Cap"").||-1||-1",S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,"Approve the reservation and issuance of shares of our common stock pursuant to Class F Common Stock Warrants and Class G Common Stock Warrants (the ""Warrants""), dated December 3, 2024, entered into between us and certain purchasers in connection with a warrant inducement letter dated the same date, to the extent that issuances under the Warrants may exceed 20% of the Company's total outstanding shares, which could trigger the share issuance cap under Rule 5635(d) of the Nasdaq Stock Market Rules (the ""Exchange Cap"")."
2235554,-1,"2025-01-17||76135L||Approval of the adjournment of the Special Meeting of the Stockholders (the ""Special Meeting"") to the extent there are insufficient proxies at the Special Meeting to approve the Reverse Stock Split.||-1||-1",S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,"Approval of the adjournment of the Special Meeting of the Stockholders (the ""Special Meeting"") to the extent there are insufficient proxies at the Special Meeting to approve the Reverse Stock Split."
2235723,-1,2025-01-17||76135L||Approve the change of domicile of the Company from the State of Delaware to the State of Nevada.||-1||-1,S03195,"REVELATION BIOSCIENCES, INC.",BN,76135L,1/17/2025,12/19/2024,12/3/2024,F,Approve the change of domicile of the Company from the State of Delaware to the State of Nevada.
-1,1293445,2025-01-23||78163D||01||Catherine Frey,S03975,RUNWAY GROWTH FINANCE CORP.,BN,78163D,1/23/2025,12/20/2024,12/9/2024,,
2236059,-1,"2025-01-23||78163D||To approve a new investment management agreement (the ""New Advisory Agreement"") between the Company and Runway Growth Capital LLC (the ""Adviser"") (the ""New Advisory Agreement Proposal"").||-1||-1",S03975,RUNWAY GROWTH FINANCE CORP.,BN,78163D,1/23/2025,12/20/2024,12/9/2024,F,"To approve a new investment management agreement (the ""New Advisory Agreement"") between the Company and Runway Growth Capital LLC (the ""Adviser"") (the ""New Advisory Agreement Proposal"")."
2236056,-1,"2025-01-23||78163D||To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the New Advisory Agreement (the ""Adjournment Proposal"").||-1||-1",S03975,RUNWAY GROWTH FINANCE CORP.,BN,78163D,1/23/2025,12/20/2024,12/9/2024,F,"To approve the adjournment of the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the New Advisory Agreement (the ""Adjournment Proposal"")."
2313750,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Michael W. Schechter||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Michael W. Schechter
2312139,-1,"2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Clarke R. Brown, Jr.||-1||-1",P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,"Election of Director for the ensuing year and until their successors are elected and qualified: Clarke R. Brown, Jr."
2296656,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Timothy J. Clarke||-1||-1,P25833,"SAGA COMMUNICATIONS, INC.",SH,786598,5/2/2025,4/10/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Timothy J. Clarke
2298265,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Roy F. Coppedge III||-1||-1,P25833,"SAGA COMMUNICATIONS, INC.",SH,786598,5/2/2025,4/10/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Roy F. Coppedge III
2312753,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Christopher S. Forgy||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Christopher S. Forgy
2313724,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Michael Scafidi||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Michael Scafidi
2312194,-1,"2025-05-02||786598||To approve, by a non-binding advisory vote, a resolution approving the compensation of our named executive officers as described in the proxy statement.||-1||-1",P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,"To approve, by a non-binding advisory vote, a resolution approving the compensation of our named executive officers as described in the proxy statement."
2312876,-1,2025-05-02||786598||Election of Director for the ensuing year and until their successors are elected and qualified: Warren S. Lada||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,Election of Director for the ensuing year and until their successors are elected and qualified: Warren S. Lada
2313186,-1,"2025-05-02||786598||To ratify the appointment of Crowe LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,"To ratify the appointment of Crowe LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2025."
2313244,-1,2025-05-02||786598||To re-approve the material terms of the Company's Chief Executive Officer Annual Incentive Plan.||-1||-1,P25381,"SAGA COMMUNICATIONS, INC.",BN,786598,5/2/2025,4/14/2025,3/14/2025,F,To re-approve the material terms of the Company's Chief Executive Officer Annual Incentive Plan.
2232352,-1,2025-01-24||79546E||Election of Director: Diana S. Ferguson||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Diana S. Ferguson
2232361,-1,2025-01-24||79546E||Election of Director: Jeffrey Boyer||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Jeffrey Boyer
2232337,-1,"2025-01-24||79546E||Election of Director: Lawrence ""Chip"" P. Molloy||-1||-1",P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,"Election of Director: Lawrence ""Chip"" P. Molloy"
2232296,-1,2025-01-24||79546E||Approval of an advisory vote on executive compensation.||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Approval of an advisory vote on executive compensation.
2232260,-1,2025-01-24||79546E||Vote on shareholder proposal (Director Election Resignation Guideline).||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,N,Vote on shareholder proposal (Director Election Resignation Guideline).
2232342,-1,2025-01-24||79546E||Election of Director: Rachel R. Bishop Ph. D.||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Rachel R. Bishop Ph. D.
2232307,-1,2025-01-24||79546E||Approval of 2025 Omnibus Incentive Plan.||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Approval of 2025 Omnibus Incentive Plan.
2232231,-1,2025-01-24||79546E||Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2025.||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Ratification of the selection of KPMG LLP as the Company's independent registered public accounting firm for fiscal year 2025.
2232220,-1,2025-01-24||79546E||Election of Director: Denise Paulonis||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Denise Paulonis
2232246,-1,2025-01-24||79546E||Election of Director: James M. Head||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: James M. Head
2232370,-1,2025-01-24||79546E||Election of Director: Debra Perelman||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Debra Perelman
2232270,-1,2025-01-24||79546E||Election of Director: Erin Nealy Cox||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Erin Nealy Cox
2232210,-1,2025-01-24||79546E||Election of Director: Dorlisa K. Flur||-1||-1,P21110,"SALLY BEAUTY HOLDINGS, INC.",BN,79546E,1/24/2025,12/13/2024,11/25/2024,F,Election of Director: Dorlisa K. Flur
2241478,-1,2025-03-10||801056||Election of Director: Jure Sola||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: Jure Sola
2241387,-1,2025-03-10||801056||Election of Director: Susan K. Barnes||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: Susan K. Barnes
2241240,-1,2025-03-10||801056||Election of Director: Krish Prabhu||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: Krish Prabhu
2241271,-1,"2025-03-10||801056||To ratify the appointment of PricewaterhouseCoopers LLP as Sanmina Corporation's independent registered public accounting firm for the fiscal year ending September 27, 2025.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"To ratify the appointment of PricewaterhouseCoopers LLP as Sanmina Corporation's independent registered public accounting firm for the fiscal year ending September 27, 2025."
2240213,-1,2025-03-10||801056||Election of Director: David V. Hedley III||-1||-1,P24639,SANMINA CORPORATION,SH,801056,3/10/2025,2/10/2025,1/17/2025,F,Election of Director: David V. Hedley III
2241241,-1,"2025-03-10||801056||To approve the reservation of an additional 1,000,000 shares of common stock for issuance under the 2019 Equity Incentive Plan of Sanmina Corporation.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"To approve the reservation of an additional 1,000,000 shares of common stock for issuance under the 2019 Equity Incentive Plan of Sanmina Corporation."
2241299,-1,2025-03-10||801056||Election of Director: Mythili Sankaran||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: Mythili Sankaran
2241431,-1,2025-03-10||801056||Election of Director: Susan A. Johnson||-1||-1,P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,Election of Director: Susan A. Johnson
2241440,-1,"2025-03-10||801056||Election of Director: Joseph G. Licata, Jr.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"Election of Director: Joseph G. Licata, Jr."
2241359,-1,"2025-03-10||801056||To consider and vote upon the stockholder proposal entitled ""Proposal 5 - Special Shareholder Meeting Improvement,"" requesting that the Board of Directors take action as necessary to amend the existing right for shareholders to call a special meeting.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,N,"To consider and vote upon the stockholder proposal entitled ""Proposal 5 - Special Shareholder Meeting Improvement,"" requesting that the Board of Directors take action as necessary to amend the existing right for shareholders to call a special meeting."
2241339,-1,"2025-03-10||801056||To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers.||-1||-1",P24568,SANMINA CORPORATION,BN,801056,3/10/2025,1/28/2025,1/17/2025,F,"To approve, on an advisory (non-binding) basis, the compensation of Sanmina Corporation's named executive officers."
2236652,-1,"2025-01-16||42237K||To approve, for purposes of complying with the NYSE American LLC listing rules, of the issuance of 20% or more of the Company's issued and outstanding Common Stock as of December 5, 2024 pursuant to a securities purchase agreement with the purchasers named therein (the ""Investors""), dated December 5, 2024, including upon the conversion of the senior secured convertible notes issued pursuant to the Purchase Agreement and the exercise of warrants issued or issuable pursuant to the Purchase Agreement (the ""Share Issuance Proposal"").||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"To approve, for purposes of complying with the NYSE American LLC listing rules, of the issuance of 20% or more of the Company's issued and outstanding Common Stock as of December 5, 2024 pursuant to a securities purchase agreement with the purchasers named therein (the ""Investors""), dated December 5, 2024, including upon the conversion of the senior secured convertible notes issued pursuant to the Purchase Agreement and the exercise of warrants issued or issuable pursuant to the Purchase Agreement (the ""Share Issuance Proposal"")."
2236742,-1,"2025-01-16||42237K||The Company seeks approval to amend its Third Amended and Restated Certificate of Incorporation, as outlined in Appendix A of the proxy statement. The amendment would authorize the Board of Directors to execute a reverse stock split of Common Stock (par value $0.0002 per share), including treasury shares, at a ratio between 1-for-5 and 1-for-35. The exact ratio will be determined and announced by the Board, which also reserves the right to abandon the proposal if necessary. This is termed the ""Reverse Stock Split Proposal.""||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"The Company seeks approval to amend its Third Amended and Restated Certificate of Incorporation, as outlined in Appendix A of the proxy statement. The amendment would authorize the Board of Directors to execute a reverse stock split of Common Stock (par value $0.0002 per share), including treasury shares, at a ratio between 1-for-5 and 1-for-35. The exact ratio will be determined and announced by the Board, which also reserves the right to abandon the proposal if necessary. This is termed the ""Reverse Stock Split Proposal."""
2236569,-1,"2025-01-16||42237K||To approve an adjournment of the Special Meeting of Stockholders to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or the Share Issuance Proposal.||-1||-1",S02513,"SCORPIUS HOLDINGS, INC.",BN,42237K,1/16/2025,12/24/2024,12/13/2024,F,"To approve an adjournment of the Special Meeting of Stockholders to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal or the Share Issuance Proposal."
2254059,-1,2025-04-24||81619Q||Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Vote to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to eliminate supermajority voting requirements.
2253845,-1,2025-04-24||81619Q||Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Russell L. Carson||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Russell L. Carson
2253842,-1,2025-04-24||81619Q||Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Marilyn B. Tavenner||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Marilyn B. Tavenner
2253822,-1,2025-04-24||81619Q||Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: William H. Frist||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: William H. Frist
2253773,-1,"2025-04-24||81619Q||Vote on a stockholder proposal to amend the Company's Amended and Restated Certificate of Incorporation to elect each director annually, if properly presented at the meeting.||-1||-1",P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,/,"Vote on a stockholder proposal to amend the Company's Amended and Restated Certificate of Incorporation to elect each director annually, if properly presented at the meeting."
2254096,-1,2025-04-24||81619Q||Non-binding advisory vote on the compensation of our named executive officers.||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Non-binding advisory vote on the compensation of our named executive officers.
2254157,-1,"2025-04-24||81619Q||Vote to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,"Vote to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
2254130,-1,2025-04-24||81619Q||Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Katherine R. Davisson||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Election of Class I Director for a term of three years or until their respective successors have been elected and qualified: Katherine R. Davisson
2254150,-1,2025-04-24||81619Q||Vote to approve the Company's Non-Employee Director Compensation Policy.||-1||-1,P23016,SELECT MEDICAL HOLDINGS CORPORATION,BN,81619Q,4/24/2025,3/13/2025,2/28/2025,F,Vote to approve the Company's Non-Employee Director Compensation Policy.
2268084,-1,"2025-04-10||81750R||Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposals 5, 6 or 7.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposals 5, 6 or 7."
-1,1303160,2025-04-10||81750R||02||Willard H. Dere,P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,,
-1,1303157,2025-04-10||81750R||01||Dennis A. Ausiello,P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,,
2268155,-1,"2025-04-10||81750R||Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers."
2269379,-1,"2025-04-10||81750R||Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025."
-1,1303080,2025-04-10||81750R||03||Eric D. Shaff,P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,,
2268758,-1,"2025-04-10||81750R||Approval of the Seres Therapeutics, Inc. 2025 Incentive Award Plan as an amendment and restatement of the Seres Therapeutics, Inc. 2015 Incentive Award Plan, which is scheduled to expire in 2025.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval of the Seres Therapeutics, Inc. 2025 Incentive Award Plan as an amendment and restatement of the Seres Therapeutics, Inc. 2015 Incentive Award Plan, which is scheduled to expire in 2025."
2268357,-1,"2025-04-10||81750R||Approval of amendments to our Restated Certificate of Incorporation, as amended, to eliminate supermajority voting requirements.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval of amendments to our Restated Certificate of Incorporation, as amended, to eliminate supermajority voting requirements."
2269008,-1,"2025-04-10||81750R||Approval of amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval of amendments to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split."
2269362,-1,"2025-04-10||81750R||Approval of amendments to our Restated Certificate of Incorporation, as amended, to clarify voting requirements to amend the number of shares of authorized common stock and preferred stock.||-1||-1",P23105,"SERES THERAPEUTICS, INC.",BN,81750R,4/10/2025,3/21/2025,2/13/2025,F,"Approval of amendments to our Restated Certificate of Incorporation, as amended, to clarify voting requirements to amend the number of shares of authorized common stock and preferred stock."
-1,1301141,2025-05-01||82489W||02||Toni Volpe,P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,,
-1,1301130,2025-05-01||82489W||01||Ty Daul,P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,,
2258900,-1,"2025-05-01||82489W||Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., ""say-on-pay"" proposal).||-1||-1",P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,F,"Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., ""say-on-pay"" proposal)."
2259511,-1,"2025-05-01||82489W||The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025.||-1||-1",P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,F,"The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025."
-1,1301193,2025-05-01||82489W||03||Niharika Taskar Ramdev,P23069,"SHOALS TECHNOLOGIES GROUP, INC.",BN,82489W,5/1/2025,3/27/2025,3/10/2025,,
2236368,-1,"2025-02-13||829214||Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2025.||-1||-1",P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,F,"Ratification of the selection of Rose, Snyder & Jacobs LLP as the independent registered public accounting firm for the Company for the fiscal year ending August 31, 2025."
-1,1293556,2025-02-13||829214||01||Dr. Daniel Weiner,P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,,
-1,1293515,2025-02-13||829214||04||Dr. Lisa LaVange,P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,,
-1,1293560,2025-02-13||829214||05||Sharlene Evans,P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,,
2236356,-1,"2025-02-13||829214||Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers.||-1||-1",P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,F,"Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers."
-1,1293459,2025-02-13||829214||03||Dr. John K. Paglia,P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,,
-1,1293457,2025-02-13||829214||02||Dr. Walter S. Woltosz,P21380,"SIMULATIONS PLUS, INC.",BN,829214,2/13/2025,1/6/2025,12/17/2024,,
2229616,-1,"2024-12-19||829392||Ratification of the appointment of Tanner LLC as SINTX's independent registered public accounting firm for the year ending December 31, 2024.||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"Ratification of the appointment of Tanner LLC as SINTX's independent registered public accounting firm for the year ending December 31, 2024."
2229507,-1,"2024-12-19||829392||Approve adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement under ""Executive Compensation.""||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"Approve adoption, on an advisory basis, of a non-binding resolution approving the compensation of the Company's named executive officers, as described in the Proxy Statement under ""Executive Compensation."""
2229420,-1,2024-12-19||829392||Election of Class I Director to hold office for a term expiring at the annual meeting of stockholders to be held in 2027 or until his respective successor is elected and qualified: Mark Froimson||-1||-1,P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,Election of Class I Director to hold office for a term expiring at the annual meeting of stockholders to be held in 2027 or until his respective successor is elected and qualified: Mark Froimson
2229630,-1,"2024-12-19||829392||To approve an amendment to our 2020 Equity Incentive Plan to increase the authorized number of shares of common stock of the Company issuable under all awards granted under the plan by 333,650 shares.||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"To approve an amendment to our 2020 Equity Incentive Plan to increase the authorized number of shares of common stock of the Company issuable under all awards granted under the plan by 333,650 shares."
2229575,-1,"2024-12-19||829392||Approve one or more adjournments of the annual meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt one or more of the foregoing Proposals.||-1||-1",P20420,SINTX TECHNOLOGIES INC,BN,829392,12/19/2024,11/21/2024,11/6/2024,F,"Approve one or more adjournments of the annual meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt one or more of the foregoing Proposals."
2259067,-1,2025-04-16||835495||Election of Director for a one-year term: Philippe Guillemot||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Philippe Guillemot
2259416,-1,"2025-04-16||835495||To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025.||-1||-1",P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,"To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2025."
2259154,-1,2025-04-16||835495||Election of Director for a one-year term: Eleni Istavridis||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Eleni Istavridis
2260048,-1,2025-04-16||835495||Election of Director for a one-year term: Thomas E. Whiddon||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Thomas E. Whiddon
2259018,-1,2025-04-16||835495||Election of Director for a one-year term: Theresa J. Drew||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Theresa J. Drew
2260051,-1,"2025-04-16||835495||Election of Director for a one-year term: Robert R. Hill, Jr.||-1||-1",P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,"Election of Director for a one-year term: Robert R. Hill, Jr."
2259584,-1,2025-04-16||835495||Advisory (non-binding) shareholder proposal regarding transparency in political spending.||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,N,Advisory (non-binding) shareholder proposal regarding transparency in political spending.
2259771,-1,2025-04-16||835495||Election of Director for a one-year term: Richard G. Kyle||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Richard G. Kyle
2259087,-1,2025-04-16||835495||Election of Director for a one-year term: Steven L. Boyd||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Steven L. Boyd
2259646,-1,2025-04-16||835495||Election of Director for a one-year term: John R. Haley||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: John R. Haley
2259132,-1,"2025-04-16||835495||To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.||-1||-1",P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,"To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers."
2259844,-1,2025-04-16||835495||Election of Director for a one-year term: R. Howard Coker||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: R. Howard Coker
2259502,-1,2025-04-16||835495||Election of Director for a one-year term: Blythe J. McGarvie||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Blythe J. McGarvie
2259564,-1,2025-04-16||835495||Election of Director for a one-year term: Dr. Pamela L. Davies||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Dr. Pamela L. Davies
2259585,-1,2025-04-16||835495||Election of Director for a one-year term: Scott A. Clark||-1||-1,P26304,SONOCO PRODUCTS COMPANY,BN,835495,4/16/2025,3/14/2025,2/26/2025,F,Election of Director for a one-year term: Scott A. Clark
-1,1295797,2025-03-11||83570H||03||Bracken Darrell,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,,
2241181,-1,2025-03-11||83570H||Approval of an amendment and restatement of the Company's Restated Certificate of Incorporation to reflect Delaware law provisions allowing for the exculpation of officers.||-1||-1,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,Approval of an amendment and restatement of the Company's Restated Certificate of Incorporation to reflect Delaware law provisions allowing for the exculpation of officers.
2241000,-1,2025-03-11||83570H||Approve amending the Company's Restated Bylaws to provide for Delaware General Corporation Law and universal proxy rule updates.||-1||-1,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,Approve amending the Company's Restated Bylaws to provide for Delaware General Corporation Law and universal proxy rule updates.
2241068,-1,2025-03-11||83570H||Approve amending the Company's Restated Bylaws to modernize the advance notice provisions.||-1||-1,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,Approve amending the Company's Restated Bylaws to modernize the advance notice provisions.
2241038,-1,2025-03-11||83570H||Advisory approval of the named executive officer compensation (the say-on-pay vote).||-1||-1,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,Advisory approval of the named executive officer compensation (the say-on-pay vote).
-1,1295790,2025-03-11||83570H||02||Joanna Coles,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,,
-1,1295814,2025-03-11||83570H||01||Karen Boone,P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,,
2240960,-1,"2025-03-11||83570H||Ratification of the appointment of KPMG LLP as Sonos' independent registered accounting firm for the fiscal year ending September 27, 2025.||-1||-1",P22542,"SONOS, INC.",BN,83570H,3/11/2025,1/31/2025,1/13/2025,F,"Ratification of the appointment of KPMG LLP as Sonos' independent registered accounting firm for the fiscal year ending September 27, 2025."
2237391,-1,"2025-01-31||848574||Proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Spirit's named executive officers that is based on or otherwise relates to the Merger (the ""Advisory Compensation Proposal"").||-1||-1",S02718,"SPIRIT AEROSYSTEMS HOLDINGS, INC.",BN,848574,1/31/2025,12/30/2024,12/20/2024,F,"Proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Spirit's named executive officers that is based on or otherwise relates to the Merger (the ""Advisory Compensation Proposal"")."
2237421,-1,"2025-01-31||848574||Proposal to approve one or more adjournments of the Special Meeting, if necessary or appropriate, to permit solicitation of additional votes or proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the ""Adjournment Proposal"").||-1||-1",S02718,"SPIRIT AEROSYSTEMS HOLDINGS, INC.",BN,848574,1/31/2025,12/30/2024,12/20/2024,F,"Proposal to approve one or more adjournments of the Special Meeting, if necessary or appropriate, to permit solicitation of additional votes or proxies if there are not sufficient votes to approve the Merger Agreement Proposal (the ""Adjournment Proposal"")."
2237438,-1,"2025-01-31||848574||Proposal (the ""Merger Agreement Proposal"") to adopt the Agreement and Plan of Merger, dated June 30, 2024, as it may be amended from time to time (the ""Merger Agreement""), among Spirit AeroSystems Holdings, Inc. (""Spirit""), The Boeing Company (""Boeing"") and Sphere Acquisition Corp., a wholly owned subsidiary of Boeing (""Merger Sub""), providing for the merger of Merger Sub with and into Spirit (the ""Merger"").||-1||-1",S02718,"SPIRIT AEROSYSTEMS HOLDINGS, INC.",BN,848574,1/31/2025,12/30/2024,12/20/2024,F,"Proposal (the ""Merger Agreement Proposal"") to adopt the Agreement and Plan of Merger, dated June 30, 2024, as it may be amended from time to time (the ""Merger Agreement""), among Spirit AeroSystems Holdings, Inc. (""Spirit""), The Boeing Company (""Boeing"") and Sphere Acquisition Corp., a wholly owned subsidiary of Boeing (""Merger Sub""), providing for the merger of Merger Sub with and into Spirit (the ""Merger"")."
2259407,-1,2025-04-03||72303P||To approve one or more adjournments of the special meeting to a later date or dates to solicit additional proxies if there are insufficient votes to approve any of the proposals at the time of the special meeting.||-1||-1,S10600,"SUNATION ENERGY, INC.",BN,72303P,4/3/2025,3/14/2025,2/27/2025,F,To approve one or more adjournments of the special meeting to a later date or dates to solicit additional proxies if there are insufficient votes to approve any of the proposals at the time of the special meeting.
2259982,-1,"2025-04-03||72303P||To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-two hundred (1-for-200); and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Proposal"").||-1||-1",S10600,"SUNATION ENERGY, INC.",BN,72303P,4/3/2025,3/14/2025,2/27/2025,F,"To grant discretionary authority to our board of directors to (i) amend our certificate of incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, or a ""reverse stock split,"" at a specific ratio within a range of one-for-five (1-for-5) to a maximum of a one-for-two hundred (1-for-200); and (ii) effect the reverse stock split, if at all, within one year of the date the proposal is approved by stockholders (the ""Reverse Stock Proposal"")."
2258920,-1,"2025-04-03||72303P||To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 27, 2025 (the ""Issuance Proposal"").||-1||-1",S10600,"SUNATION ENERGY, INC.",BN,72303P,4/3/2025,3/14/2025,2/27/2025,F,"To authorize, for purposes of complying with Nasdaq listing rule 5635(d), the issuance of Warrants, shares of Common Stock underlying the Warrants and certain provisions of the Warrants, issued in connection with an offering and sale of securities of the Company that was consummated on February 27, 2025 (the ""Issuance Proposal"")."
2258772,-1,"2025-04-03||72303P||To approve an amendment to our certificate of incorporation to increase the number of authorized shares of common stock, par value of $0.05 per share, from 25,000,000 to 1,000,000,000 (the ""Authorized Share Increase Proposal"").||-1||-1",S10600,"SUNATION ENERGY, INC.",BN,72303P,4/3/2025,3/14/2025,2/27/2025,F,"To approve an amendment to our certificate of incorporation to increase the number of authorized shares of common stock, par value of $0.05 per share, from 25,000,000 to 1,000,000,000 (the ""Authorized Share Increase Proposal"")."
2244354,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Luis Borgen||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Luis Borgen
2244499,-1,"2025-04-10||871607||To vote on a stockholder proposal regarding shareholder ratification of golden parachutes, if properly presented at the meeting.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,N,"To vote on a stockholder proposal regarding shareholder ratification of golden parachutes, if properly presented at the meeting."
2244427,-1,"2025-04-10||871607||To approve our Employee Stock Purchase Plan, as amended.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,"To approve our Employee Stock Purchase Plan, as amended."
2244561,-1,"2025-04-10||871607||To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,"To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the attached Proxy Statement."
2244341,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Jeannine P. Sargent||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Jeannine P. Sargent
2244554,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Dr. Aart J. de Geus||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Dr. Aart J. de Geus
2244602,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Robert G. Painter||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Robert G. Painter
2244536,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Janice D. Chaffin||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Janice D. Chaffin
2244357,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Bruce R. Chizen||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Bruce R. Chizen
2244485,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Mercedes Johnson||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Mercedes Johnson
2244523,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: John G. Schwarz||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: John G. Schwarz
2244348,-1,2025-04-10||871607||Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Sassine Ghazi||-1||-1,P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,Election of Director to hold office until the next annual meeting of stockholders or until their successors have been elected: Sassine Ghazi
2244412,-1,"2025-04-10||871607||To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2025.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,"To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending October 31, 2025."
2244459,-1,"2025-04-10||871607||To approve our 2006 Employee Equity Incentive Plan, as amended.||-1||-1",P22733,"SYNOPSYS, INC.",BN,871607,4/10/2025,2/27/2025,2/10/2025,F,"To approve our 2006 Employee Equity Incentive Plan, as amended."
2244359,-1,2025-04-02||87162W||Election of Director: Claude Pumilia||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Claude Pumilia
2244439,-1,2025-04-02||87162W||Election of Director: Kathleen Crusco||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Kathleen Crusco
2244556,-1,2025-04-02||87162W||Charter amendment to remove obsolete provisions.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Charter amendment to remove obsolete provisions.
2244469,-1,2025-04-02||87162W||Election of Director: Kenneth Lamneck||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Kenneth Lamneck
2244549,-1,2025-04-02||87162W||Election of Director: Merline Saintil||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Merline Saintil
2244346,-1,"2025-04-02||87162W||Stockholder proposal regarding shareholder ability to call for a special shareholder meeting, if properly presented.||-1||-1",P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,N,"Stockholder proposal regarding shareholder ability to call for a special shareholder meeting, if properly presented."
2244446,-1,2025-04-02||87162W||Charter amendment to eliminate supermajority voting requirements.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Charter amendment to eliminate supermajority voting requirements.
2244407,-1,2025-04-02||87162W||An advisory vote to approve our Executive Compensation.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,An advisory vote to approve our Executive Compensation.
2244520,-1,2025-04-02||87162W||Ratification of the appointment of KPMG LLP as our independent registered public accountants.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Ratification of the appointment of KPMG LLP as our independent registered public accountants.
2244493,-1,2025-04-02||87162W||Board of Directors' proposal on creation of a stockholder right to call a special meeting of stockholders.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Board of Directors' proposal on creation of a stockholder right to call a special meeting of stockholders.
2244343,-1,2025-04-02||87162W||Election of Director: Richard Hume||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Richard Hume
2244509,-1,2025-04-02||87162W||Charter amendment limiting liability of certain officers.||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Charter amendment limiting liability of certain officers.
2244414,-1,2025-04-02||87162W||Election of Director: Patrick Zammit||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Patrick Zammit
2244399,-1,2025-04-02||87162W||Election of Director: Dennis Polk||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Dennis Polk
2244483,-1,2025-04-02||87162W||Election of Director: Nayaki Nayyar||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Nayaki Nayyar
2244456,-1,2025-04-02||87162W||Election of Director: Ting Herh||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Ting Herh
2244557,-1,2025-04-02||87162W||Election of Director: Ann Vezina||-1||-1,P23310,TD SYNNEX CORPORATION,BN,87162W,4/2/2025,2/26/2025,2/3/2025,F,Election of Director: Ann Vezina
2255014,-1,"2025-04-23||879360||Approval of a non-binding advisory resolution on the Company's 2024 executive compensation (""say on pay"")||-1||-1",P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,"Approval of a non-binding advisory resolution on the Company's 2024 executive compensation (""say on pay"")"
2255245,-1,2025-04-23||879360||Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025
2255054,-1,2025-04-23||879360||Approval of amendments to the Company's Restated Certificate of Incorporation to adopt majority voting provisions||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,Approval of amendments to the Company's Restated Certificate of Incorporation to adopt majority voting provisions
2255483,-1,2025-04-23||879360||Election of Director: Michael T. Smith||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Michael T. Smith
2254852,-1,2025-04-23||879360||Approval of a stockholder proposal to support shareholder ability to call for a special shareholder meeting||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,N,Approval of a stockholder proposal to support shareholder ability to call for a special shareholder meeting
2254975,-1,2025-04-23||879360||Election of Director: Jane C. Sherburne||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Jane C. Sherburne
2254686,-1,2025-04-23||879360||Election of Director: Robert Mehrabian||-1||-1,P26930,TELEDYNE TECHNOLOGIES INCORPORATED,BN,879360,4/23/2025,3/17/2025,3/3/2025,F,Election of Director: Robert Mehrabian
2228304,-1,"2024-12-03||87978U||To approve a series of alternate amendments to the Company's Restated Certificate of Incorporation to effect, at the option of the Company's Board of Directors, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, as determined by the Company's Board of Directors in its sole discretion.||-1||-1",Z88881,"TEMPEST THERAPEUTICS, INC.",BN,87978U,12/3/2024,11/14/2024,11/5/2024,F,"To approve a series of alternate amendments to the Company's Restated Certificate of Incorporation to effect, at the option of the Company's Board of Directors, a reverse stock split of the Company's common stock at a ratio in the range of 1-for-2 to 1-for-15, inclusive, as determined by the Company's Board of Directors in its sole discretion."
2248825,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Charles S. Hyle||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Charles S. Hyle
2248638,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Elysia Holt Ragusa||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Elysia Holt Ragusa
2248664,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Ranjana B. Clark||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Ranjana B. Clark
2248494,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. Long||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. Long
2249050,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Steven P. Rosenberg||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Steven P. Rosenberg
2248953,-1,"2025-04-15||88224Q||To approved the 2022 Long-Term Incentive Plan, as amended and restated, as described in the Proxy Statement;||-1||-1",P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,"To approved the 2022 Long-Term Incentive Plan, as amended and restated, as described in the Proxy Statement;"
2248980,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: David S. Huntley||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: David S. Huntley
2248548,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Mark W. Midkiff||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Mark W. Midkiff
2248896,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Paola M. Arbour||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Paola M. Arbour
2248442,-1,"2025-04-15||88224Q||To ratify the apointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025;||-1||-1",P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,"To ratify the apointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025;"
2248563,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Rob C. Holmes||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Rob C. Holmes
2248647,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Laura L. Whitley||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Laura L. Whitley
2248857,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Robert W. Stallings||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Robert W. Stallings
2249044,-1,"2025-04-15||88224Q||To approve, on an advisory basis, the 2024 compensation of the Company's named executive officers as described in the Proxy Statement;||-1||-1",P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,"To approve, on an advisory basis, the 2024 compensation of the Company's named executive officers as described in the Proxy Statement;"
2248786,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Dale W. Tremblay||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Dale W. Tremblay
2248445,-1,2025-04-15||88224Q||Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Jonathan E. Baliff||-1||-1,P24569,"TEXAS CAPITAL BANCSHARES, INC.",BN,88224Q,4/15/2025,3/10/2025,2/19/2025,F,Election of Director to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Jonathan E. Baliff
2250442,-1,2025-04-17||882508||Election of Director: Jean Hobby||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Jean Hobby
2249944,-1,2025-04-17||882508||Election of Director: Carrie Cox||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Carrie Cox
2250396,-1,2025-04-17||882508||Board proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025.||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Board proposal to ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2025.
2250549,-1,2025-04-17||882508||Election of Director: Todd Bluedorn||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Todd Bluedorn
2250445,-1,2025-04-17||882508||Election of Director: Pamela Patsley||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Pamela Patsley
2250125,-1,2025-04-17||882508||Election of Director: Martin Craighead||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Martin Craighead
2250608,-1,2025-04-17||882508||Election of Director: Richard Templeton||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Richard Templeton
2250546,-1,2025-04-17||882508||Election of Director: Haviv Ilan||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Haviv Ilan
2250612,-1,2025-04-17||882508||Stockholder proposal to permit a combined 10% of stockholders to call a special meeting.||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,N,Stockholder proposal to permit a combined 10% of stockholders to call a special meeting.
2250291,-1,2025-04-17||882508||Election of Director: Reginald DesRoches||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Reginald DesRoches
2250353,-1,2025-04-17||882508||Election of Director: Curtis Farmer||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Curtis Farmer
2250293,-1,2025-04-17||882508||Election of Director: Mark Blinn||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Mark Blinn
2250208,-1,2025-04-17||882508||Board proposal regarding advisory approval of the Company's executive compensation.||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Board proposal regarding advisory approval of the Company's executive compensation.
2250444,-1,2025-04-17||882508||Election of Director: Janet Clark||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Janet Clark
2250317,-1,2025-04-17||882508||Election of Director: Robert Sanchez||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Robert Sanchez
2249967,-1,2025-04-17||882508||Election of Director: Ronald Kirk||-1||-1,P24453,TEXAS INSTRUMENTS INCORPORATED,BN,882508,4/17/2025,3/12/2025,2/20/2025,F,Election of Director: Ronald Kirk
2254904,-1,2025-04-23||38141G||Election of Director: Kevin Johnson||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Kevin Johnson
2254818,-1,2025-04-23||38141G||Election of Director: David Viniar||-1||-1,Z89264,"THE GOLDMAN SACHS GROUP, INC.",SH,38141G,4/23/2025,3/20/2025,2/25/2025,F,Election of Director: David Viniar
2255311,-1,2025-04-23||38141G||Election of Director: John Hess||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: John Hess
2255531,-1,2025-04-23||38141G||Approval of The Goldman Sachs Amended and Restated Stock Incentive Plan (2025)||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Approval of The Goldman Sachs Amended and Restated Stock Incentive Plan (2025)
2255030,-1,2025-04-23||38141G||Election of Director: Jan Tighe||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Jan Tighe
2254810,-1,2025-04-23||38141G||Election of Director: Thomas Montag||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Thomas Montag
2255415,-1,2025-04-23||38141G||Shareholder Proposal Regarding DEI Goals in Executive Pay Incentives||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,N,Shareholder Proposal Regarding DEI Goals in Executive Pay Incentives
2255217,-1,2025-04-23||38141G||Election of Director: David Solomon||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: David Solomon
2255026,-1,2025-04-23||38141G||Election of Director: Kimberley Harris||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Kimberley Harris
2255305,-1,2025-04-23||38141G||Election of Director: Peter Oppenheimer||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Peter Oppenheimer
2255539,-1,2025-04-23||38141G||Election of Director: KC McClure||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: KC McClure
2255124,-1,2025-04-23||38141G||Ratification of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for 2025||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Ratification of PricewaterhouseCoopers LLP as our Independent Registered Public Accounting Firm for 2025
2255085,-1,2025-04-23||38141G||Shareholder Proposal Regarding Disclosure of Energy Supply Financing Ratio||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,N,Shareholder Proposal Regarding Disclosure of Energy Supply Financing Ratio
2255391,-1,2025-04-23||38141G||Advisory Vote to Approve Executive Compensation (Say on Pay)||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Advisory Vote to Approve Executive Compensation (Say on Pay)
2254796,-1,2025-04-23||38141G||Shareholder Proposal Regarding Racial Discrimination Audit||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,N,Shareholder Proposal Regarding Racial Discrimination Audit
2254878,-1,2025-04-23||38141G||Election of Director: Ellen Kullman||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Ellen Kullman
2255341,-1,2025-04-23||38141G||Election of Director: John Waldron||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: John Waldron
2254838,-1,2025-04-23||38141G||Election of Director: Lakshmi Mittal||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Lakshmi Mittal
2254952,-1,2025-04-23||38141G||Election of Director: Michele Burns||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Michele Burns
2254712,-1,2025-04-23||38141G||Election of Director: Mark Flaherty||-1||-1,P20379,"THE GOLDMAN SACHS GROUP, INC.",BN,38141G,4/23/2025,3/19/2025,2/24/2025,F,Election of Director: Mark Flaherty
2266008,-1,2025-05-01||404609||Election of Director: Robert A. Rivero||-1||-1,P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,Election of Director: Robert A. Rivero
2266112,-1,"2025-05-01||404609||To approve, in an advisory vote, the Company's executive compensation.||-1||-1",P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,"To approve, in an advisory vote, the Company's executive compensation."
2266665,-1,2025-05-01||404609||Election of Director: Alan T. G. Wix||-1||-1,P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,Election of Director: Alan T. G. Wix
2266818,-1,"2025-05-01||404609||To approve an amendment to the Company's 1998 Stock Option and Incentive Plan (the ""Plan"") to (i) increase the sublimit under the Plan for restricted stock and restricted stock unit issuances by 1,950,000 shares; and (ii) increase the number of shares authorized for issuance under the Plan by 1,950,000 shares.||-1||-1",P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,"To approve an amendment to the Company's 1998 Stock Option and Incentive Plan (the ""Plan"") to (i) increase the sublimit under the Plan for restricted stock and restricted stock unit issuances by 1,950,000 shares; and (ii) increase the number of shares authorized for issuance under the Plan by 1,950,000 shares."
2266513,-1,2025-05-01||404609||Election of Director: Ted A. Fernandez||-1||-1,P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,Election of Director: Ted A. Fernandez
2266904,-1,"2025-05-01||404609||To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2025||-1||-1",P25285,THE HACKETT GROUP INC,BN,404609,5/1/2025,3/25/2025,3/14/2025,F,"To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 26, 2025"
2243313,-1,"2025-03-18||460690||IPG Compensation Proposal: Proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to IPG's named executive officers that is based on or otherwise relates to the merger.||-1||-1",S06324,"THE INTERPUBLIC GROUP OF COMPANIES, INC.",BN,460690,3/18/2025,2/6/2025,1/27/2025,F,"IPG Compensation Proposal: Proposal to approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to IPG's named executive officers that is based on or otherwise relates to the merger."
2243369,-1,"2025-03-18||460690||IPG Adjournment Proposal: Proposal to approve one or more adjournments of the Interpublic special meeting to a later date or time, if necessary or appropriate, to permit the solicitation of additional votes or proxies if there are not sufficient votes to approve proposal 1.||-1||-1",S06324,"THE INTERPUBLIC GROUP OF COMPANIES, INC.",BN,460690,3/18/2025,2/6/2025,1/27/2025,F,"IPG Adjournment Proposal: Proposal to approve one or more adjournments of the Interpublic special meeting to a later date or time, if necessary or appropriate, to permit the solicitation of additional votes or proxies if there are not sufficient votes to approve proposal 1."
2243368,-1,"2025-03-18||460690||IPG Merger Proposal: to adopt the Agreement and Plan of Merger, dated as of December 8, 2024 (as it may be amended from time to time, the ""merger agreement""), by and among Omnicom Group Inc., EXT Subsidiary Inc. (""Merger Sub"") and IPG, providing for, among other things, the acquisition of IPG by Omnicom pursuant to a merger between Merger Sub, a direct wholly owned subsidiary of Omnicom, and IPG, with each outstanding share of common stock of IPG being converted into right to receive 0.344 shares of common stock of Omnicom, with cash paid in lieu of fractional shares.||-1||-1",S06324,"THE INTERPUBLIC GROUP OF COMPANIES, INC.",BN,460690,3/18/2025,2/6/2025,1/27/2025,F,"IPG Merger Proposal: to adopt the Agreement and Plan of Merger, dated as of December 8, 2024 (as it may be amended from time to time, the ""merger agreement""), by and among Omnicom Group Inc., EXT Subsidiary Inc. (""Merger Sub"") and IPG, providing for, among other things, the acquisition of IPG by Omnicom pursuant to a merger between Merger Sub, a direct wholly owned subsidiary of Omnicom, and IPG, with each outstanding share of common stock of IPG being converted into right to receive 0.344 shares of common stock of Omnicom, with cash paid in lieu of fractional shares."
2234561,-1,2025-01-27||810186||Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: David C. Evans||-1||-1,P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: David C. Evans
2234520,-1,"2025-01-27||810186||Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,"Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2025."
2234370,-1,2025-01-27||810186||Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Adam Hanft||-1||-1,P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Adam Hanft
2234537,-1,2025-01-27||810186||Approval of an amendment and restatement of The Scotts Miracle-Gro Company Discounted Stock Purchase Plan to increase the maximum number of common shares available for grant to participants.||-1||-1,P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,Approval of an amendment and restatement of The Scotts Miracle-Gro Company Discounted Stock Purchase Plan to increase the maximum number of common shares available for grant to participants.
2234379,-1,2025-01-27||810186||Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Stephen L. Johnson||-1||-1,P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Stephen L. Johnson
2234548,-1,2025-01-27||810186||Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Katherine Hagedorn Littlefield||-1||-1,P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,Election of Director to serve for a term of three years to expire at the 2028 Annual Meeting of Shareholders: Katherine Hagedorn Littlefield
2234535,-1,"2025-01-27||810186||Approval, on an advisory basis, of the compensation of the Company's named executive officers.||-1||-1",P20355,THE SCOTTS MIRACLE-GRO COMPANY,BN,810186,1/27/2025,12/24/2024,12/2/2024,F,"Approval, on an advisory basis, of the compensation of the Company's named executive officers."
2319179,-1,"2025-05-02||89357L||To approve an amendment to our amended and restated certificate of Inc, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our Board, effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at any time prior to the one-year anniversary date of the Special Meeting, at a ratio, ranging from one-for- ten (1:10) to one-for-forty (1:40), with the exact ratio to be set within that range at the discretion of our Board without further approval (the ""Reverse Stock Split Proposal"").||-1||-1",Z90062,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,5/2/2025,4/16/2025,4/3/2025,F,"To approve an amendment to our amended and restated certificate of Inc, as amended, in the form attached to the proxy statement as Annex A, to, at the discretion of our Board, effect a reverse stock split of our outstanding shares of common stock, par value $0.0001 per share, at any time prior to the one-year anniversary date of the Special Meeting, at a ratio, ranging from one-for- ten (1:10) to one-for-forty (1:40), with the exact ratio to be set within that range at the discretion of our Board without further approval (the ""Reverse Stock Split Proposal"")."
2238526,-1,"2025-02-25||89357L||To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of proposal 1.||-1||-1",Z89155,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,2/25/2025,1/9/2025,12/23/2024,F,"To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of proposal 1."
2318062,-1,"2025-05-02||89357L||To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal.||-1||-1",Z90062,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,5/2/2025,4/16/2025,4/3/2025,F,"To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal."
2238467,-1,"2025-02-25||89357L||To approve, (i) for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share by TransCode Therapeutics, Inc. upon exercise of the Series C and the Series D (together with the Series C Warrants, the ""Warrants""), (ii) a series of adjustments to the exercise price of the Warrants and an increase in the underlying Common Stock of the Warrants, (iii) an alternative cashless exercise feature in the Series D Warrants (iv) an adjustment to the exercise price and number of Warrants.||-1||-1",Z89155,"TRANSCODE THERAPEUTICS, INC.",BN,89357L,2/25/2025,1/9/2025,12/23/2024,F,"To approve, (i) for purposes of complying with Nasdaq Listing Rule 5635(d), the full issuance of shares of common stock, par value $0.0001 per share by TransCode Therapeutics, Inc. upon exercise of the Series C and the Series D (together with the Series C Warrants, the ""Warrants""), (ii) a series of adjustments to the exercise price of the Warrants and an increase in the underlying Common Stock of the Warrants, (iii) an alternative cashless exercise feature in the Series D Warrants (iv) an adjustment to the exercise price and number of Warrants."
2253643,-1,2025-04-24||89469A||Election of Director: Joseph E. Scalzo||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Election of Director: Joseph E. Scalzo
2253705,-1,2025-04-24||89469A||Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025.||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Ratification of the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2025.
2253875,-1,2025-04-24||89469A||Election of Director: Steven Oakland||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Election of Director: Steven Oakland
2254036,-1,2025-04-24||89469A||Election of Director: Jason T. Tyler||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Election of Director: Jason T. Tyler
2254191,-1,2025-04-24||89469A||Advisory vote to approve the Company's executive compensation.||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Advisory vote to approve the Company's executive compensation.
2252599,-1,2025-04-24||89469A||Election of Director: Adam J. DeWitt||-1||-1,P20243,"TREEHOUSE FOODS, INC.",SH,89469A,4/24/2025,3/20/2025,2/25/2025,F,Election of Director: Adam J. DeWitt
2253942,-1,2025-04-24||89469A||Stockholder proposal to implement a simple majority vote requirement in the Company's governance documents.||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Stockholder proposal to implement a simple majority vote requirement in the Company's governance documents.
2254192,-1,2025-04-24||89469A||Approval of an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by law.||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Approval of an amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers as permitted by law.
2254004,-1,2025-04-24||89469A||Election of Director: Linda K. Massman||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Election of Director: Linda K. Massman
2253847,-1,2025-04-24||89469A||Election of Director: Jill A. Rahman||-1||-1,P20123,"TREEHOUSE FOODS, INC.",BN,89469A,4/24/2025,3/19/2025,2/25/2025,F,Election of Director: Jill A. Rahman
2257972,-1,"2025-04-30||89677Y||To ratify the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"To ratify the selection of Deloitte & Touche LLP to serve as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
2257274,-1,"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Gilbert E. Ahye||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Gilbert E. Ahye"
2257477,-1,"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Steven P. Bird||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Steven P. Bird"
2257364,-1,"2025-04-30||89677Y||Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Kimberley H. Vogel||-1||-1",P25283,TRIPLEPOINT VENTURE GROWTH BDC CORP.,BN,89677Y,4/30/2025,3/17/2025,3/7/2025,F,"Election of Class II Director to serve until the 2028 Annual Meeting of the Company's stockholders, or until their respective successors are duly elected and qualified: Kimberley H. Vogel"
2247464,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Bruce L. Tanner||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Bruce L. Tanner
2247694,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Donna S. Morea||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Donna S. Morea
2248248,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Linnie M. Haynesworth||-1||-1,Z89233,TRUIST FINANCIAL CORPORATION,SH,89832Q,4/29/2025,3/28/2025,2/21/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Linnie M. Haynesworth
2247615,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Laurence Stein||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Laurence Stein
2247740,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Charles A. Patton||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Charles A. Patton
2247612,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Steven C. Voorhees||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Steven C. Voorhees
2247392,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Agnes Bundy Scanlan||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Agnes Bundy Scanlan
2247413,-1,"2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: K. David Boyer, Jr.||-1||-1",P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,"Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: K. David Boyer, Jr."
2247484,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Dallas S. Clement||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Dallas S. Clement
2247617,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Jennifer S. Banner||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Jennifer S. Banner
2248206,-1,2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Thomas E. Skains||-1||-1,Z89233,TRUIST FINANCIAL CORPORATION,SH,89832Q,4/29/2025,3/28/2025,2/21/2025,F,Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: Thomas E. Skains
2247692,-1,2025-04-29||89832Q||Ratification of the appointment of PricewaterhouseCoopers LLP as Truist's independent registered public accounting firm for 2025.||-1||-1,P24498,TRUIST FINANCIAL CORPORATION,BN,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Ratification of the appointment of PricewaterhouseCoopers LLP as Truist's independent registered public accounting firm for 2025.
2245879,-1,"2025-04-29||89832Q||Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: William H. Rogers, Jr.||-1||-1",P24482,TRUIST FINANCIAL CORPORATION,SH,89832Q,4/29/2025,3/24/2025,2/20/2025,F,"Election of Director for a one-year term expiring at the 2026 Annual Meeting of Shareholders: William H. Rogers, Jr."
2245965,-1,2025-04-29||89832Q||Advisory vote to approve Truist's executive compensation program.||-1||-1,P24482,TRUIST FINANCIAL CORPORATION,SH,89832Q,4/29/2025,3/24/2025,2/20/2025,F,Advisory vote to approve Truist's executive compensation program.
2239191,-1,"2025-02-05||90184D||To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the ""EIP"") to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the ""evergreen"" provision and make other amendments.||-1||-1",P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,F,"To approve an amendment and restatement of the Company's 2018 Equity Incentive Plan (the ""EIP"") to increase the number of shares of common stock reserved for issuance of awards under the EIP, eliminate the ""evergreen"" provision and make other amendments."
2239123,-1,"2025-02-05||90184D||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the ""Charter"") to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares.||-1||-1",P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation (the ""Charter"") to increase the number of shares of common stock of the Company authorized thereunder by an additional 100,000,000 shares."
2239217,-1,2025-02-05||90184D||To approve an amendment to the Charter to provide for officer exculpation.||-1||-1,P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,F,To approve an amendment to the Charter to provide for officer exculpation.
2239102,-1,"2025-02-05||90184D||To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025.||-1||-1",P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,F,"To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025."
-1,1294948,2025-02-05||90184D||01||Nelson Chan,P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,,
-1,1294974,2025-02-05||90184D||03||Melissa Starovasnik,P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,,
-1,1295010,2025-02-05||90184D||02||Robert Ragusa,P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,,
2239179,-1,"2025-02-05||90184D||To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under ""Executive Compensation.""||-1||-1",P22021,TWIST BIOSCIENCE CORPORATION,BN,90184D,2/5/2025,1/14/2025,12/27/2024,F,"To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under ""Executive Compensation."""
2232256,-1,2025-01-14||904708||Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Sergio A. Pupkin||-1||-1,P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Sergio A. Pupkin
2232303,-1,"2025-01-14||904708||Ratification of appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending August 30, 2025.||-1||-1",P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,"Ratification of appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending August 30, 2025."
2232238,-1,2025-01-14||904708||Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Cynthia Croatti||-1||-1,P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Cynthia Croatti
2232202,-1,2025-01-14||904708||Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Cecilia McKenney||-1||-1,P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,Election of Class III Director to serve for a term of three years until the 2028 Annual Meeting of Shareholders and until their respective successors are duly elected and qualified: Cecilia McKenney
2232278,-1,"2025-01-14||904708||Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers as more fully described in the accompanying Proxy Statement.||-1||-1",P20987,UNIFIRST CORPORATION,BN,904708,1/14/2025,12/9/2024,11/15/2024,F,"Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers as more fully described in the accompanying Proxy Statement."
2237529,-1,2025-04-15||913821||To approve the Charter Amendment.||-1||-1,S04126,"UNIVERSAL SECURITY INSTRUMENTS, INC.",BD,913821,4/15/2025,1/2/2025,12/19/2024,F,To approve the Charter Amendment.
2237526,-1,"2025-04-15||913821||To approve the Board's authority to adjourn or postpone the Special Meeting, if necessary.||-1||-1",S04126,"UNIVERSAL SECURITY INSTRUMENTS, INC.",BD,913821,4/15/2025,1/2/2025,12/19/2024,F,"To approve the Board's authority to adjourn or postpone the Special Meeting, if necessary."
2237565,-1,2025-04-15||913821||To approve the Asset Sale.||-1||-1,S04126,"UNIVERSAL SECURITY INSTRUMENTS, INC.",BD,913821,4/15/2025,1/2/2025,12/19/2024,F,To approve the Asset Sale.
2237531,-1,2025-04-15||913821||To approve the Dissolution.||-1||-1,S04126,"UNIVERSAL SECURITY INSTRUMENTS, INC.",BD,913821,4/15/2025,1/2/2025,12/19/2024,F,To approve the Dissolution.
2306749,-1,2025-05-02||917488||Election of Director to serve a three year term and until their successor is elected and qualified: Carrie Leigh||-1||-1,P27196,"UTAH MEDICAL PRODUCTS, INC.",BN,917488,5/2/2025,4/9/2025,3/3/2025,F,Election of Director to serve a three year term and until their successor is elected and qualified: Carrie Leigh
2306462,-1,"2025-05-02||917488||To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the year ending December 31, 2025.||-1||-1",P27196,"UTAH MEDICAL PRODUCTS, INC.",BN,917488,5/2/2025,4/9/2025,3/3/2025,F,"To ratify the selection of Haynie & Co. as the Company's independent registered public accounting firm for the year ending December 31, 2025."
2306680,-1,"2025-05-02||917488||To approve, by advisory vote, the Company's executive compensation program.||-1||-1",P27196,"UTAH MEDICAL PRODUCTS, INC.",BN,917488,5/2/2025,4/9/2025,3/3/2025,F,"To approve, by advisory vote, the Company's executive compensation program."
2231882,-1,2025-01-15||928251||Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Jatinder Dhaliwal||-1||-1,Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Jatinder Dhaliwal
2231776,-1,"2025-01-15||928251||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the BOD of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.00001 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-240, with the ratio within such Range to be determined at the discretion of the Board and included in a public announcement.||-1||-1",Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation, in substantially the form attached to the proxy statement as Annex A, to, at the discretion of the BOD of the Company, effect a reverse stock split with respect to the Company's issued and outstanding common stock, par value $0.00001 per share, including stock held by the Company as treasury shares, at a ratio of 1-for-2 to 1-for-240, with the ratio within such Range to be determined at the discretion of the Board and included in a public announcement."
2231777,-1,2025-01-15||928251||Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Jaydriane Panis||-1||-1,Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Jaydriane Panis
2231659,-1,2025-01-15||928251||Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Judy Su||-1||-1,Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Judy Su
2231739,-1,2025-01-15||928251||Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Katharyn Field||-1||-1,Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Katharyn Field
2231660,-1,"2025-01-15||928251||To approve an adjournment of the 2025 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the Director Proposal (the ""Adjournment Proposal"" or ""Proposal 3"").||-1||-1",Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,"To approve an adjournment of the 2025 Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of the Reverse Stock Split Proposal and/or the Director Proposal (the ""Adjournment Proposal"" or ""Proposal 3"")."
2231758,-1,2025-01-15||928251||Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Esha Randhawa||-1||-1,Z88995,"VIRPAX PHARMACEUTICALS, INC.",BN,928251,1/15/2025,12/13/2024,11/21/2024,F,Election of Director to hold office until our Annual Meeting of Stockholders to be held in 2025 or their respective successor is duly elected and qualified: Esha Randhawa
2291372,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Ellen H. Masterson||-1||-1,P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Ellen H. Masterson
2259596,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Brian O. Casey||-1||-1,P24825,"WESTWOOD HOLDINGS GROUP, INC.",SH,961765,4/30/2025,4/1/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Brian O. Casey
2290314,-1,"2025-04-30||961765||Ratification of the appointment of BDO USA, P.C. as Westwood's independent auditors for the year ending December 31, 2025.||-1||-1",P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,"Ratification of the appointment of BDO USA, P.C. as Westwood's independent auditors for the year ending December 31, 2025."
2259236,-1,"2025-04-30||961765||To cast a non-binding, advisory vote on Westwood's executive compensation.||-1||-1",P24825,"WESTWOOD HOLDINGS GROUP, INC.",SH,961765,4/30/2025,4/1/2025,3/3/2025,F,"To cast a non-binding, advisory vote on Westwood's executive compensation."
2291385,-1,"2025-04-30||961765||To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan.||-1||-1",P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,"To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan."
2291549,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Katherine Murray||-1||-1,P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Katherine Murray
2291475,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Randy A. Bowman||-1||-1,P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Randy A. Bowman
2259167,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: J. Hale Hoak||-1||-1,P24825,"WESTWOOD HOLDINGS GROUP, INC.",SH,961765,4/30/2025,4/1/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: J. Hale Hoak
2290807,-1,2025-04-30||961765||Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Geoffrey R. Norman||-1||-1,P24596,"WESTWOOD HOLDINGS GROUP, INC.",BN,961765,4/30/2025,4/2/2025,3/3/2025,F,Election of Director to hold office until the next Annual Meeting of stockholders and until their respective successors shall have been duly elected and qualified: Geoffrey R. Norman
2239059,-1,"2025-02-03||97382D||To approve an amendment to our Amended and Restated Windtree Therapeutics, Inc. 2020 Equity Incentive Plan to increase the number of shares of common stock, par value $0.001 per share, authorized for issuance under such plan from 41,010 shares to 1,141,010 shares.||-1||-1",S05496,"WINDTREE THERAPEUTICS, INC.",BN,97382D,2/3/2025,1/10/2025,12/20/2024,F,"To approve an amendment to our Amended and Restated Windtree Therapeutics, Inc. 2020 Equity Incentive Plan to increase the number of shares of common stock, par value $0.001 per share, authorized for issuance under such plan from 41,010 shares to 1,141,010 shares."
2239116,-1,"2025-02-03||97382D||To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of common stock, par value $0.001 per share by a ratio of any whole number between 1-for-5 and 1-for 50, the implementation and timing of which shall be subject to the discretion of the Board of Directors.||-1||-1",S05496,"WINDTREE THERAPEUTICS, INC.",BN,97382D,2/3/2025,1/10/2025,12/20/2024,F,"To approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our outstanding shares of common stock, par value $0.001 per share by a ratio of any whole number between 1-for-5 and 1-for 50, the implementation and timing of which shall be subject to the discretion of the Board of Directors."
2239212,-1,2025-02-03||97382D||To approve adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve Proposal 1 or Proposal 2 or to establish a quorum.||-1||-1,S05496,"WINDTREE THERAPEUTICS, INC.",BN,97382D,2/3/2025,1/10/2025,12/20/2024,F,To approve adjournment of the Special Meeting to the extent there are insufficient votes at the Special Meeting to approve Proposal 1 or Proposal 2 or to establish a quorum.
2288536,-1,"2025-04-17||98420X||To approve an adjournment of the Special Meeting, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes in favor of Proposal No. 1 (the Reverse Stock Split).||-1||-1",S11873,"X4 PHARMACEUTICALS, INC.",BN,98420X,4/17/2025,3/31/2025,3/13/2025,F,"To approve an adjournment of the Special Meeting, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes in favor of Proposal No. 1 (the Reverse Stock Split)."
2287097,-1,"2025-04-17||98420X||To approve an amendment to our Restated Certificate of Incorporation, as amended to combine outstanding shares of our common stock, par value $0.001 per share, into a lesser number of outstanding shares (the ""Reverse Stock Split""), by a ratio of not less than one-for-fifteen and not more than one-for-thirty, with the exact ratio to be set within this range by our board of directors in its sole discretion.||-1||-1",S11873,"X4 PHARMACEUTICALS, INC.",BN,98420X,4/17/2025,3/31/2025,3/13/2025,F,"To approve an amendment to our Restated Certificate of Incorporation, as amended to combine outstanding shares of our common stock, par value $0.001 per share, into a lesser number of outstanding shares (the ""Reverse Stock Split""), by a ratio of not less than one-for-fifteen and not more than one-for-thirty, with the exact ratio to be set within this range by our board of directors in its sole discretion."
2247096,-1,"2025-04-10||98420U||To adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the proposals at the Special Meeting.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the proposals at the Special Meeting."
2247247,-1,"2025-04-10||98420U||To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of the Company's common stock, underlying shares of Series G convertible preferred stock, Series A warrants & Series B warrants issued by the Company pursuant to that certain Securities Purchase Agreement, dated as of 1/14/2025, by & among the Company & the investors named therein, in an amount equal to or in excess of 20% of the Company's Common Stock outstanding immediately prior to the issuance of the Series G Preferred Stock and warrants.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To authorize, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of the Company's common stock, underlying shares of Series G convertible preferred stock, Series A warrants & Series B warrants issued by the Company pursuant to that certain Securities Purchase Agreement, dated as of 1/14/2025, by & among the Company & the investors named therein, in an amount equal to or in excess of 20% of the Company's Common Stock outstanding immediately prior to the issuance of the Series G Preferred Stock and warrants."
2247110,-1,"2025-04-10||98420U||To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the Board of Directors into two classes, with the directors in each class to serve staggered two-year terms.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to classify the Board of Directors into two classes, with the directors in each class to serve staggered two-year terms."
2246837,-1,"2025-04-10||98420U||To ratify the selection of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To ratify the selection of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025."
2247129,-1,"2025-04-10||98420U||To approve an amendment to the XWELL, Inc. 2020 Equity Incentive Plan (as amended, the ""2020 Plan"") to (i) increase the aggregate number of shares of Common Stock reserved for issuance under the 2020 Plan by 2,500,000 shares to a total of 3,125,000 shares and (ii) increase the maximum number of shares of Common Stock subject to awards granted during a single fiscal year to any director who is not an employee or consultant during the fiscal year to $750,000.||-1||-1",S09917,"XWELL, INC.",BN,98420U,4/10/2025,3/4/2025,2/14/2025,F,"To approve an amendment to the XWELL, Inc. 2020 Equity Incentive Plan (as amended, the ""2020 Plan"") to (i) increase the aggregate number of shares of Common Stock reserved for issuance under the 2020 Plan by 2,500,000 shares to a total of 3,125,000 shares and (ii) increase the maximum number of shares of Common Stock subject to awards granted during a single fiscal year to any director who is not an employee or consultant during the fiscal year to $750,000."
2259462,-1,"2025-05-01||98585X||Ratification of the appointment of PricewaterhouseCoopers LLP as YETI Holdings, Inc.'s independent registered public accounting firm for the fiscal year ending January 3, 2026.||-1||-1",P20958,"YETI HOLDINGS, INC.",BN,98585X,5/1/2025,3/21/2025,3/3/2025,F,"Ratification of the appointment of PricewaterhouseCoopers LLP as YETI Holdings, Inc.'s independent registered public accounting firm for the fiscal year ending January 3, 2026."
-1,1301253,2025-05-01||98585X||02||Frank D. Gibeau,P20958,"YETI HOLDINGS, INC.",BN,98585X,5/1/2025,3/21/2025,3/3/2025,,
-1,1301055,2025-05-01||98585X||01||Elizabeth L. Axelrod,P20958,"YETI HOLDINGS, INC.",BN,98585X,5/1/2025,3/21/2025,3/3/2025,,
-1,1301255,2025-05-01||98585X||03||Matthew J. Reintjes,P20958,"YETI HOLDINGS, INC.",BN,98585X,5/1/2025,3/21/2025,3/3/2025,,
2259232,-1,"2025-05-01||98585X||Approval, on an advisory basis, of the compensation paid to our named executive officers.||-1||-1",P20958,"YETI HOLDINGS, INC.",BN,98585X,5/1/2025,3/21/2025,3/3/2025,F,"Approval, on an advisory basis, of the compensation paid to our named executive officers."
2229947,-1,"2025-01-10||98980G||To approve on a non-binding, advisory basis, the compensation of our named executive officers.||-1||-1",P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,F,"To approve on a non-binding, advisory basis, the compensation of our named executive officers."
2230219,-1,"2025-01-10||98980G||To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending July 31, 2025.||-1||-1",P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,F,"To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending July 31, 2025."
-1,1290938,2025-01-10||98980G||03||Eileen Naughton,P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,,
2230196,-1,"2025-01-10||98980G||To approve an amendment and restatement of the Zscaler, Inc. FY2018 Equity Incentive Plan.||-1||-1",P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,F,"To approve an amendment and restatement of the Zscaler, Inc. FY2018 Equity Incentive Plan."
-1,1290924,2025-01-10||98980G||01||Karen Blasing,P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,,
-1,1291035,2025-01-10||98980G||02||Charles Giancarlo,P19619,"ZSCALER, INC.",BN,98980G,1/10/2025,12/3/2024,11/13/2024,,
2240729,-1,"2025-03-04||98987D||The approval of the issuance of up to an aggregate of 1,637,000 shares of the Company's common stock issuable upon the exercise of certain warrants to purchase the Company's common stock, in accordance with Nasdaq Listing Rule 5635(d).||-1||-1",S03116,"ZYVERSA THERAPEUTICS, INC.",BN,98987D,3/4/2025,1/23/2025,1/7/2025,F,"The approval of the issuance of up to an aggregate of 1,637,000 shares of the Company's common stock issuable upon the exercise of certain warrants to purchase the Company's common stock, in accordance with Nasdaq Listing Rule 5635(d)."
